Any feedback?
Information on EC 3.1.1.34 - lipoprotein lipase and Organism(s) Homo sapiens
for references in articles please use BRENDA:EC3.1.1.34Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
3.1.1.34 lipoprotein lipaseIUBMB Comments
Hydrolyses triacylglycerols and diacylglycerol in chylomicrons and low-density lipoprotein particles. Human protein purified from post-heparin plasma (LPL) shows no activity against triglyceride in the absence of added lipoprotein. The principal reaction sequence of that enzyme is triglyceride -> 1,2-diglyceride -> 2-monoglyceride. The hepatic enzyme (LIPC) also hydrolyses triglycerides and phospholipids present in circulating plasma lipoproteins.
Specify your search results
Word Map
- 3.1.1.34
- triglyceride
- cholesterol
-
apolipoproteins
- hdl
- adipocytes
- hypertriglyceridemia
-
lipolysis
-
high-density
-
low-density
- peroxisome
- obesity
- atherosclerosis
- triacylglycerols
- chylomicron
- cardiovascular
-
proliferator-activated
-
post-heparin
- coronary
- milk
-
triglyceride-rich
-
obese
-
remnant
-
postprandial
-
atherogenic
-
high-fat
- hyperlipidemia
- dyslipidemia
-
ppars
- lipases
-
very-low-density
- hyperlipoproteinemia
- preadipocytes
-
lipogenesis
-
depot
-
angiopoietin-like
- epididymal
- leptin
-
normolipidemic
-
adipogenic
-
hormone-sensitive
-
hdl-cholesterol
-
heparin-sepharose
- nefas
-
lecithin:cholesterol
- triolein
- medicine
- intralipid
- synthesis
-
perirenal
- pvuii
-
lipoprotein-cholesterol
- emulsions
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria
Synonyms
lipoprotein lipase, adipose tissue lpl, dag lipase, diglyceride lipase, clearing factor, postheparin lipase, postheparin esterase, placental lipoprotein lipase, diacylglycerol hydrolase, triacylglycero-protein acylhydrolase, 
more
topPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYNONYM 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
clearing factor
-
-
-
-
diacylglycerol hydrolase
-
-
-
-
diacylglycerol lipase
-
-
-
-
diglyceride lipase
-
-
-
-
lipemia-clearing factor
-
-
-
-
LPL
postheparin esterase
-
-
-
-
postheparin lipase
-
-
-
-
LPL
-
-
-
-
LPL
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
hydrolysis of carboxylic ester
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYSTEMATIC NAME
IUBMB Comments
triacylglycero-protein acylhydrolase
Hydrolyses triacylglycerols and diacylglycerol in chylomicrons and low-density lipoprotein particles. Human protein purified from post-heparin plasma (LPL) shows no activity against triglyceride in the absence of added lipoprotein. The principal reaction sequence of that enzyme is triglyceride -> 1,2-diglyceride -> 2-monoglyceride. The hepatic enzyme (LIPC) also hydrolyses triglycerides and phospholipids present in circulating plasma lipoproteins.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CAS REGISTRY NUMBER
COMMENTARY
9004-02-8
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
1,2-di-O-lauryl-rac-glycero-3-(glutaric acid 6-methylresorufin ester) + H2O
?
DGGR, a synthetic substrate that produces a fluorescent signal upon hydrolysis
-
-
?
1,2-O-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester + H2O
?
-
-
-
-
?
triolein + H2O
dioleylglycerol + oleate
-
mutant D204 E, very low activity in presence of emulsifier Triton X-100 or phosphatidylcholine. In presence of phosphatidylethenolamine, phospatidylserine, and cardiolipin as emulsifier, triolein-hydrolizing activity of the mutant is higher than wild-type activity
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
-
-
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
-
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
catalyzes the hydrolysis of triglycerides in circulating chylomicrons and very-low density lipoproteins
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
lipoproteins with high triglyceride
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
a 14C-triolein phosphatidylcholine-stabilized substrate containing ApoC2 is used for in vitro enzyme activity assays
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
from chylomicrons, lipoproteins isolated from human blood
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
the lipase substrate used is plasma or VLDL with or without added ligands, enzyme source is postheparin plasma, lipoproteins with high triglyceride
-
-
?
triolein + H2O
oleate + diolein
-
-
-
-
?
additional information
?
-
-
plays a key role in the metabolism of the triglyceride-rich lipoproteins, namely chylomicrons and very-low-density lipoproteins
-
-
?
additional information
?
-
-
plays a key role in the metabolism of the triglyceride-rich lipoproteins, namely chylomicrons and very-low-density lipoproteins
-
-
?
additional information
?
-
-
lipoprotein lipase mediates hepatitis C virus cell entry and inhibits HCV infection
-
-
?
additional information
?
-
-
the enzyme shows no activity toward cholesterol and high-density lipoprotein
-
-
?
additional information
?
-
tic activity of cell-surface heparin-released LPL is measured using a phospholipid (PL)/3H-triolein substrate with human serum as a source of ApoC2
-
-
?
additional information
?
-
-
tic activity of cell-surface heparin-released LPL is measured using a phospholipid (PL)/3H-triolein substrate with human serum as a source of ApoC2
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
triacylglycerol + H2O
diacylglycerol + a carboxylate
-
-
-
?
triacylglycerol + H2O
diacylglycerol + a carboxylate
lipoproteins with high triglyceride
-
-
?
additional information
?
-
-
plays a key role in the metabolism of the triglyceride-rich lipoproteins, namely chylomicrons and very-low-density lipoproteins
-
-
?
additional information
?
-
-
plays a key role in the metabolism of the triglyceride-rich lipoproteins, namely chylomicrons and very-low-density lipoproteins
-
-
?
additional information
?
-
-
lipoprotein lipase mediates hepatitis C virus cell entry and inhibits HCV infection
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
COFACTOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
3-[4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)biphenyl-3-yl]propanoic acid
-
4-tert-butyl-N-[4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3(2H)-yl)phenyl]benzamide
-
ethanol
inhibits the enzyme, LPL activity is reduced by 23-25% 2-4 hours after the administration of alcohol, respectively, with respect to controls, in vivo or in post-heparin plasma. The concentrations of inhibitors ANGPTL3 and ANGPTL4 drops to 67% and 86% of baseline values, respectively, at 280 min after alcohol consumption. The acute effects of alcohol consumption, especially on postprandial lipemia, seem to be accentuated in hypertriglyceridemic subjects
angiopoietin-like protein 3
-
mainly exhibits reversible inhibition of the catalytic activity of LPL, heparin is able to overcome the inhibitory effect of angiopoietin-like protein 3 on LPL at a concentration as low as 0.8 units/ml
-
angiopoietin-like protein 3
ANGPTL3 causes reduction of the activity of LPL via a two-step mechanism
-
angiopoietin-like protein 3
ANGPTL3 inhibits the enzyme. The concentrations of inhibitor ANGPTL3 drops to 67% of baseline value at 280 min after alcohol consumption
-
angiopoietin-like protein 4
-
heparin is not able to overcome the inhibitory effect of angiopoietin-like protein 4 on LPL at concentrations up to 10 units/ml
-
angiopoietin-like protein 4
ANGPTL4, ANGPTL4 inhibits LPL by a noncompetitive mechanism, unaltered in the presence or absence of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1), inhibits wild-type and mutant LPLS447X enzymes to the same extent
-
angiopoietin-like protein 4
ANGPTL4 causes reduction of the activity of LPL via a two-step mechanism. The N-terminal coiled-coil domain of human ANGPTL4, residues 26-184, is expressed in Escherichia coli and purified
-
angiopoietin-like protein 4
ANGPTL4 inhibits the enzyme. The concentrations of inhibitor ANGPTL4 drops to 86% of baseline value at 280 min after alcohol consumption
-
apoC-III
derived from chylomicrons of a patient with severe hypertriglyceridemia, inhibits wild-type and enzyme mutant LPLS447X
-
additional information
-
LPL activity in post-heparin normal human plasma is suppressed following co-incubation with 0.02 mg/ml cyclosporin A for 90 min, LPL activity in post-heparin normal human plasma is suppressed following co-incubation with 20 ng/ml rapamycin for 90 min, LPL activity in post-heparin normal human plasma is suppressed following co-incubation with 20 ng/ml tacrolimus for 90 min, LPL activity in post-heparin normal human plasma is suppressed following co-incubation with 0.01 mg/ml mycophenolate mofetil for 90 min
-
additional information
-
polyaspartate, polyglutamate and a a rabbit antiserum against the acidic domain of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) block the binding of LPL to GPIHBP1
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
heparin
-
heparin treatment results in an 11.75fold increase of LPL in the cell culture medium
apoC-II
derived from chylomicrons of a patient with severe hypertriglyceridemia, activates wild-type and enzyme mutant LPLS447X
-
additional information
-
2.4 higher LPL activity in patients treated with prednisolone is most probably due to an increase in the active dimeric form of LPL
-
additional information
-
lipoprotein lipase is upregulated at the transcriptional/translational level in patients with mucoskeletal sarcoma
-
additional information
-
LpL is regulated by feeding/fasting and muscle contraction, insulin stimulates LpL by increasing the level of LpL mRNA and regulating LpL activity through both posttranscriptional and posttranslational mechanisms
-
additional information
-
treatment of macrophages with native C-reactive protein increases LPL protein expression and secretion in a dose- and time-dependent manner with maximum stimulatory effect at 0.003 mg/ml, incubation of LPL with vitamin E (0.05 mM) or NAC (10 mM) prevents the stimulatory effect of C-reactive protein on LPL
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abetalipoproteinemia
Apoproteins of human serum high density lipoproteins. Isolation and characterization of the peptides of Sephadex fraction V from normal subjects and patients with abeta-lipoproteinemia.
Abetalipoproteinemia
Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia.
Abetalipoproteinemia
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Acne Vulgaris
Decreased eicosapentaenoic acid levels in acne vulgaris reveals the presence of a proinflammatory state.
Acquired Immunodeficiency Syndrome
Effect of fasting on free fatty acid, glycerol and cholesterol concentrations in blood plasma and lipoprotein lipase activity in adipose tissue of cattle.
Acquired Immunodeficiency Syndrome
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.
Acquired Immunodeficiency Syndrome
Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Acromegaly
Effects of acromegaly treatment and growth hormone on adipose tissue lipoprotein lipase.
Acute Coronary Syndrome
[The relation of the activity of postheparin lipoprotein lipase with the CBC parameters in patients with acute coronary syndrome]
Acute Kidney Injury
Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.
Adenocarcinoma
[Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma]
Adenocarcinoma of Lung
Expression of lipoprotein lipase associated with lung adenocarcinoma tissues.
Adiposis Dolorosa
Fat-cell heat production, adipose tissue fatty acids, lipoprotein lipase activity and plasma lipoproteins in adiposis dolorosa.
Albuminuria
Release of endothelium-associated proteins into blood by injection of heparin in normal subjects and in patients with Type 1 diabetes.
Alzheimer Disease
A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Alzheimer Disease
Apolipoprotein E3Basel: new insights into a highly conserved protein region.
Alzheimer Disease
Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer's Disease Risk.
Alzheimer Disease
Implication of lipid metabolism disturbance and Alzheimer's disease: focus on the lipoprotein lipase plays an important role in learning and memory function.
Alzheimer Disease
Intermittent Fasting Alleviates the Increase of Lipoprotein Lipase Expression in Brain of a Mouse Model of Alzheimer's Disease: Possibly Mediated by ?-hydroxybutyrate.
Alzheimer Disease
Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease.
Alzheimer Disease
Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus in Alzheimer's disease brain.
Alzheimer Disease
Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.
Alzheimer Disease
Meta-analyses of four polymorphisms of lipoprotein lipase associated with the risk of Alzheimer's disease.
Alzheimer Disease
No association between the lipoprotein lipase S447X polymorphism and Alzheimer's disease.
Alzheimer Disease
Roles for lipoprotein lipase in Alzheimer's disease: an association study.
Alzheimer Disease
The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease.
Amyloidosis
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Anemia
Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.
Anemia
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Anemia
Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.
Anemia, Sickle Cell
Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.
Aneurysm
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Angina Pectoris
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group.
Angina, Stable
[Connection of HindIII-polymorphism in the lipoprotein lipase gene with myocardial infarct and life span in elderly ischemic heart disease patients]
Aortic Valve Stenosis
Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling.
Arteriosclerosis
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Arteriosclerosis
Relationship between a glycoprotein acting as lipoprotein lipase inhibitor and arteriosclerosis.
Arteriosclerosis
[Clearing factor and heparin in the blood of patients with arteriosclerosis and the influence of iodine therapy on these indices.]
Arthritis
Suppression of up-regulated LXR? by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.
Arthritis, Rheumatoid
Active-dimeric form of lipoprotein lipase increases in the adipose tissue of patients with rheumatoid arthritis treated with prednisolone.
Arthritis, Rheumatoid
Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis.
Ascorbic Acid Deficiency
Hyperlipidemia in guinea-pigs induced by ascorbic acid deficiency. The effects of cholesterol, DL-ethionine and aflatoxin.
Ascorbic Acid Deficiency
Wide variations of plasma triglyceride concentrations in guinea pigs.
Atherosclerosis
A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis.
Atherosclerosis
A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages.
Atherosclerosis
A lipoprotein lipase activator, NO-1886 prevents impaired endothelium-dependent relaxation of aorta caused by exercise in aged rats.
Atherosclerosis
A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging.
Atherosclerosis
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis.
Atherosclerosis
A novel Lipoprotein lipase (LPL) agonist rescues the enzyme from inhibition by angiopoietin-like 4 (ANGPTL4).
Atherosclerosis
A novel role of Sp1 and Sp3 in the interferon-gamma -mediated suppression of macrophage lipoprotein lipase gene transcription.
Atherosclerosis
A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins.
Atherosclerosis
Adeno-associated virus LPL(S447X) gene therapy in LDL receptor knockout mice.
Atherosclerosis
Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression.
Atherosclerosis
Altered lipid profile, postheparin lipolytic activity, and xanthoma of choroid plexus in vasectomized rabbits fed an atherogenic diet.
Atherosclerosis
Analysis and lipoprotein lipase activation capacity of plasma lipoproteins isolated from atherosclerosis-susceptible White Carneau pigeon and atherosclerosis-resistant Show Racer pigeon.
Atherosclerosis
Angiopoietin-like 4: A double-edged sword in atherosclerosis and ischemic stroke?
Atherosclerosis
Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
Atherosclerosis
Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Atherosclerosis
Apelin-13 inhibits lipoprotein lipase expression via the APJ/PKC?/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells.
Atherosclerosis
Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
Atherosclerosis
Assessment of lipoprotein lipase activity in patients with atherosclerosis and nonspecific pulmonary diseases.
Atherosclerosis
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Atherosclerosis
Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.
Atherosclerosis
Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Atherosclerosis
Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.
Atherosclerosis
Can lipoprotein lipase be the culprit in cholesteryl ester accretion in smooth muscle cells in atheroma?
Atherosclerosis
Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
Atherosclerosis
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4.
Atherosclerosis
Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression.
Atherosclerosis
Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes.
Atherosclerosis
Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis.
Atherosclerosis
COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity.
Atherosclerosis
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Atherosclerosis
Corrigendum to: "Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo" [Atherosclerosis Volume 289, (October 2019), Pages 143-161].
Atherosclerosis
Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques.
Atherosclerosis
Dietary cholesterol reduces lipoprotein lipase activity in the atherosclerosis-susceptible Bio F(1)B hamster.
Atherosclerosis
Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines.
Atherosclerosis
Effect of dietary sucrose and cholesterol on atherosclerosis, liver malate dehydrogenase and plasma lipoprotein lipase levels in pigeons.
Atherosclerosis
Effect of the calcium channel antagonist nitrendipine on lipoprotein lipase and hepatic lipase in the normal rat.
Atherosclerosis
Effects of a liquid high-fat meal on postprandial lipid metabolism in type 2 diabetic patients with abdominal obesity.
Atherosclerosis
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
Atherosclerosis
Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits.
Atherosclerosis
EFFECTS OF ORAL CHONDROITIN SULFATE ON LIPID AND ANTIOXIDANT METABOLISMS IN RATS FED A HIGH-FAT DIET
Atherosclerosis
Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte-derived macrophages.
Atherosclerosis
Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits.
Atherosclerosis
Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase.
Atherosclerosis
Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
Atherosclerosis
Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice.
Atherosclerosis
Enhanced lipoprotein lipase secretion and foam cell formation by macrophages of patients with growth hormone deficiency: possible contribution to increased risk of atherogenesis?
Atherosclerosis
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Atherosclerosis
Fibrinogen-coated chylomicrons in gastrointestinal lymph: a new rationale regarding the arterial deposition of postprandial lipids.
Atherosclerosis
Folic acid and lipoprotein lipase from aorta and blood plasma of atherosclerotic rats.
Atherosclerosis
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Atherosclerosis
Haplotypes in the lipoprotein lipase gene influence fasting insulin and discovery of a new risk haplotype.
Atherosclerosis
Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts.
Atherosclerosis
HDL Cholesterol - Third Annual International Conference. Metabolic Pathways and Drug Development. 25-26 February 2002, Boston, MA, USA.
Atherosclerosis
High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis.
Atherosclerosis
High myocardial and low hepatic lipoprotein lipase activities responsible for the initiation of atherosclerosis.
Atherosclerosis
High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis.
Atherosclerosis
HindIII DNA polymorphism in the lipoprotein lipase gene and plasma lipid phenotypes and carotid artery atherosclerosis.
Atherosclerosis
Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models.
Atherosclerosis
Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.
Atherosclerosis
Involvement of both the tyrosine kinase and the phosphatidylinositol-3' kinase signal transduction pathways in the regulation of lipoprotein lipase expression in J774.2 macrophages by cytokines and lipopolysaccharide.
Atherosclerosis
Krüppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated down-regulation of lipoprotein lipase expression in vivo.
Atherosclerosis
Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C.
Atherosclerosis
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.
Atherosclerosis
Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.
Atherosclerosis
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.
Atherosclerosis
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
Atherosclerosis
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).
Atherosclerosis
Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.
Atherosclerosis
Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages.
Atherosclerosis
Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts.
Atherosclerosis
Lipoprotein lipase secretion by human monocytes and rabbit alveolar macrophages in culture.
Atherosclerosis
Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies.
Atherosclerosis
Lipoprotein lipase: Biosynthesis, regulatory factors, and its role in atherosclerosis and other diseases.
Atherosclerosis
Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.
Atherosclerosis
Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.
Atherosclerosis
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice.
Atherosclerosis
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo.
Atherosclerosis
Macrophage-derived lipoprotein lipase increases aortic atherosclerosis in cholesterol-fed Tg rabbits.
Atherosclerosis
Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein e knockout mice but not in C57BL/6 mice.
Atherosclerosis
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions.
Atherosclerosis
Marked neointimal lipoprotein lipase increase in distinct models of proclivity to atherosclerosis: a feature independent of endothelial layer integrity.
Atherosclerosis
Mechanisms of atherogenesis: endothelial hypoxia proposed as the major initiator.
Atherosclerosis
MicroRNA-182 Promotes Lipoprotein Lipase Expression and Atherogenesisby Targeting Histone Deacetylase 9 in Apolipoprotein E-Knockout Mice.
Atherosclerosis
MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Atherosclerosis
MicroRNA-590 attenuates lipid accumulation and pro-inflammatory cytokine secretion by targeting lipoprotein lipase gene in human THP-1 macrophages.
Atherosclerosis
MicroRNA-590 Inhibits Lipoprotein Lipase Expression and Prevents Atherosclerosis in apoE Knockout Mice.
Atherosclerosis
Mild oxidation of lipoproteins increases their affinity for surfaces covered by heparan sulfate and lipoprotein lipase.
Atherosclerosis
MiR-27 alleviates myocardial cell damage induced by hypoxia/reoxygenation via targeting TGFBR1 and inhibiting NF-?B pathway.
Atherosclerosis
New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis.
Atherosclerosis
No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61-->stop) in the lipoprotein lipase gene.
Atherosclerosis
Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis.
Atherosclerosis
On hepatic and extrahepatic postheparin serum lipase activities and the influence of experimental hypercortisolism and diabetes on these activities.
Atherosclerosis
Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice.
Atherosclerosis
Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits.
Atherosclerosis
Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis.
Atherosclerosis
Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis.
Atherosclerosis
Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial.
Atherosclerosis
PdPt nanoparticles anchored on the N-G with the integration of PANI nanohybrids as novel redox probe and catalyst for the detection of rs1801177.
Atherosclerosis
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis.
Atherosclerosis
Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
Atherosclerosis
Presence of lipoprotein lipase S447X stop codon affects the magnitude of interleukin 8 release after cardiac surgery with cardiopulmonary bypass.
Atherosclerosis
Recent advances in factors that alter lipid metabolism in chronic renal failure.
Atherosclerosis
Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase.
Atherosclerosis
Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer.
Atherosclerosis
Role of lipoprotein lipase and apolipoprotein E secretion by macrophages in modulating lipoprotein uptake. Possible role in acceleration of atherosclerosis in diabetes.
Atherosclerosis
Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis.
Atherosclerosis
Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production.
Atherosclerosis
Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.
Atherosclerosis
Synergism between interferon gamma and tumour necrosis factor alpha in the regulation of lipoprotein lipase in the macrophage J774.2 cell line.
Atherosclerosis
Synergism between lipopolysaccharide and interferon gamma in the regulation of lipoprotein lipase in macrophages.
Atherosclerosis
The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity.
Atherosclerosis
The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models.
Atherosclerosis
The histochemistry of lipoprotein lipase in the normal organism and in atherosclerosis.
Atherosclerosis
The long non-coding RNA metastasis-associated lung adenocarcinoma transcript-1 regulates CCDC80 expression by targeting miR-141-3p/miR-200a-3p in vascular smooth muscle cells.
Atherosclerosis
The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.
Atherosclerosis
The therapeutic role of very low-density lipoprotein receptor gene in hyperlipidemia in type 2 diabetic rats.
Atherosclerosis
THP-1 macrophage cholesterol efflux is impaired by palmitoleate through Akt activation.
Atherosclerosis
Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice.
Atherosclerosis
Transcriptomic Analysis of THP-1 Macrophages Exposed to Lipoprotein Hydrolysis Products Generated by Lipoprotein Lipase.
Atherosclerosis
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors.
Atherosclerosis
Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
Atherosclerosis
Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?
Atherosclerosis
[Activity of lipoprotein lipase and other lipolytic enzymes in experimental atherosclerosis in rabbits]
Atherosclerosis
[Age characteristics of lipoprotein lipase activity and cholesterol levels in various lipoprotein fractions]
Atherosclerosis
[Blood lipoprotein lipase in normal rabbits and during the development of experimental atherosclerosis and the effect of zinc salts on lipase activity]
Atherosclerosis
[Clearing factor of blood plasma after heparin in relation to atherosclerosis.]
Atherosclerosis
[Effect of nicotinic acid on blood coagulation, blood heparin content and clearing factor in patients with atherosclerosis.]
Atherosclerosis
[HEPARIN, LIPOPROTEIN LIPASE AND BLOOD FIBRINOLYTIC ACTIVITY IN PATIENTS WITH ATHEROSCLEROSIS DURING IODINE PREPARATION TREATMENT.]
Atherosclerosis
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Atherosclerosis
[Lipoprotein lipase fractionation of very low density serum lipoproteins from healthy subjects and persons afflicted with atherosclerosis]
Atherosclerosis
[Lipoprotein lipase gene polymorphism in non-insulin-dependent diabetics: preliminary study]
Atherosclerosis
[ON SEMEIOLOGIC AND PHYSIOPATHOLOGIC SIGNIFICANCE OF TESTS OF HEPARIN STIMULATION OF THE CLEARING FACTOR IN ATHEROSCLEROSIS.]
Atherosclerosis
[Views on the pathogenesis of atherosclerosis in connection with the clearing factor in blood coagulation.]
Bacterial Infections
Antimicrobial peptides of an anti-lipopolysaccharide factor, epinecidin-1, and hepcidin reduce the lethality of Riemerella anatipestifer sepsis in ducks.
Bardet-Biedl Syndrome
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Biotinidase Deficiency
Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.
Bone Resorption
Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats.
Brachydactyly
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Brain Diseases
Severe Familial Hypertriglyceridemia: Successful Treatment With Insulin and a Modified Meal Plan.
Brain Infarction
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.
Brain Ischemia
Lipoprotein lipase and endothelial lipase expression in mouse brain: regional distribution and selective induction following kainic acid-induced lesion and focal cerebral ischemia.
Breast Neoplasms
Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells.
Breast Neoplasms
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Breast Neoplasms
Spot 14: A marker of aggressive breast cancer and a potential therapeutic target.
Bronchopneumonia
The involvement of polymorphonuclear leukocytes in the pathogenesis of bronchopneumonia in calves. VI. Superoxide dismutase and lipoprotein lipase activities.
Carcinoma
Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus.
Carcinoma
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Carcinoma
Reduction of synthetic rate of lipoprotein lipase in adipose tissues of patients with carcinoma.
Carcinoma
The biochemical alterations following administration of Kalpaamruthaa and Semecarpus anacardium in mammary carcinoma.
Carcinoma
[Elective induction in mice of solid and ascitic carcinoma of the exocrine pancreas by the repeated doses of antibodies against a lipoprotein lipase fraction]
Carcinoma 256, Walker
Low-density lipoproteins and lipoprotein lipase activity in tissues from rats bearing Walker carcinosarcoma 256.
Carcinoma 256, Walker
Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256.
Carcinoma, Ehrlich Tumor
Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.
Carcinoma, Ehrlich Tumor
Release of lipoprotein lipase from Ehrlich ascites tumor produced by an association with a rapid increase in cyclic AMP content.
Carcinoma, Ehrlich Tumor
Stimulatory release of lipoprotein lipase activity with activation of protein tyrosine kinase produced by low molecular weight dextran sulfate in Ehrlich ascites tumor cells.
Carcinoma, Hepatocellular
alpha-Adrenergic receptors may contribute to the hypertriglyceridemia associated with tumour growth.
Carcinoma, Hepatocellular
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.
Carcinoma, Hepatocellular
Comparison of the changes in lipid metabolism between hepatoma-bearing and lipopolysaccharide-treated rats.
Carcinoma, Hepatocellular
Effects of sulfur amino acids, L: -methionine, L: -cystine and L: -cysteine on lipoprotein lipase and hormone-sensitive lipase in differentiated mouse 3T3-L1 adipocytes.
Carcinoma, Hepatocellular
Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
Carcinoma, Hepatocellular
Lipoprotein lipase expression in undifferentiated hepatoma cells is regulated by progesterone and protein kinase A.
Carcinoma, Hepatocellular
Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats.
Carcinoma, Hepatocellular
The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2.
Carcinoma, Non-Small-Cell Lung
Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity.
Carcinoma, Non-Small-Cell Lung
Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Carcinoma, Non-Small-Cell Lung
Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.
Carcinoma, Non-Small-Cell Lung
Reply: Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Carcinoma, Squamous Cell
Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus.
Carcinosarcoma
Low-density lipoproteins and lipoprotein lipase activity in tissues from rats bearing Walker carcinosarcoma 256.
Carcinosarcoma
Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256.
Cardiomegaly
Cold acclimation induces physiological cardiac hypertrophy and increases assimilation of triacylglycerol metabolism through lipoprotein lipase.
Cardiomegaly
Endothelial Lipase Modulates Pressure Overload-Induced Heart Failure Through Alternative Pathway for Fatty Acid Uptake.
Cardiomegaly
Ketamine-induced changes in metabolic and endocrine parameters of normal and 2-kidney 1-clip rats.
Cardiomyopathies
Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
Cardiomyopathies
Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.
Cardiomyopathies
Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy.
Cardiomyopathies
Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
Cardiomyopathies
Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
Cardiomyopathy, Dilated
Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
Cardiovascular Diseases
A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia.
Cardiovascular Diseases
Angiopoietin-like Protein 4 Inhibition of Lipoprotein Lipase: EVIDENCE FOR REVERSIBLE COMPLEX FORMATION.
Cardiovascular Diseases
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins.
Cardiovascular Diseases
Association between lipoprotein lipase gene polymorphisms and cardiovascular disease risk factors in European adolescents: The Healthy Lifestyle in Europe by Nutrition in Adolescence study.
Cardiovascular Diseases
Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels.
Cardiovascular Diseases
Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
Cardiovascular Diseases
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
Cardiovascular Diseases
Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance.
Cardiovascular Diseases
Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.
Cardiovascular Diseases
DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene.
Cardiovascular Diseases
Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.
Cardiovascular Diseases
Ethanol consumption affects lipoprotein lipase gene expression in C57BL/6 mice.
Cardiovascular Diseases
Functional variants in the lipoprotein lipase gene and risk cardiovascular disease.
Cardiovascular Diseases
Interaction Effects of Lipoprotein Lipase Polymorphisms with Lifestyle on Lipid Levels in a Korean Population: A Cross-sectional Study.
Cardiovascular Diseases
Lipoprotein lipase 1595 c/g and hepatic lipase -480 c/t polymorphisms--impact on lipid profile in incident dialysis patients.
Cardiovascular Diseases
Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk.
Cardiovascular Diseases
Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease.
Cardiovascular Diseases
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Cardiovascular Diseases
Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease.
Cardiovascular Diseases
Triglyceride-lowering LPL alleles combined with LDL-C-lowering alleles are associated with an additively improved lipoprotein profile.
Cardiovascular Diseases
Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease.
Cardiovascular Diseases
[Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity.]
Cardiovascular Diseases
[Lipoprotein lipase gene polymorphism in non-insulin-dependent diabetics: preliminary study]
Carotid Artery Diseases
Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
Carotid Stenosis
Association between well-characterized lipoprotein-related genetic variants and carotid intimal medial thickness and stenosis: The Framingham Heart Study.
Carotid Stenosis
Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque.
Carotid Stenosis
Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis.
Carotid Stenosis
[Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction]
Cataract
Suppression of hyperlipidemia-associated cataracts in diabetic rats with the lipoprotein lipase activator NO-1886.
Cerebral Hemorrhage
Lipoprotein lipase gene Hind III polymorphism was associated with hemorrhagic stroke.
Cerebral Hemorrhage
Relationship between lipoprotein lipase gene polymorphism and hemorrhagic stroke in a Chinese population.
Cerebral Infarction
Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese.
Cerebral Infarction
Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese.
Cerebral Infarction
The D9N, N291S, and T495G Polymorphisms of the Lipoprotein Lipase Gene Are Not Associated with Cerebral Infarction.
Cerebral Infarction
[Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction]
Cerebral Infarction
[Effect of intravenous glucose load on post-heparin lipoprotein lipase and hepatic lipase activities in the plasma of patients with cerebral infarction]
Cerebrovascular Disorders
A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men.
Cerebrovascular Disorders
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.
Cerebrovascular Disorders
Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients.
Cerebrovascular Disorders
Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism.
Cerebrovascular Disorders
Lipoprotein lipase genetic variation and gender-specific ischemic cerebrovascular disease risk.
Cerebrovascular Disorders
The D9N, N291S, and T495G Polymorphisms of the Lipoprotein Lipase Gene Are Not Associated with Cerebral Infarction.
Chagas Disease
[Activity of lipoprotein lipase in vivo in the chronic form of Chagas' disease]
Chemical and Drug Induced Liver Injury
[THE BLOOD CLEARING FACTOR IN ACUTE EXPERIMENTAL TOXIC HEPATITIS.]
Cholera
Cold-induced beta-adrenergic recruitment of lipoprotein lipase in brown fat is due to increased transcription.
Cholera
Effect of cholera toxin on triacylglycerol lipase activity and triacylglycerol content of rat heart.
Cholera
Effects of cholera toxin on gene expression in brown preadipocytes differentiating in culture.
Cholera
Lipoprotein lipase activity in cultured macrophage cell line J774(2) and its increase in variants deficient in adenylate cyclase and cyclic AMP-dependent protein kinase.
Cholera
Modulation of lipoprotein lipase activity in cultured rat mesenchymal heart cells and preadipocytes by dibutyryl cyclic AMP, cholera toxin and 3-isobutyl-1-methylxanthine.
Cholera
Modulation of lipoprotein lipase in the intact rat by cholera toxin--an irreversible agonist of cyclic AMP.
Cholera
Regulation of lipoprotein lipase activity in the sand rat: effect of nutritional state and cAMP modulation.
Cholera
Regulation of lipoprotein lipase by dibutyryl cAMP, cholera toxin, Hepes and heparin in F1 heart-cell cultures.
Cholera
Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
Cholestasis
Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis.
Cholestasis, Intrahepatic
Lipoprotein lipase and lipid profiles in plasma and placenta from normal pregnancies compared with patients with intrahepatic cholestasis of pregnancy.
Cholesterol Ester Storage Disease
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Chronic Urticaria
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
Chylous Ascites
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
Coinfection
Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia.
Coinfection
Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Coinfection
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Colonic Neoplasms
Changes in activity of lipoprotein lipase, plasma free fatty acids and triglycerides with weight loss in a cachexia model.
Communicable Diseases
Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins.
Congenital Abnormalities
[Congenital defects of post-heparin lipoprotein lipase. Diagnosis of familial combined lipoproteinemia]
Coronary Artery Disease
Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease.
Coronary Artery Disease
Analysis of gene-environment interaction in coronary artery disease: lipoprotein lipase and smoking as examples.
Coronary Artery Disease
Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci.
Coronary Artery Disease
Association between HindIII (rs320) variant in the lipoprotein lipase gene and the presence of coronary artery disease and stroke among the Saudi population.
Coronary Artery Disease
Association of lipoprotein lipase gene polymorphisms with coronary artery disease among Filipinos.
Coronary Artery Disease
Association of lipoprotein lipase gene polymorphisms with coronary artery disease.
Coronary Artery Disease
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Coronary Artery Disease
Association of PvuII polymorphism in the lipoprotein lipase gene with the coronary artery disease in Macedonian population.
Coronary Artery Disease
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
Coronary Artery Disease
Association of Three Lipoprotein Lipase Polymorphisms with Coronary Artery Disease in Chinese and Asian Indians.
Coronary Artery Disease
Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.
Coronary Artery Disease
Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population.
Coronary Artery Disease
Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Coronary Artery Disease
Associations of lipoprotein lipase S447X and apolipoprotein E genotypes with low-density lipoprotein subfractions in Turkish patients with coronary artery disease.
Coronary Artery Disease
Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease.
Coronary Artery Disease
Cholesterol ester transfer protein, apolipoprotein E and lipoprotein lipase genotypes in patients with coronary artery disease in the Turkish population.
Coronary Artery Disease
Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.
Coronary Artery Disease
Clinical significance of preheparin serum lipoprotein lipase mass in coronary vasospasm.
Coronary Artery Disease
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
Coronary Artery Disease
Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes.
Coronary Artery Disease
Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects.
Coronary Artery Disease
Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease.
Coronary Artery Disease
Common variants in the lipoprotein lipase gene in Brazil: association with lipids and angiographically assessed coronary atherosclerosis.
Coronary Artery Disease
Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels.
Coronary Artery Disease
Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation.
Coronary Artery Disease
Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Coronary Artery Disease
Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans.
Coronary Artery Disease
Diet and the role of lipoproteins, lipases, and thyroid hormones in coronary lesion growth.
Coronary Artery Disease
DNA polymorphisms of the lipoprotein lipase gene and their association with coronary artery disease in the saudi population.
Coronary Artery Disease
Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.
Coronary Artery Disease
Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers.
Coronary Artery Disease
Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease.
Coronary Artery Disease
Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease.
Coronary Artery Disease
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Coronary Artery Disease
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.
Coronary Artery Disease
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
Coronary Artery Disease
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Coronary Artery Disease
Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians.
Coronary Artery Disease
Genetic variation at the lipoprotein lipase gene associates with coronary arteriosclerosis.
Coronary Artery Disease
Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction.
Coronary Artery Disease
Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study.
Coronary Artery Disease
Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population.
Coronary Artery Disease
Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis.
Coronary Artery Disease
Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.
Coronary Artery Disease
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins.
Coronary Artery Disease
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
Coronary Artery Disease
Lipoprotein lipase gene polymorphism and lipid profile in coronary artery disease.
Coronary Artery Disease
Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.
Coronary Artery Disease
Lipoprotein lipase gene polymorphisms and blood pressure levels in the Northern Chinese Han population.
Coronary Artery Disease
Lipoprotein lipase gene polymorphisms in Croatian patients with coronary artery disease.
Coronary Artery Disease
Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: meta-analysis.
Coronary Artery Disease
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).
Coronary Artery Disease
Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.
Coronary Artery Disease
Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease.
Coronary Artery Disease
Metabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism.
Coronary Artery Disease
Plasma concentrations of LPL and LCAT are in putative association with females and alcohol use which are independent negative risk factors for coronary atherosclerosis among Japanese.
Coronary Artery Disease
Polymorphisms of the lipoprotein lipase gene and premature atherosclerosis.
Coronary Artery Disease
Potentially protective effects of the Ser447-Ter mutation of the lipoprotein lipase gene against the development of coronary artery disease in Japanese subjects via a beneficial lipid profile.
Coronary Artery Disease
Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis.
Coronary Artery Disease
Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth.
Coronary Artery Disease
Recent advances in factors that alter lipid metabolism in chronic renal failure.
Coronary Artery Disease
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
Coronary Artery Disease
Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
Coronary Artery Disease
Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.
Coronary Artery Disease
Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis.
Coronary Artery Disease
Single-nucleotide polymorphisms in the lipoprotein lipase gene associated with coronary heart disease in Chinese.
Coronary Artery Disease
Synergistic Effect Between Lipoprotein Lipase and Apolipoprotein C3 Genes in Determining the Severity of Coronary Artery Disease.
Coronary Artery Disease
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group.
Coronary Artery Disease
The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study.
Coronary Artery Disease
The Association of Lipoprotein Lipase Genes, HindIII and S447X Polymorphisms With Coronary Artery Disease in Shiraz City.
Coronary Artery Disease
The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis.
Coronary Artery Disease
The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
Coronary Artery Disease
The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease.
Coronary Artery Disease
The Ser447-Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twins.
Coronary Artery Disease
Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.
Coronary Artery Disease
[Changes in lipoprotein lipase activity in patients with coronary atherosclerosis under the action of therapy with small doses of heparin]
Coronary Artery Disease
[Clinical significance of preheparin serum lipoprotein lipase mass in normocholesterolemic patients with coronary artery disease]
Coronary Artery Disease
[Effect of carbohydrates on the vascular wall, heparin levels and the activity of blood lipoprotein lipase in patients with coronary atherosclerosis]
Coronary Artery Disease
[STUDY OF THE LIPOPROTEIN LIPASE ACTIVITY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS.]
Coronary Disease
A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study.
Coronary Disease
A Lipoprotein Lipase Gene Polymorphism Interacts with Consumption of Alcohol and Unsaturated Fat to Modulate Serum HDL-Cholesterol Concentrations.
Coronary Disease
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Coronary Disease
Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar.
Coronary Disease
Association of lipoprotein lipase gene with coronary heart disease in Sudanese population.
Coronary Disease
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study.
Coronary Disease
Associations between lipoprotein lipase gene polymorphisms and insulin resistance in coronary heart disease.
Coronary Disease
Common genetic determinants of dyslipidemia: the hypertriglyceridemia/low-high-density lipoprotein syndrome.
Coronary Disease
Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Coronary Disease
Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter.
Coronary Disease
Functional variants in the lipoprotein lipase gene and risk cardiovascular disease.
Coronary Disease
Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
Coronary Disease
High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Coronary Disease
Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides.
Coronary Disease
Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
Coronary Disease
Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids.
Coronary Disease
Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
Coronary Disease
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
Coronary Disease
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies.
Coronary Disease
Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.
Coronary Disease
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Coronary Disease
Meta-analysis of genetic association studies under different inheritance models using data reported as merged genotypes.
Coronary Disease
Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.
Coronary Disease
Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men.
Coronary Disease
Polymorphisms of the human lipoprotein lipase gene: possible association with lipid levels in patients with coronary heart disease in Beijing area.
Coronary Disease
Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking.
Coronary Disease
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Coronary Disease
Relationship between a novel polymorphism of lipoprotein lipase gene and coronary heart disease.
Coronary Disease
Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes.
Coronary Disease
S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies.
Coronary Disease
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.
Coronary Disease
Single-nucleotide polymorphisms in the lipoprotein lipase gene associated with coronary heart disease in Chinese.
Coronary Disease
Study of common variants of the apolipoprotein E and lipoprotein lipase genes in patients with coronary heart disease and variable body mass index.
Coronary Disease
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
Coronary Disease
The S447X polymorphism of lipoprotein lipase: effect on the incidence of premature coronary disease and on plasma lipids.
Coronary Disease
[Association between variants of lipoprotein lipase and coronary heart disease in a Tunisian population.]
Coronary Disease
[ESTIMATING THE EFFECTIVENESS OF HYPOLIPIDEMIC THERAPY WITH ROSUVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE DEPENDING ON THE GENOTYPE OF LIPOPROTEIN LIPASE].
Coronary Disease
[Lipoprotein lipase--physiological and pathophysiological roles of this gene variant in Croatian population]
Coronary Disease
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease]
Coronary Disease
[Peculiarities of postprandial activity of lipoprotein lipase in coronary heart disease]
Coronary Stenosis
Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population.
Coronary Vasospasm
Clinical significance of preheparin serum lipoprotein lipase mass in coronary vasospasm.
Craniopharyngioma
Elevated adipose tissue lipoprotein lipase activity in craniopharyngioma patients.
Cushing Syndrome
Blockade of the glucocorticoid receptor with RU 486: effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity.
Cushing Syndrome
Synthesis of active high mannose-type lipoprotein lipase in human adipose tissues.
Cushing Syndrome
[Lipolytic and lipoprotein lipase activity of subcutaneous and visceral adipose tissue in Cushing's syndrome]
Cystic Fibrosis
Association Analyses of Genetic Polymorphisms of GSTM1, GSTT1, NQO1, NAT2, LPL, PRSS1, PSTI, and CFTR With Chronic Alcoholic Pancreatitis in Japan.
Cystic Fibrosis
Studies on mechanism for decreased lipoprotein lipase in cystic fibrosis of the pancrease.
Deafness
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation-associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report.
Demyelinating Diseases
Lipoprotein Lipase Is a Feature of Alternatively-Activated Microglia and May Facilitate Lipid Uptake in the CNS During Demyelination.
Diabetes Mellitus
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Diabetes Mellitus
Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Diabetes Mellitus
Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus.
Diabetes Mellitus
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Diabetes Mellitus
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.
Diabetes Mellitus
Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus.
Diabetes Mellitus
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Diabetes Mellitus
Diabetes Mellitus Severity and a Switch From Using Lipoprotein Lipase to Adipose-Derived Fatty Acid Results in a Cardiac Metabolic Signature That Embraces Cell Death.
Diabetes Mellitus
DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with non-insulin dependent diabetes mellitus.
Diabetes Mellitus
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Diabetes Mellitus
Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea.
Diabetes Mellitus
Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.
Diabetes Mellitus
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Diabetes Mellitus
Endothelial Heparanase Regulates Heart Metabolism by Stimulating Lipoprotein Lipase Secretion From Cardiomyocytes.
Diabetes Mellitus
Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy.
Diabetes Mellitus
Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease.
Diabetes Mellitus
Hyperglycemia-induced secretion of endothelial heparanase stimulates a vascular endothelial growth factor autocrine network in cardiomyocytes that promotes recruitment of lipoprotein lipase.
Diabetes Mellitus
Impact of 1,25(OH) 2 D 3 on TG content in liver of rats with type 2 diabetes.
Diabetes Mellitus
In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
Diabetes Mellitus
Increased frequency of the lipoprotein lipase 9N allele in adults with Type I (insulin-dependent) diabetes mellitus.
Diabetes Mellitus
Lipoprotein lipase activity in patients with diabetes mellitus, with and without hyperlipemia.
Diabetes Mellitus
Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Diabetes Mellitus
Lipoprotein lipase deficiency and transient diabetes mellitus in a neonate.
Diabetes Mellitus
Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.
Diabetes Mellitus
Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia.
Diabetes Mellitus
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia.
Diabetes Mellitus
Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
Diabetes Mellitus
Potential role of insulin in the clearance of remnant lipoproteins in dysbetalipoproteinaemia.
Diabetes Mellitus
Response to pioglitazone treatment is associated with the lipoprotein lipase S447X variant in subjects with type 2 diabetes mellitus.
Diabetes Mellitus
Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).
Diabetes Mellitus
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
Diabetes Mellitus
Severe hypertriglyceridaemia in diabetic ketoacidosis: clinical and genetic study.
Diabetes Mellitus
Streptozotocin-induced diabetes decreases mammary gland lipoprotein lipase activity and messenger ribonucleic acid in pregnant and nonpregnant rats.
Diabetes Mellitus
The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults.
Diabetes Mellitus
The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue.
Diabetes Mellitus
The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
Diabetes Mellitus
[DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with type 2 diabetes mellitus]
Diabetes Mellitus
[Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment]
Diabetes Mellitus
[Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis]
Diabetes Mellitus
[Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH]
Diabetes Mellitus
[Serum lipoprotein lipase activity in diabetes mellitus. I. Activity in primary pancreatic diabetes mellitus and diabetes mellitus of contra-regulation]
Diabetes Mellitus
[Serum lipoprotein lipase activity in diabetes mellitus. II. Hypertriglyceridemia and lipoprotein lipase activity]
Diabetes Mellitus, Type 1
Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 1
Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.
Diabetes Mellitus, Type 1
Effects of omega-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM.
Diabetes Mellitus, Type 1
Elevated Lipoprotein Lipase Activity Does Not Account for the Association Between Adiponectin and HDL in Type 1 Diabetes.
Diabetes Mellitus, Type 1
Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 1
Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Diabetes Mellitus, Type 1
Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).
Diabetes Mellitus, Type 1
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
Diabetes Mellitus, Type 1
Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.
Diabetes Mellitus, Type 1
Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Diabetes Mellitus, Type 1
Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
Diabetes Mellitus, Type 1
Serum lipids and postheparin plasma lipase activity in Japanese children with ketosis-prone diabetes mellitus.
Diabetes Mellitus, Type 1
Severe hypertriglyceridaemia in diabetic ketoacidosis: clinical and genetic study.
Diabetes Mellitus, Type 1
Severe hypertriglyceridemia, large lipoproteins and protection against atherosclerosis.
Diabetes Mellitus, Type 1
Very low density lipoprotein subfraction abnormalities in IDDM patients: any effect of blood glucose control?
Diabetes Mellitus, Type 2
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Diabetes Mellitus, Type 2
Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Diabetes Mellitus, Type 2
Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes.
Diabetes Mellitus, Type 2
Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase.
Diabetes Mellitus, Type 2
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Diabetes Mellitus, Type 2
Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes.
Diabetes Mellitus, Type 2
Association of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes The genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.
Diabetes Mellitus, Type 2
Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population.
Diabetes Mellitus, Type 2
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Diabetes Mellitus, Type 2
Atherogenic factors in diabetes: the role of lipoprotein metabolism.
Diabetes Mellitus, Type 2
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.
Diabetes Mellitus, Type 2
C-reactive protein enhances macrophage lipoprotein lipase expression.
Diabetes Mellitus, Type 2
Change in skeletal muscle lipoprotein lipase activity in response to insulin/glucose in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
Diabetes Mellitus, Type 2
Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians.
Diabetes Mellitus, Type 2
DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with non-insulin dependent diabetes mellitus.
Diabetes Mellitus, Type 2
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Diabetes Mellitus, Type 2
Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea.
Diabetes Mellitus, Type 2
Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients.
Diabetes Mellitus, Type 2
Effects of clofibrate treatment on plasma triglyceride concentration, plasma post-heparin clearing factor lipase (lipoprotein lipase) activity and serum clearing factor lipase activating ability in maturity-onset diabetes.
Diabetes Mellitus, Type 2
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes.
Diabetes Mellitus, Type 2
Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM.
Diabetes Mellitus, Type 2
Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy.
Diabetes Mellitus, Type 2
Fasting and postprandial adipose tissue LPL and HSL in obesity and type 2 diabetes.
Diabetes Mellitus, Type 2
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
Diabetes Mellitus, Type 2
Gender differences in the effect of type 2 diabetes on serum lipids, pre-heparin plasma lipoprotein lipase mass and other metabolic parameters in Japanese population.
Diabetes Mellitus, Type 2
Glycohemoglobin levels relate to the response of adipose tissue lipoprotein lipase to insulin/glucose in obese non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
High fat diet modifies the association of lipoprotein lipase gene polymorphism with high density lipoprotein cholesterol in an Asian Indian population.
Diabetes Mellitus, Type 2
Impact of 1,25(OH) 2 D 3 on TG content in liver of rats with type 2 diabetes.
Diabetes Mellitus, Type 2
Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
Diabetes Mellitus, Type 2
Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone.
Diabetes Mellitus, Type 2
Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C.
Diabetes Mellitus, Type 2
Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.
Diabetes Mellitus, Type 2
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Diabetes Mellitus, Type 2
Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study.
Diabetes Mellitus, Type 2
Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy.
Diabetes Mellitus, Type 2
Micro R-410 Binding Site Single Nucleotide Polymorphism rs13702 in Lipoprotein Lipase Gene is Effective to Increase Susceptibility to Type 2 Diabetes in Iranian Population.
Diabetes Mellitus, Type 2
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
Diabetes Mellitus, Type 2
Pathogenic mutations of the lipoprotein lipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes.
Diabetes Mellitus, Type 2
Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Diabetes Mellitus, Type 2
Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects.
Diabetes Mellitus, Type 2
Pre-heparin lipoprotein lipase mass as a potential mediator in the association between adiponectin and HDL-cholesterol in type 2 diabetes.
Diabetes Mellitus, Type 2
Rarity of the Asn291Ser mutation of lipoprotein lipase gene in Japanese NIDDM patients.
Diabetes Mellitus, Type 2
Regulation of Mitochondrial Biogenesis by Lipoprotein Lipase in Muscle of Insulin-Resistant Offspring of Parents With Type 2 Diabetes.
Diabetes Mellitus, Type 2
Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients.
Diabetes Mellitus, Type 2
Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
Diabetes Mellitus, Type 2
Response to pioglitazone treatment is associated with the lipoprotein lipase S447X variant in subjects with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
Diabetes Mellitus, Type 2
The association of the R219K polymorphism in the ATP-binding cassette transporter 1 ( ABCA1) gene with coronary heart disease and hyperlipidaemia.
Diabetes Mellitus, Type 2
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1? signalling pathway.
Diabetes Mellitus, Type 2
The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum.
Diabetes Mellitus, Type 2
The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults.
Diabetes Mellitus, Type 2
The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes.
Diabetes Mellitus, Type 2
UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
Diabetes Mellitus, Type 2
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors.
Diabetes Mellitus, Type 2
Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?
Diabetes Mellitus, Type 2
[Association of Hind RFLP in lipoprotein lipase gene with type 2 diabetes]
Diabetes Mellitus, Type 2
[DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with type 2 diabetes mellitus]
Diabetes Mellitus, Type 2
[Mutation-function analysis in the lipoprotein lipase gene of Chinese patients with hypertriglyceridemic type 2 diabetes]
Diabetes, Gestational
Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat mass in pregnant women with gestational diabetes mellitus.
Diabetes, Gestational
Placental lipoprotein lipase DNA methylation alterations are associated with gestational diabetes and body composition at 5 years of age.
Diabetes, Gestational
Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles.
Diabetes, Gestational
Relationship between a lipoprotein lipase gene polymorphism in placental tissue and insulin resistance in patients with gestational diabetes mellitus.
Diabetes, Gestational
[TOTAL PARENTERAL NUTRITION IN A PREGNANT PATIENT WITH ACUTE PANCREATITIS AND LIPOPROTEIN LIPASE DEFICIENCY].
Diabetic Cardiomyopathies
Lipoprotein lipase mediated fatty acid delivery and its impact in diabetic cardiomyopathy.
Diabetic Nephropathies
Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy.
Diabetic Nephropathies
High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
Diabetic Nephropathies
Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group.
Diabetic Neuropathies
Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy.
Dwarfism
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Dyslipidemias
A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases.
Dyslipidemias
Abnormality of hepatic triglyceride metabolism in ApcMin/+ mice with colon cancer cachexia.
Dyslipidemias
Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies.
Dyslipidemias
Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction.
Dyslipidemias
Angelica acutiloba Root Attenuates Insulin Resistance Induced by High-Fructose Diet in Rats.
Dyslipidemias
Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
Dyslipidemias
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Dyslipidemias
Association between the lipoprotein lipase rs1534649 gene polymorphism in intron one with Body Mass Index and High Density Lipoprotein-Cholesterol.
Dyslipidemias
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Dyslipidemias
Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
Dyslipidemias
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Dyslipidemias
Association of the lipoprotein lipase gene T+495G polymorphism with central obesity and serum lipids in a twin study.
Dyslipidemias
Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.
Dyslipidemias
Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Dyslipidemias
Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.
Dyslipidemias
Common genetic determinants of dyslipidemia: the hypertriglyceridemia/low-high-density lipoprotein syndrome.
Dyslipidemias
Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen.
Dyslipidemias
Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography.
Dyslipidemias
Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population.
Dyslipidemias
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Dyslipidemias
Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells.
Dyslipidemias
Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran.
Dyslipidemias
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity.
Dyslipidemias
Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells?
Dyslipidemias
Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides.
Dyslipidemias
Incidence of lipoprotein lipase genotype for premature termination codon (Ser447-Ter) in Japanese, and association with dyslipoproteinemia.
Dyslipidemias
Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes.
Dyslipidemias
Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.
Dyslipidemias
Lipoprotein lipase gene polymorphisms and risks of childhood obesity in Chinese preschool children.
Dyslipidemias
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation-associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report.
Dyslipidemias
Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness.
Dyslipidemias
Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4.
Dyslipidemias
New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
Dyslipidemias
Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia.
Dyslipidemias
Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.
Dyslipidemias
Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats.
Dyslipidemias
Preventive effect of small-leaved Kuding tea (Ligustrum robustum) on high-diet-induced obesity in C57BL/6J mice.
Dyslipidemias
Suppression of up-regulated LXR? by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.
Dyslipidemias
The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis.
Dyslipidemias
The Ser447-Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twins.
Dyslipidemias
The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage.
Dyslipidemias
The translational regulation of lipoprotein lipase in diabetic rats involves the 3'-untranslated region of the lipoprotein lipase mRNA.
Dyslipidemias
Vitamin D deficiency serves as a precursor to stunted growth and central adiposity in zebrafish.
Dyslipidemias
Water-Based Aerobic Training Successfully Improves Lipid Profile of Dyslipidemic Women: A Randomized Controlled Trial.
Dyslipidemias
[Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Dyslipidemias
[Dyslipoproteinemias in Quebec: primary deficit in lipoprotein lipase and familial hypercholesterolemia]
Dyslipidemias
[Polymorphisms of lipoprotein lipase gene and their participation in metabolic processes].
Dyslipidemias
[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension]
Endometrial Neoplasms
Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.
Epilepsy
LncRNAs expression signatures of human brain arteriovenous malformation revealed by microarray.
Epilepsy
[Lipoprotein lipase expression in the hippocampus and its effects on vitamin E levels in rats with epilepsy]
Erectile Dysfunction
Downregulated lncRNA-MIAT confers protection against erectile dysfunction by downregulating lipoprotein lipase via activation of miR-328a-5p in diabetic rats.
Essential Hypertension
A study of lipoprotein lipase gene intron 8 polymorphisms in Chinese Han race essential hypertension patients.
Essential Hypertension
Linkage analysis of five candidate genes and essential hypertension in 106 Chinese nuclear families.
Essential Hypertension
Lipoprotein lipase gene is in linkage with blood pressure phenotypes in Chinese pedigrees.
Essential Hypertension
The S447X polymorphism of the lipoprotein lipase gene is associated with lipoprotein lipid and blood pressure levels in Chinese patients with essential hypertension.
Essential Hypertension
[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension]
Fatty Liver
A case of non-alcoholic steatohepatitis complicated with severe acute pancreatitis induced by decreased lipoprotein lipase and hepatic triglyceride lipase activity levels in a young Japanese woman.
Fatty Liver
Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
Fatty Liver
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Fatty Liver
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Fatty Liver
Chrysanthemum morifolium extract attenuates high-fat milk-induced fatty liver through peroxisome proliferator-activated receptor ?-mediated mechanism in mice.
Fatty Liver
Effects of long-term high-sucrose and dexamethasone on fat depots, liver fat, and lipid fuel fluxes through the retroperitoneal adipose tissue and splanchnic area in rats.
Fatty Liver
Fatty liver in dairy cows post partum is associated with decreased concentration of plasma triacylglycerols and decreased activity of lipoprotein lipase in adipocytes.
Fatty Liver
Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
Fatty Liver
Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats.
Fatty Liver
Lipoprotein Lipase Expression in Livers of Morbidly Obese Patients Could be Responsible for Liver Steatosis.
Fatty Liver
Loss of the lipoprotein lipase activating ability of rat serum after administration of some fatty liver inducing drugs.
Fatty Liver
Molecular Mechanism of Age-Specific Hepatic Lipid Accumulation in PPARalpha (+/-):LDLR (+/-) Mice, an Obese Mouse Model.
Fatty Liver
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Fatty Liver
On the mechanism of protective action of cold acclimatization against carbon tetrachloride- and ethionine-induced fatty liver.
Fatty Liver
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Fatty Liver
Pyrazinamide alleviates rifampin-induced steatohepatitis in mice by regulating the activities of cholesterol-activated 7?-hydroxylase and lipoprotein lipase.
Fatty Liver
The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities.
Fatty Liver, Alcoholic
Hepatic lipogenesis and mobilization of peripheral fats in the formation of alcoholic fatty liver.
Fetal Death
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Fibrosarcoma
Effect of intralipid infusion on serum high- and low-density lipoprotein cholesterol, lecithin:cholesterol acyltransferase, and lipoprotein lipase in tumor-bearing rats.
Friedreich Ataxia
Plasma lipoprotein lipase and hepatic lipase activities in Friedreich's ataxia.
Gallstones
[Changes of lipoprotein lipase and hepatic lipase and their significance in gallstone formation in rabbit model]
Gallstones
[Relationship of gallstone formation after radical gastrectomy with the polymorphisms of apolipoprotein B Xba I and lipoprotein lipase Hind III gene]
Gastrointestinal Neoplasms
Tumor-associated metabolic alterations in patients with gastric and esophageal cancer.
Genetic Diseases, Inborn
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Genetic Diseases, Inborn
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
Genetic Diseases, Inborn
Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: A case report.
Genetic Diseases, Inborn
Development of a direct DNA sequencing method for detecting heterozygous mutations of the human lipoprotein lipase gene.
Genetic Diseases, Inborn
Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
Genetic Diseases, Inborn
JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function.
Genetic Diseases, Inborn
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Genetic Diseases, Inborn
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Genetic Diseases, Inborn
Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec.
Genetic Diseases, Inborn
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
Genetic Diseases, Inborn
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
Genetic Diseases, Inborn
The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.
Genetic Diseases, Inborn
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
Genetic Diseases, Inborn
The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
Genetic Diseases, Inborn
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Glioma
Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration.
Glomerulonephritis
Tissue lipoprotein lipase, serum, and urinary lipids and lipoproteins in experimental glomerulonephritis of rats (Heymann's nephritis).
Glomerulonephritis
[Lipoprotein lipase activity of the blood in chronic glomerulonephritis patients]
Glomerulosclerosis, Focal Segmental
Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis.
Glomerulosclerosis, Focal Segmental
Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.
Glucose Intolerance
Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal.
Glucose Intolerance
Comparison of the effect of bezafibrate on improvement of atherogenic lipoproteins in Japanese familial combined hyperlipidemic patients with or without impaired glucose tolerance.
Glucose Intolerance
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Glucose Intolerance
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
Glucose Intolerance
Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
Glycogen Storage Disease
A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia.
Glycogen Storage Disease
Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.
Glycogen Storage Disease
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
Glycogen Storage Disease
The activity of hepatic lipase and lipoprotein lipase in glycogen storage disease: evidence for a circulating inhibitor of postheparin lipolytic activity.
Glycogen Storage Disease Type I
Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.
Glycogen Storage Disease Type I
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
Goiter
[On the behavior of the clearing factor in patients of hyperfunctioning goiters before and after surgical intervention.]
Gout
Decreased activities of lipoprotein lipase and hepatic triglyceride lipase in patients with gout.
Gout
Postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities in gout.
Gout
Postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities in patients with primary asymptomatic gout.
Gout
Study on lipoprotein lipase and hepatic triglyceride lipase activities in patients with gout.
Hearing Loss, Mixed Conductive-Sensorineural
The genotypic and phenotypic spectrum of PIGA deficiency.
Heart Defects, Congenital
[Lipid metabolism in congenital heart diseases. 2. Lipase activity of the feces, lipoprotein lipase activity in the blood and various serum lipid fractions]
Heart Diseases
A preliminary study of single nucleotide polymorphisms of lipoprotein lipase gene in coronary atherosclerotic heart disease.
Heart Diseases
Lipoprotein lipase and angiopoietin-like 4 - Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease.
Heart Diseases
Post heparin lipoprotein lipase activity in patients of ischaemic heart disease and in controls.
Heart Diseases
Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.
Heart Diseases
The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients.
Heart Diseases
[Some peculiarities of the activity of postheparin lipoprotein lipase and parameters of lipid metabolism at ischaemic heart disease]
Heart Failure
Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.
Heart Failure
Myocardial lipoprotein lipase levels in hamsters with congestive heart failure.
Hemophilia B
Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.
Hemorrhagic Stroke
Lipoprotein lipase gene Hind III polymorphism was associated with hemorrhagic stroke.
Hemorrhagic Stroke
Relationship between lipoprotein lipase gene polymorphism and hemorrhagic stroke in a Chinese population.
Hepatitis
Lipoprotein lipase and hepatic lipase deficiencies associated with impaired chylomicron clearance in D-(+) galactosamine hepatitis.
Hepatitis
The effect of lipoprotein lipase and hepatic lipase on the electrophoretic mobility of lipoprotein-X.
Hepatitis C
Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.
Hepatitis C
Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
Hepatitis C
Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Hepatitis C, Chronic
Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C.
Hepatitis C, Chronic
The Correlation between miR-122 and Lipoprotein Lipase Expression in Chronic Hepatitis C Patients.
Hepatitis, Chronic
The effect of lipoprotein lipase and hepatic lipase on the electrophoretic mobility of lipoprotein-X.
Hepatitis, Chronic
[On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis]
Hepatomegaly
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
HIV-Associated Lipodystrophy Syndrome
Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome.
Homozygous Familial Hypercholesterolemia
Gene therapy for dyslipidemia: clinical prospects.
Homozygous Familial Hypercholesterolemia
Gene-based therapies in lipidology: current status and future challenges.
Homozygous Familial Hypercholesterolemia
Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.
Homozygous Familial Hypercholesterolemia
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
hormone-sensitive lipase deficiency
Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle.
Hyperaldosteronism
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Hypercholesterolemia
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia.
Hypercholesterolemia
Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein.
Hypercholesterolemia
Dyslipidemia and cardiovascular health in childhood nephrotic syndrome.
Hypercholesterolemia
Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.
Hypercholesterolemia
Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
Hypercholesterolemia
Exercise Increases Lipoprotein Lipase in the Porcine Heart, Even During Hypercholesterolemia: 66: 1:10 PM-1:35 PM.
Hypercholesterolemia
Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
Hypercholesterolemia
Inhibition of miR-27b Regulates Lipid Metabolism in Skeletal Muscle of Obese Rats During Hypoxic Exercise by Increasing PPAR? Expression.
Hypercholesterolemia
Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia.
Hypercholesterolemia
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia.
Hypercholesterolemia
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia.
Hypercholesterolemia
Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis.
Hypercholesterolemia
Progress of research on dyslipidemia accompanied by nephrotic syndrome.
Hypercholesterolemia
Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
Hypercholesterolemia
Whole exome sequencing for non-selective pediatric patients with hyperlipidemia.
Hypercholesterolemia
[Lipids profile in a group of hypothyroid patients vs. treated hypothyroid patients]
Hypercholesterolemia
[The mechanism of formation of spectrum of nonesterified fatty acids in biological fluids of rabbits with alimentary hypercholesterolemia]
Hyperglycemia
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Hyperglycemia
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Hyperglycemia
Defining the Regulated Secreted Proteome of Rodent Adipocytes upon the Induction of Insulin Resistance.
Hyperglycemia
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.
Hyperglycemia
Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
Hyperglycemia
Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.
Hyperglycemia
Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model.
Hyperinsulinism
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
Hyperinsulinism
Alterations in cholesteryl ester transfer, lipoprotein lipase, and lipoprotein composition after combined pancreas-kidney transplantation.
Hyperinsulinism
Association of polymorphism genes
LPL
,
ADRB2
,
AGT
and
AGTR1
with risk of hyperinsulinism and insulin resistance in the Kazakh population.
Hyperinsulinism
Comparative responsiveness to prolonged hyperinsulinemia between adipose-tissue and mammary-gland lipoprotein lipase activities in pregnant rats.
Hyperinsulinism
Contribution of hyperinsulinemia to modulation of lipoprotein lipase activity in the obese Zucker rat.
Hyperinsulinism
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Hyperinsulinism
Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus.
Hyperinsulinism
Development of pancreatic and plasma insulin in prenatal and suckling Zucker rats.
Hyperinsulinism
Eating behavior disorders in uremia: a question of balance in appetite regulation.
Hyperinsulinism
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Hyperinsulinism
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Hyperinsulinism
Enzymatic and metabolic responses to affluent diet of two diabetes-prone species of spiny mice: Acomys cahirinus and Acomys russatus.
Hyperinsulinism
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Hyperinsulinism
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Hyperinsulinism
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
Hyperinsulinism
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Hyperinsulinism
Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications.
Hyperinsulinism
In vivo regulation of adipose tissue lipoprotein lipase in normal rats made hyperinsulinemic and in hyperinsulinemic genetically-obese (fa/fa) rats.
Hyperinsulinism
Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus.
Hyperinsulinism
Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model.
Hyperinsulinism
Postheparin plasma lipoprotein and hepatic lipase activities in hyperinsulinemic infants of diabetic mothers and in large-for-date infants at birth.
Hyperinsulinism
Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.
Hyperinsulinism
Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia.
Hyperinsulinism
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
Hyperinsulinism
Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study.
Hyperinsulinism
Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion.
Hyperinsulinism
The effect of growth hormone administration on lipids and lipoproteins in growth hormone-deficient patients.
Hyperlipidemia, Familial Combined
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.
Hyperlipidemia, Familial Combined
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
Hyperlipidemia, Familial Combined
A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene.
Hyperlipidemia, Familial Combined
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Hyperlipidemia, Familial Combined
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Hyperlipidemia, Familial Combined
Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment.
Hyperlipidemia, Familial Combined
Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
Hyperlipidemia, Familial Combined
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
Hyperlipidemia, Familial Combined
Familial combined hyperlipidemia and abnormal lipoprotein lipase.
Hyperlipidemia, Familial Combined
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
Hyperlipidemia, Familial Combined
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
Hyperlipidemia, Familial Combined
In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
Hyperlipidemia, Familial Combined
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies.
Hyperlipidemia, Familial Combined
Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
Hyperlipidemia, Familial Combined
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Hyperlipidemia, Familial Combined
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Hyperlipidemia, Familial Combined
Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms.
Hyperlipidemia, Familial Combined
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
Hyperlipidemia, Familial Combined
Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.
Hyperlipidemia, Familial Combined
Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
Hyperlipidemia, Familial Combined
[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia]
Hyperlipidemia, Familial Combined
[Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)]
Hyperlipidemias
A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis.
Hyperlipidemias
A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.
Hyperlipidemias
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
Hyperlipidemias
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.
Hyperlipidemias
A heterozygous mutation (the codon for Ser447----a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia.
Hyperlipidemias
A missense mutation (Ala334-->Thr) in exon 7 of the lipoprotein lipase gene in a case with type I hyperlipidemia.
Hyperlipidemias
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
Hyperlipidemias
A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene.
Hyperlipidemias
A novel frameshift mutation in exon 6 (the site of Asn 291) of the lipoprotein lipase gene in type I hyperlipidemia.
Hyperlipidemias
Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Hyperlipidemias
Abnormality of hepatic triglyceride metabolism in ApcMin/+ mice with colon cancer cachexia.
Hyperlipidemias
Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Hyperlipidemias
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Hyperlipidemias
Adrenal and liver in normal and cld/cld mice synthesize and secrete hepatic lipase, but the lipase is inactive in cld/cld mice.
Hyperlipidemias
Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
Hyperlipidemias
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Hyperlipidemias
Associations of the ABCA1 and LPL Gene Polymorphisms With Lipid Levels in a Hyperlipidemic Population.
Hyperlipidemias
Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment.
Hyperlipidemias
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Hyperlipidemias
Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics.
Hyperlipidemias
Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.
Hyperlipidemias
Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
Hyperlipidemias
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
Hyperlipidemias
Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice.
Hyperlipidemias
Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy.
Hyperlipidemias
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
Hyperlipidemias
Corn oil, palm oil and butterfat fractions affect postprandial lipemia and lipoprotein lipase in meal-fed rats.
Hyperlipidemias
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Hyperlipidemias
Decreased cardiac lipoprotein lipase activity in rats treated chronically with adriamycin.
Hyperlipidemias
Decreased expression of murine PPARgamma in adipose tissue during endotoxemia.
Hyperlipidemias
Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: insulin dependency of the VLDL receptor.
Hyperlipidemias
Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol.
Hyperlipidemias
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Hyperlipidemias
Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.
Hyperlipidemias
Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia.
Hyperlipidemias
Diurnal changes in plasma and liver lipids and lipoprotein lipase activity in heart and adipose tissue in rats fed a high and low fat diet.
Hyperlipidemias
Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia.
Hyperlipidemias
Effect of eggplant (Solanum melongena) on the metabolic syndrome: A review.
Hyperlipidemias
Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men.
Hyperlipidemias
Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol.
Hyperlipidemias
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
Hyperlipidemias
Effects of a liquid high-fat meal on postprandial lipid metabolism in type 2 diabetic patients with abdominal obesity.
Hyperlipidemias
Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis.
Hyperlipidemias
Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects.
Hyperlipidemias
Effects of low and moderate exercise intensity on postprandial lipemia and postheparin plasma lipoprotein lipase activity in physically active men.
Hyperlipidemias
Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes.
Hyperlipidemias
Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats.
Hyperlipidemias
Effects of sulfur amino acids, L: -methionine, L: -cystine and L: -cysteine on lipoprotein lipase and hormone-sensitive lipase in differentiated mouse 3T3-L1 adipocytes.
Hyperlipidemias
Enhancement of cholesteryl ester transfer in plasma by hormone-replacement therapy.
Hyperlipidemias
Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
Hyperlipidemias
Factors regulating blood levels of free fatty acids during alimentary lipemia.
Hyperlipidemias
Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus.
Hyperlipidemias
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
Hyperlipidemias
Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia.
Hyperlipidemias
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
Hyperlipidemias
Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat.
Hyperlipidemias
Heparininduced lipemia clearing factor in rats: role of the pancreas in its production.
Hyperlipidemias
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
Hyperlipidemias
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.
Hyperlipidemias
High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity.
Hyperlipidemias
High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase.
Hyperlipidemias
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
Hyperlipidemias
Human plasma lipoproteins and total parenteral nutrition with intravenous fat emulsion.
Hyperlipidemias
Hyperlipemia in acute pancreatitis. Metabolic studies in a patient and demonstration of abnormal lipoprotein-triglyceride complexes resistant to the action of lipoprotein lipase.
Hyperlipidemias
Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene.
Hyperlipidemias
Hyperlipidemia in guinea-pigs induced by ascorbic acid deficiency. The effects of cholesterol, DL-ethionine and aflatoxin.
Hyperlipidemias
Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl.
Hyperlipidemias
Hyperlipidemia Resulting in Abnormal Density and Signal Intensity of Blood in a Neonate with Lipoprotein Lipase Deficiency.
Hyperlipidemias
Hypocholesterolemia and dysregulated production of angiopoietin-like proteins in sickle cell anemia patients.
Hyperlipidemias
Hypolipidemic and antioxidant activities of polysaccharides from Rosae Laevigatae Fructus in rats
Hyperlipidemias
Hypolipidemic and antioxidant activities of polysaccharides from Rosae Laevigatae Fructus in rats.
Hyperlipidemias
Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis.
Hyperlipidemias
Improved visual function with dietary intervention in a child with lipemia retinalis.
Hyperlipidemias
In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
Hyperlipidemias
Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia.
Hyperlipidemias
Iron deficiency hyperlipidemia in 18-day-old rat pups: effects of milk lipids, lipoprotein lipase, and triglyceride synthesis.
Hyperlipidemias
Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
Hyperlipidemias
Lipid-lowering effects of Zanthoxylum schinifolium Siebold & Zucc. seed oil (ZSO) in hyperlipidemic rats and lipolytic effects in 3T3-L1 adipocytes.
Hyperlipidemias
Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals.
Hyperlipidemias
Lipoprotein lipase activity in patients with diabetes mellitus, with and without hyperlipemia.
Hyperlipidemias
Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature.
Hyperlipidemias
Lipoprotein lipase activity of huuman adipose tissue in different types of hyperlipidemia.
Hyperlipidemias
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
Hyperlipidemias
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies.
Hyperlipidemias
LIPOPROTEIN LIPASE INHIBITION IN THE HYPERLIPEMIA OF ACUTE ALCOHOLIC PANCREATITIS.
Hyperlipidemias
Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
Hyperlipidemias
Lipoprotein metabolism in diabetics treated with diet, oral hypoglycemic drug and insulin.
Hyperlipidemias
Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
Hyperlipidemias
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Hyperlipidemias
Major involvement of mTOR in the PPAR?-induced stimulation of adipose tissue lipid uptake and fat accretion.
Hyperlipidemias
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation-associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report.
Hyperlipidemias
Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness.
Hyperlipidemias
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Hyperlipidemias
Metabolism of liver triacylglycerols in rats tube-fed a threonine-devoid diet.
Hyperlipidemias
Mitigation of alimentary lipemia by postprandial exercise--phenomena and mechanisms.
Hyperlipidemias
Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity.
Hyperlipidemias
Neonatal hyperlipidemia with pancreatitis: Novel gene mutation of lipoprotein lipase.
Hyperlipidemias
Origin and pattern of glucocorticoid-induced hyperlipidemia in rats. Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity.
Hyperlipidemias
Origin of endocrine-metabolic changes in the weanling rat ventromedial syndrome.
Hyperlipidemias
Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity.
Hyperlipidemias
Pancreatitis in a child with lipemia due to novel lipoprotein lipase mutations.
Hyperlipidemias
Pathogenesis of the hyperlipidemia of Gram-negative bacterial sepsis may involve pathomorphological changes in liver sinusoidal endothelial cells.
Hyperlipidemias
Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
Hyperlipidemias
Physical activity and postprandial lipidemia: are energy expenditure and lipoprotein lipase activity the real modulators of the positive effect?
Hyperlipidemias
Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats.
Hyperlipidemias
Platycodi radix beverage ameliorates postprandial lipemia response through lipid clearance of triglyceride-rich lipoprotein: A randomized controlled study in healthy subjects with a high-fat load.
Hyperlipidemias
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Hyperlipidemias
Postprandial lipemia and lipoprotein lipase in the rabbit are modified by olive and coconut oil.
Hyperlipidemias
Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms.
Hyperlipidemias
Postprandial triglyceridemia after single dose of alcohol in healthy young men.
Hyperlipidemias
PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.
Hyperlipidemias
Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias.
Hyperlipidemias
Protective role of L-carnitine and vitamin E on the testis of atherosclerotic rats.
Hyperlipidemias
Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.
Hyperlipidemias
Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.
Hyperlipidemias
Reduced adipose tissue lipoprotein lipase responses, postprandial lipemia, and low high-density lipoprotein-2 subspecies levels in older athletes with silent myocardial ischemia.
Hyperlipidemias
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
Hyperlipidemias
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
Hyperlipidemias
Relation of endocrines and clearing factor inhibitors to hyperlipemia in fasted animals.
Hyperlipidemias
Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
Hyperlipidemias
Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.
Hyperlipidemias
Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an SstI polymorphism.
Hyperlipidemias
Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.
Hyperlipidemias
Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.
Hyperlipidemias
Studies on heparin and lipemia clearing factor; inhibition towards clearing in plasma from normal and atherosclerotic individuals.
Hyperlipidemias
Suppression of hyperlipidemia-associated cataracts in diabetic rats with the lipoprotein lipase activator NO-1886.
Hyperlipidemias
The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.
Hyperlipidemias
The effect of pancreatectomy in lipoprotein lipase activity: an experimental study in pancreatectomized rats.
Hyperlipidemias
The effects of medications used for the management of dyslipidemia on postprandial lipemia.
Hyperlipidemias
The environmental and genetic evidence for the association of hyperlipidemia and hypertension.
Hyperlipidemias
The impact of the leucine 7 to proline 7 polymorphism of the neuropeptide Y gene on postprandial lipemia and on the response of serum total and lipoprotein lipids to a reduced fat diet.
Hyperlipidemias
The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
Hyperlipidemias
The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.
Hyperlipidemias
The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin--A biochemical study in rats subjected to experimental hyperlipidemia and obesity.
Hyperlipidemias
Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity.
Hyperlipidemias
Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
Hyperlipidemias
Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.
Hyperlipidemias
[ACTIVITY OF LIPOPROTEIN LIPASE AND POSTHEPARIN ESTERASE IN IDIOPATHIC HYPERLIPEMIA.]
Hyperlipidemias
[Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome]
Hyperlipidemias
[Alimentary lipemia and post-heparin lipoprotein lipase activity (PHLA) in children with dysthyroidism]
Hyperlipidemias
[Alimentary lipemia and postheparin activity of lipoprotein lipase in children with malabsorption syndrome]
Hyperlipidemias
[Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure]
Hyperlipidemias
[Determination of total plasma lipoprotein lipase in patients with vascular diseases and hyperlipemia]
Hyperlipidemias
[EFFECT OF ALIMENTARY LIPEMIA ON ACTIVATION OF LIPOPROTEIN LIPASE AND POSTHEPARIN ESTERASE.]
Hyperlipidemias
[Effect of Astragalus Angelica Mixture on lipoprotein lipase and lecithin cholesterol acyltransferase of nephrotic rats]
Hyperlipidemias
[ESTIMATING THE EFFECTIVENESS OF HYPOLIPIDEMIC THERAPY WITH ROSUVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE DEPENDING ON THE GENOTYPE OF LIPOPROTEIN LIPASE].
Hyperlipidemias
[Hyperlipemia and tumors : post heparin lipase activity of the hamster bearing a malignant lymphoma]
Hyperlipidemias
[In vitro inhibition of lipoprotein lipase by a monoclonal immunoglobulin in a case of nephrotic syndrome with hyperlipemia caused by auto-antibodies]
Hyperlipidemias
[In vivo effects of triton WR 1339 on plasma lipoproteins and the postheparin activity of lipoprotein lipase and liver triglyceride lipase (triton hyperlipidemia in rabbits)]
Hyperlipidemias
[Inhibition of the clearing factor and of pancreatic lipase by the serum of patients with idiopathic hyperlipemia.]
Hyperlipidemias
[Lipoproteins, post-heparin lipoprotein lipase and hepatic triglyceride lipase in patients with and without severe hyperlipemia caused by alcoholism]
Hyperlipidemias
[Molecular mechanism of wendan tang in prevention of lipid metabolism disorder in adult rats]
Hyperlipidemias
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease]
Hyperlipidemias
[Possibility of New Circulating Atherosclerosis-Related Lipid Markers Measurement in Medical and Complete Medical Checkups: Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein Lipase].
Hyperlipidemias
[Post-heparin lipolytic activity. (III). Lipoprotein lipase and monoglyceride hydrolase activities on hyperlipemia and the organs responsible for their biosynthesis]
Hyperlipidemias
[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia]
Hyperlipidemias
[Relations of lipoprotein lipase gene polymorphism at Pvu II locus and dietary intervention predisposition in hyperlipidemia population]
Hyperlipidemias
[Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)]
Hyperlipoproteinemia Type I
11-year Follow-up in Biliopancreatic Diversion for Recurrent Pancreatitis Due to Lipoprotein Lipase Deficiency.
Hyperlipoproteinemia Type I
A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion.
Hyperlipoproteinemia Type I
A 4 basepair deletion in exon 4 of the human lipoprotein lipase gene results in type I hyperlipoproteinemia.
Hyperlipoproteinemia Type I
A case of severe acquired hypertriglyceridemia in a 7-year-old girl.
Hyperlipoproteinemia Type I
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
Hyperlipoproteinemia Type I
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
Hyperlipoproteinemia Type I
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
A G----C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family.
Hyperlipoproteinemia Type I
A Japanese patient with lipoprotein lipase deficiency homozygous for the Gly188Glu mutation prevalent worldwide.
Hyperlipoproteinemia Type I
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
A missense mutation (Trp86----Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia.
Hyperlipoproteinemia Type I
A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries.
Hyperlipoproteinemia Type I
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.
Hyperlipoproteinemia Type I
A mutation in the lipoprotein lipase gene associated with hyperlipoproteinemia type I in mink: studies on lipid and lipase levels in heterozygotes.
Hyperlipoproteinemia Type I
A new Italian case of lipoprotein lipase deficiency: a Leu365- > Val change resulting in loss of enzyme activity.
Hyperlipoproteinemia Type I
A new mutation in the human lipoprotein lipase gene causing familial hyperchylomicronaemia.
Hyperlipoproteinemia Type I
A newly identified lipoprotein lipase (LPL) gene mutation (F270L) in a Japanese patient with familial LPL deficiency.
Hyperlipoproteinemia Type I
A newly identified null allelic mutation in the human lipoprotein lipase (LPL) gene of a compound heterozygote with familial LPL deficiency.
Hyperlipoproteinemia Type I
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing.
Hyperlipoproteinemia Type I
A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia.
Hyperlipoproteinemia Type I
A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia.
Hyperlipoproteinemia Type I
A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia).
Hyperlipoproteinemia Type I
A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.
Hyperlipoproteinemia Type I
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
Hyperlipoproteinemia Type I
A sweet heart: Increased cardiac glucose uptake in patients with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Absence of serum-stimulated lipase activity and altered lipid content in milk from a patient with type I hyperlipoproteinaemia.
Hyperlipoproteinemia Type I
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
Hyperlipoproteinemia Type I
Acute and chronic pancreatitis in patients with inborn errors of metabolism.
Hyperlipoproteinemia Type I
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Hyperlipoproteinemia Type I
Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.
Hyperlipoproteinemia Type I
Adipose cell size and distribution in familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Adipose Specific Lipoprotein Lipase Deficiency More Profoundly Affects Brown Than White Fat Biology.
Hyperlipoproteinemia Type I
Adipose tissue fatty acid composition in humans with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Alterations in erythrocyte membrane lipid composition and fluidity in primary lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin.
Hyperlipoproteinemia Type I
An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
Hyperlipoproteinemia Type I
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Hyperlipoproteinemia Type I
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Hyperlipoproteinemia Type I
Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
Hyperlipoproteinemia Type I
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
Hyperlipoproteinemia Type I
Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism.
Hyperlipoproteinemia Type I
Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro.
Hyperlipoproteinemia Type I
C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
Hyperlipoproteinemia Type I
Capecitabine-induced severe hypertriglyceridemia: report of two cases.
Hyperlipoproteinemia Type I
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
Hyperlipoproteinemia Type I
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
Hyperlipoproteinemia Type I
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
Hyperlipoproteinemia Type I
Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities.
Hyperlipoproteinemia Type I
Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
Hyperlipoproteinemia Type I
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
Hyperlipoproteinemia Type I
Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: A case report.
Hyperlipoproteinemia Type I
Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
Hyperlipoproteinemia Type I
Comparison of plasmapheresis with medical apheresis in terms of efficacy and cost in the acute treatment of hypertriglyceridemia in children with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
Hyperlipoproteinemia Type I
Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.
Hyperlipoproteinemia Type I
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
Hyperlipoproteinemia Type I
Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene.
Hyperlipoproteinemia Type I
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
Hyperlipoproteinemia Type I
Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy.
Hyperlipoproteinemia Type I
Congenital lipoprotein lipase deficiency in hyperlipemic kitten siblings.
Hyperlipoproteinemia Type I
Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation.
Hyperlipoproteinemia Type I
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Hyperlipoproteinemia Type I
Cost-Effectiveness Analysis of Glybera for The Treatment of Lipoprotein Lipase Deficiency.
Hyperlipoproteinemia Type I
Critical review of non-statin treatments for dyslipoproteinemia.
Hyperlipoproteinemia Type I
Deceptive hyperbilirubinaemia in a newborn with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Detailed analysis of lipolytic enzymes in a Japanese woman of familial lipoprotein lipase deficiency - Effects of pemafibrate treatment.
Hyperlipoproteinemia Type I
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Detection of a new compound heterozygote (del G916/G1401A) for lipoprotein lipase deficiency and a comparative haplotype analysis of the mutant lipoprotein lipase gene from Japanese patients.
Hyperlipoproteinemia Type I
Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia.
Hyperlipoproteinemia Type I
Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.
Hyperlipoproteinemia Type I
Development and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis(®) Fixed-Bed Bioreactor.
Hyperlipoproteinemia Type I
Diagnosis and management of type I and type V hyperlipoproteinemia.
Hyperlipoproteinemia Type I
Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
Hyperlipoproteinemia Type I
Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism.
Hyperlipoproteinemia Type I
Dissociation between plasma triglyceride concentration and tissue lipoprotein lipase deficiency in insulin-deficient rats.
Hyperlipoproteinemia Type I
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Hyperlipoproteinemia Type I
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Hyperlipoproteinemia Type I
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.
Hyperlipoproteinemia Type I
Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues.
Hyperlipoproteinemia Type I
Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man.
Hyperlipoproteinemia Type I
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
Hyperlipoproteinemia Type I
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Hyperlipoproteinemia Type I
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Hyperlipoproteinemia Type I
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification.
Hyperlipoproteinemia Type I
Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure.
Hyperlipoproteinemia Type I
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy.
Hyperlipoproteinemia Type I
Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.
Hyperlipoproteinemia Type I
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
Hyperlipoproteinemia Type I
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Hyperlipoproteinemia Type I
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
Hyperlipoproteinemia Type I
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
Hyperlipoproteinemia Type I
Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives.
Hyperlipoproteinemia Type I
Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutations.
Hyperlipoproteinemia Type I
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study.
Hyperlipoproteinemia Type I
Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
Hyperlipoproteinemia Type I
Familial lipoprotein lipase deficiency: abnormal lipoproteins and defective metabolism of low density lipoproteins in cultured human skin fibroblasts.
Hyperlipoproteinemia Type I
Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Gene polymorphism identified by PvuII in familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Gene therapy for genetic lipid disorders: lipoprotein lipase deficiency as a paradigm.
Hyperlipoproteinemia Type I
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
Hyperlipoproteinemia Type I
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
Hyperlipoproteinemia Type I
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Hyperlipoproteinemia Type I
Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions.
Hyperlipoproteinemia Type I
Gene therapy on demand: site specific regulation of gene therapy.
Hyperlipoproteinemia Type I
Gene-based therapies in lipidology: current status and future challenges.
Hyperlipoproteinemia Type I
Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec.
Hyperlipoproteinemia Type I
Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.
Hyperlipoproteinemia Type I
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
Hyperlipoproteinemia Type I
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Hyperlipoproteinemia Type I
Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Québec, Canada).
Hyperlipoproteinemia Type I
Geographic distribution and genealogy of mutation 207 of the lipoprotein lipase gene in the French Canadian population of Québec.
Hyperlipoproteinemia Type I
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
Hyperlipoproteinemia Type I
Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
Hyperlipoproteinemia Type I
HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family.
Hyperlipoproteinemia Type I
Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
Hyperlipoproteinemia Type I
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Hyperlipoproteinemia Type I
High frequency of lipoprotein lipase deficiency in the Quebec population.
Hyperlipoproteinemia Type I
Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
Hyperlipoproteinemia Type I
Homozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombination.
Hyperlipoproteinemia Type I
Homozygous LPL p.Gly188Glu Mutation in a Mexican Girl With Lipoprotein Lipase Deficiency.
Hyperlipoproteinemia Type I
Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells?
Hyperlipoproteinemia Type I
Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.
Hyperlipoproteinemia Type I
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Hyperlipidemia Resulting in Abnormal Density and Signal Intensity of Blood in a Neonate with Lipoprotein Lipase Deficiency.
Hyperlipoproteinemia Type I
Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus.
Hyperlipoproteinemia Type I
Hyperlipoproteinemia type I in a patient with active lipoprotein lipase in adipose tissue and indications of defective transport of the enzyme.
Hyperlipoproteinemia Type I
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
Hyperlipoproteinemia Type I
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction.
Hyperlipoproteinemia Type I
Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Hyperlipoproteinemia Type I
Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome.
Hyperlipoproteinemia Type I
Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event.
Hyperlipoproteinemia Type I
Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPL(S447X)) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy.
Hyperlipoproteinemia Type I
Improved visual function with dietary intervention in a child with lipemia retinalis.
Hyperlipoproteinemia Type I
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
Hyperlipoproteinemia Type I
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis.
Hyperlipoproteinemia Type I
Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.
Hyperlipoproteinemia Type I
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Irradiation-induced free cholesterol accumulation in very-low-density lipoproteins. Role of lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) - First Step Towards a Pro Measure in Lpld.
Hyperlipoproteinemia Type I
Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Lipaemia retinalis in a 29-day-old infant with type 1 hyperlipoproteinaemia.
Hyperlipoproteinemia Type I
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
Hyperlipoproteinemia Type I
Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
Hyperlipoproteinemia Type I
Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6.
Hyperlipoproteinemia Type I
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency and transient diabetes mellitus in a neonate.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency due to a 3' splice site mutation in intron 6 of the lipoprotein lipase gene.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy.
Hyperlipoproteinemia Type I
Lipoprotein Lipase Deficiency Impairs Bone Marrow Myelopoiesis and Reduces Circulating Monocyte Levels.
Hyperlipoproteinemia Type I
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein (ASP) plasma levels.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency leads to ?-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency presenting with neonatal perianal abscesses.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency: benefits and limitations of a novel therapeutic surgical approach.
Hyperlipoproteinemia Type I
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
Hyperlipoproteinemia Type I
Lipoprotein lipase secretion by human monocyte-derived macrophages.
Hyperlipoproteinemia Type I
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Hyperlipoproteinemia Type I
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Hyperlipoproteinemia Type I
Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
Hyperlipoproteinemia Type I
Management strategy and novel ophthalmological findings in neonatal severe hypertriglyceridemia: a case report and literature review.
Hyperlipoproteinemia Type I
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Maternal expression of functional lipoprotein lipase and effects on body fat mass and body condition scores of mature cats with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Mechanisms of atherogenesis: endothelial hypoxia proposed as the major initiator.
Hyperlipoproteinemia Type I
Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humans.
Hyperlipoproteinemia Type I
Metabolic surgery for the treatment of hypertriglyceridemia-related pancreatitis due to familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
Hyperlipoproteinemia Type I
Milk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia.
Hyperlipoproteinemia Type I
Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
Hyperlipoproteinemia Type I
Molecular and functional characterization of familial chylomicronemia syndrome.
Hyperlipoproteinemia Type I
Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.
Hyperlipoproteinemia Type I
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia.
Hyperlipoproteinemia Type I
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
Hyperlipoproteinemia Type I
Molecular genetics of apoC-II and lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Molecular studies on primary lipoprotein lipase (LPL) deficiency. One base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript.
Hyperlipoproteinemia Type I
Neonatal pancreatitis associated with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism.
Hyperlipoproteinemia Type I
Novel compound heterozygous mutations for lipoprotein lipase deficiency. A G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5' splice site mutation of intron 8.
Hyperlipoproteinemia Type I
Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review.
Hyperlipoproteinemia Type I
Occurrence of idiopathic, familial hyperchylomicronaemia in a cat.
Hyperlipoproteinemia Type I
Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Hyperlipoproteinemia Type I
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Hyperlipoproteinemia Type I
Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer.
Hyperlipoproteinemia Type I
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Hyperlipoproteinemia Type I
Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Hyperlipoproteinemia Type I
Potential of AAV vectors in the treatment of metabolic disease.
Hyperlipoproteinemia Type I
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Hyperlipoproteinemia Type I
Pregnancy-induced hyperlipoproteinemia: review of the literature.
Hyperlipoproteinemia Type I
Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
Hyperlipoproteinemia Type I
Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Hyperlipoproteinemia Type I
Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec.
Hyperlipoproteinemia Type I
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy.
Hyperlipoproteinemia Type I
Primary type 1 hyperlipoproteinemia: significance of lipoprotein lipase and hepatic triglyceride lipase activity in heterozygotes of patients with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Primary type I hyperlipoproteinemia with normal lipoprotein lipase activity.
Hyperlipoproteinemia Type I
Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
Hyperlipoproteinemia Type I
Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia.
Hyperlipoproteinemia Type I
Recurrent acute and chronic pancreatitis in two brothers with familial chylomicronemia syndrome.
Hyperlipoproteinemia Type I
Recurrent missense mutations at the first and second base of codon Arg243 in human lipoprotein lipase in patients of different ancestries.
Hyperlipoproteinemia Type I
Reduced cholesteryl ester transfer in plasma of patients with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Risk factors for coronary artery disease: a study comparing hypercholesterolaemia and hypertriglyceridaemia in angiographically characterized patients.
Hyperlipoproteinemia Type I
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).
Hyperlipoproteinemia Type I
Scientifically-based strategies for nutrition of the high-risk low birth weight infant.
Hyperlipoproteinemia Type I
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
Hyperlipoproteinemia Type I
Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
Hyperlipoproteinemia Type I
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
Hyperlipoproteinemia Type I
Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience.
Hyperlipoproteinemia Type I
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
Hyperlipoproteinemia Type I
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
Hyperlipoproteinemia Type I
Severe hypertriglyceridemia, large lipoproteins and protection against atherosclerosis.
Hyperlipoproteinemia Type I
Severe, gestational, non-familial, non-genetic hypertriglyceridemia.
Hyperlipoproteinemia Type I
Siblings with hepatosplenomegaly and lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Successful management of acute pancreatitis due to apolipoprotein C-II deficiency in a 37-day-old infant.
Hyperlipoproteinemia Type I
Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
Hyperlipoproteinemia Type I
Support for founder effect for two lipoprotein lipase (LPL) gene mutations in French Canadians by analysis of GT microsatellites flanking the LPL gene.
Hyperlipoproteinemia Type I
The burden of familial chylomicronemia syndrome in Canadian patients.
Hyperlipoproteinemia Type I
The burden of familial chylomicronemia syndrome: interim results from the IN-FOCUS study.
Hyperlipoproteinemia Type I
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
Hyperlipoproteinemia Type I
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Hyperlipoproteinemia Type I
The effect of gestational age on intralipid tolerance in newborn infants.
Hyperlipoproteinemia Type I
The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative study.
Hyperlipoproteinemia Type I
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Hyperlipoproteinemia Type I
The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
Hyperlipoproteinemia Type I
The role of lecithin: cholesterol acyltransferase in high density lipoprotein3/high density lipoprotein2 interconversion.
Hyperlipoproteinemia Type I
The role of patient registries for rare genetic lipid disorders.
Hyperlipoproteinemia Type I
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
The ultrastructural pathology of five lipoprotein lipase-deficient cats.
Hyperlipoproteinemia Type I
Tocopherol content of adipose tissue from vitamin E-deficient humans.
Hyperlipoproteinemia Type I
Transient lipoprotein lipase deficiency with hyperchylomicronemia.
Hyperlipoproteinemia Type I
Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.
Hyperlipoproteinemia Type I
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Type I hyperlipidaemia caused by lipoprotein lipase deficiency in a nurseling: the role of the clinical laboratory in processing biological samples and contributing to the diagnosis and therapeutic follow-up of patients.
Hyperlipoproteinemia Type I
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
Hyperlipoproteinemia Type I
Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.
Hyperlipoproteinemia Type I
Use of plasma lipoprotein lipase activity without heparin injection for detection of homozygous and heterozygous lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.
Hyperlipoproteinemia Type I
Volanesorsen for treatment of patients with familial chylomicronemia syndrome.
Hyperlipoproteinemia Type I
Whole exome sequencing for non-selective pediatric patients with hyperlipidemia.
Hyperlipoproteinemia Type I
Xanthoma of bone associated with lipoprotein lipase deficiency.
Hyperlipoproteinemia Type I
[A case of neonatal lipoprotein lipase deficiency caused by novel compound heterozygous variants of LPL gene].
Hyperlipoproteinemia Type I
[A gene analysis of familial lipoprotein lipase deficiency in China]
Hyperlipoproteinemia Type I
[Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene]
Hyperlipoproteinemia Type I
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Hyperlipoproteinemia Type I
[Lipoprotein lipase deficiency due to lipoprotein lipase gene mutations (current overview)]
Hyperlipoproteinemia Type I
[Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)]
Hyperlipoproteinemia Type I
[Lipoprotein lipase: a multifunctional enzyme in lipoprotein metabolism]
Hyperlipoproteinemia Type I
[Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome]
Hyperlipoproteinemia Type I
[Primary lipoprotein lipase deficiency: clinical and genetic aspects]
Hyperlipoproteinemia Type II
A common mutation in the lipoprotein lipase gene (N291S) alters the lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolemia.
Hyperlipoproteinemia Type II
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Hyperlipoproteinemia Type II
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy.
Hyperlipoproteinemia Type II
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
Hyperlipoproteinemia Type II
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Hyperlipoproteinemia Type II
High density lipoprotein, apoproteins A-I and A-II and postheparin plasma lipolytic enzymes after ileal bypass.
Hyperlipoproteinemia Type II
Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
Hyperlipoproteinemia Type II
Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
Hyperlipoproteinemia Type II
Low-dose colestipol plus fenofibrate: effects on plasma lipoproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
Hyperlipoproteinemia Type II
Selective deficiency of hepatic triglyceride lipase in uremic patients.
Hyperlipoproteinemia Type II
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Hyperlipoproteinemia Type II
[A study of low density lipoprotein in a patient with hyper-high density lipoprotein cholesterolemia with normal cholesterolester transfer protein]
Hyperlipoproteinemia Type II
[Dyslipoproteinemias in Quebec: primary deficit in lipoprotein lipase and familial hypercholesterolemia]
Hyperlipoproteinemia Type II
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Hyperlipoproteinemia Type II
[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia]
Hyperlipoproteinemia Type III
Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia.
Hyperlipoproteinemia Type III
Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentration.
Hyperlipoproteinemia Type III
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Hyperlipoproteinemia Type III
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Hyperlipoproteinemia Type III
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Hyperlipoproteinemia Type III
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
Hyperlipoproteinemia Type III
Impaired very low density lipoprotein and triglyceride removal in broad beta disease: comparison with endogenous hypertriglyceridemia.
Hyperlipoproteinemia Type III
Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?
Hyperlipoproteinemia Type III
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.
Hyperlipoproteinemia Type III
Pregnancy-induced hyperlipoproteinemia: review of the literature.
Hyperlipoproteinemia Type III
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Hyperlipoproteinemia Type IV
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Hyperlipoproteinemia Type IV
A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
Hyperlipoproteinemia Type IV
Characterization of apoprotein metabolism and atherogenic lipoproteins during oral isotretinoin treatment.
Hyperlipoproteinemia Type IV
Development of a direct DNA sequencing method for detecting heterozygous mutations of the human lipoprotein lipase gene.
Hyperlipoproteinemia Type IV
Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene.
Hyperlipoproteinemia Type IV
Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
Hyperlipoproteinemia Type IV
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
Hyperlipoproteinemia Type IV
In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
Hyperlipoproteinemia Type IV
Metabolic consequences of genetic heterogeneity of lipoprotein composition (lipoprotein heterogeneity).
Hyperlipoproteinemia Type IV
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
Hyperlipoproteinemia Type IV
No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes.
Hyperlipoproteinemia Type IV
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Hyperlipoproteinemia Type IV
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Hyperlipoproteinemia Type IV
Severe Familial Hypertriglyceridemia: Successful Treatment With Insulin and a Modified Meal Plan.
Hyperlipoproteinemia Type IV
Severe, gestational, non-familial, non-genetic hypertriglyceridemia.
Hyperlipoproteinemia Type IV
The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia.
Hyperlipoproteinemia Type IV
Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.
Hyperlipoproteinemia Type IV
[Alcohol-induced hypertriglyceridemia in subjects with decreased lipoprotein lipase--improvement after cessation of alcohol intake]
Hyperlipoproteinemia Type IV
[Hyperchylomicronemia and hyperprebetalipoproteinemia. Study of the lipoprotein lipase system]
Hyperlipoproteinemia Type V
Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type v hyperlipoproteinemia.
Hyperlipoproteinemia Type V
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
Hyperlipoproteinemia Type V
Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
Hyperlipoproteinemia Type V
Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody.
Hyperlipoproteinemia Type V
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Hyperlipoproteinemia Type V
Diagnosis and management of type I and type V hyperlipoproteinemia.
Hyperlipoproteinemia Type V
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Hyperlipoproteinemia Type V
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Hyperlipoproteinemia Type V
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.
Hyperlipoproteinemia Type V
[Possibility of New Circulating Atherosclerosis-Related Lipid Markers Measurement in Medical and Complete Medical Checkups: Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein Lipase].
Hyperlipoproteinemias
A 4 basepair deletion in exon 4 of the human lipoprotein lipase gene results in type I hyperlipoproteinemia.
Hyperlipoproteinemias
A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
Hyperlipoproteinemias
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Hyperlipoproteinemias
A mutation in the lipoprotein lipase gene associated with hyperlipoproteinemia type I in mink: studies on lipid and lipase levels in heterozygotes.
Hyperlipoproteinemias
A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
Hyperlipoproteinemias
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing.
Hyperlipoproteinemias
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
Hyperlipoproteinemias
Activation of adipose tissue lipoprotein lipase by lipoprotein fractions from normals and patients with type v hyperlipoproteinemia.
Hyperlipoproteinemias
Adipose tissue lipoprotein lipase activity in type III hyperlipoproteinemia.
Hyperlipoproteinemias
An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
Hyperlipoproteinemias
Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody.
Hyperlipoproteinemias
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
Hyperlipoproteinemias
Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentration.
Hyperlipoproteinemias
Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities.
Hyperlipoproteinemias
Congenital lipoprotein lipase deficiency in hyperlipemic kitten siblings.
Hyperlipoproteinemias
Correlations between the apoprotein C composition of very-low-density lipoproteins and triglyceridemia in subjects with type IV hyperlipoproteinemia.
Hyperlipoproteinemias
Development of a direct DNA sequencing method for detecting heterozygous mutations of the human lipoprotein lipase gene.
Hyperlipoproteinemias
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Hyperlipoproteinemias
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Hyperlipoproteinemias
Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia.
Hyperlipoproteinemias
Effect of oral mesoglycan on plasma lipoprotein concentration and on lipoprotein lipase activity in primary hyperlipoproteinemia.
Hyperlipoproteinemias
Effect of the apolipoprotein C-II/C-III1 ratio on the capacity of purified milk lipoprotein lipase to hydrolyse triglycerides in monolayer vesicles.
Hyperlipoproteinemias
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Hyperlipoproteinemias
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Hyperlipoproteinemias
Heparin-released blood plasma lipoprotein lipase activity in patients with hyperlipoproteinemia.
Hyperlipoproteinemias
Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
Hyperlipoproteinemias
Hyperlipoproteinemia type I in a patient with active lipoprotein lipase in adipose tissue and indications of defective transport of the enzyme.
Hyperlipoproteinemias
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.
Hyperlipoproteinemias
Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Hyperlipoproteinemias
Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?
Hyperlipoproteinemias
Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
Hyperlipoproteinemias
Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
Hyperlipoproteinemias
Lipolytic enzymes, metablic syndrome and atherosclerosis (revisiting and revising a 40 years old study).
Hyperlipoproteinemias
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia.
Hyperlipoproteinemias
Milk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia.
Hyperlipoproteinemias
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia.
Hyperlipoproteinemias
Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.
Hyperlipoproteinemias
Polymorphism of the gene encoding lipoprotein lipase in thai primary hyperlipoproteinemias.
Hyperlipoproteinemias
Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Hyperlipoproteinemias
Primary type 1 hyperlipoproteinemia: significance of lipoprotein lipase and hepatic triglyceride lipase activity in heterozygotes of patients with familial lipoprotein lipase deficiency.
Hyperlipoproteinemias
Primary type I hyperlipoproteinemia with normal lipoprotein lipase activity.
Hyperlipoproteinemias
Purified postheparin plasma lipoprotein lipase in primary hyperlipoproteinemias.
Hyperlipoproteinemias
Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
Hyperlipoproteinemias
Selective deficiency of hepatic triglyceride lipase in uremic patients.
Hyperlipoproteinemias
The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia.
Hyperlipoproteinemias
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.
Hyperlipoproteinemias
Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene.
Hyperlipoproteinemias
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
Hyperlipoproteinemias
Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.
Hyperlipoproteinemias
[Alcohol-induced hypertriglyceridemia in subjects with decreased lipoprotein lipase--improvement after cessation of alcohol intake]
Hyperlipoproteinemias
[Lipoprotein lipase activity of adipose tissue in various types of primary familial hyperlipoproteinemias]
Hyperlipoproteinemias
[Lipoprotein lipase activity of ischemic heart disease patients with different types of hyperlipoproteinemia on the basis of fat loading]
Hyperlipoproteinemias
[Lipoprotein lipase and post-heparin esterase activity in primary type IV and V hyperlipoproteinemia]
Hyperlipoproteinemias
[Study on lipoprotein lipase gene Hind III polymorphism in Chinese type IIb hyperlipoproteinemia]
Hyperlipoproteinemias
[Type ? hyperlipoproteinemia caused by lipoprotein lipase gene mutation in three Chinese children].
Hyperparathyroidism
Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects.
Hyperparathyroidism, Secondary
Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.
Hyperprolactinemia
Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.
Hypertension
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Hypertension
Association of the lipoprotein lipase gene Ser447Ter polymorphism with hypertension and blood pressure variation: evidence from an updated meta-analysis.
Hypertension
Effects of long-term therapy with labetalol on lipoprotein metabolism in patients with mild hypertension.
Hypertension
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Hypertension
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
Hypertension
Genetic polymorphism of S447X lipoprotein lipase (LPL) and the susceptibility to hypertension.
Hypertension
Incorporating covariates into multipoint association mapping in the case-parent design.
Hypertension
Investigation of lipoprotein lipase (LPL) as a candidate gene for dyslipidaemic hypertension.
Hypertension
Lipoprotein lipase gene is linked and associated with hypertension in Taiwan young-onset hypertension genetic study.
Hypertension
Lipoprotein lipase gene polymorphisms and blood pressure levels in the Northern Chinese Han population.
Hypertension
Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides.
Hypertension
Meta-based association of the lipoprotein lipase gene S447X variant with hypertension and blood pressure variation.
Hypertension
No association between alpha-adducin 460 polymorphism and essential hypertension in a Japanese population.
Hypertension
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Hypertension
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
Hypertension
The environmental and genetic evidence for the association of hyperlipidemia and hypertension.
Hypertension
Variation near the region of the lipoprotein lipase gene and hypertension or blood pressure levels in Chinese.
Hyperthyroidism
Adrenergic binding sites and enzyme activities in the heart of hyperthyroid rats.
Hyperthyroidism
Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein.
Hyperthyroidism
EFFECTS OF HYPERTHYROIDISM, EPINEPHRINE, AND DIET ON HEART LIPOPROTEIN LIPASE ACTIVITY.
Hyperthyroidism
Experimental hyperthyroidism in man: effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase.
Hyperthyroidism
High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
Hyperthyroidism
Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Hyperthyroidism
Tissue lipoprotein lipase in the hyperthyroid rat. Effect of growth and aging.
Hyperthyroidism
Treatment of hyperthyroidism: effects on hepatic lipase, lipoprotein lipase, LCAT and plasma lipoproteins.
Hypertriglyceridemia
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
Hypertriglyceridemia
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
Hypertriglyceridemia
A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
Hypertriglyceridemia
A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
Hypertriglyceridemia
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
Hypertriglyceridemia
A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing.
Hypertriglyceridemia
A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis.
Hypertriglyceridemia
A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia.
Hypertriglyceridemia
A novel nonsense mutation in exon 1 and a transition in intron 3 of the lipoprotein lipase gene.
Hypertriglyceridemia
A novel nonsense mutation in the LPL gene in a Chinese neonate with hypertriglyceridemia.
Hypertriglyceridemia
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
Hypertriglyceridemia
A variant primary structure of apolipoprotein C-II in individuals of African descent.
Hypertriglyceridemia
Ability of exercise to inhibit carbohydrate-induced hypertriglyceridemia in rats.
Hypertriglyceridemia
Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia.
Hypertriglyceridemia
Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents.
Hypertriglyceridemia
Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
Hypertriglyceridemia
Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction.
Hypertriglyceridemia
Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.
Hypertriglyceridemia
Alcoholic hypertriglyceridemia with decreased activity of lipoprotein lipase and hepatic triglyceride lipase.
Hypertriglyceridemia
Alpha-adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats.
Hypertriglyceridemia
Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL.
Hypertriglyceridemia
An ELISA for quantifying GPIHBP1 autoantibodies and making a diagnosis of the GPIHBP1 autoantibody syndrome.
Hypertriglyceridemia
Anti-TNF treatment does not reverse the abnormalities in lipid metabolism of the obese Zucker rat.
Hypertriglyceridemia
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
Hypertriglyceridemia
ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.
Hypertriglyceridemia
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Hypertriglyceridemia
Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Hypertriglyceridemia
Apolipoprotein C-II Deficiency with No Rare Variant in the APOC2 Gene.
Hypertriglyceridemia
Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
Hypertriglyceridemia
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.
Hypertriglyceridemia
Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
Hypertriglyceridemia
Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.
Hypertriglyceridemia
Artemisia Iwayomogi Extract Attenuates High-Fat Diet-Induced Hypertriglyceridemia in Mice: Potential Involvement of the Adiponectin-AMPK Pathway and Very Low Density Lipoprotein Assembly in the Liver.
Hypertriglyceridemia
Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians.
Hypertriglyceridemia
Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.
Hypertriglyceridemia
Carbohydrate-lipid interactions during gestation and their control by insulin.
Hypertriglyceridemia
Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice.
Hypertriglyceridemia
Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.
Hypertriglyceridemia
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
Hypertriglyceridemia
Cellular Glycolysis and The Differential Survival of Lung Fibroblast and Lung Carcinoma Cell Lines.
Hypertriglyceridemia
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
Hypertriglyceridemia
Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation.
Hypertriglyceridemia
Charge-based heterogeneity of human plasma lipoproteins at hypertriglyceridemia: capillary isotachophoresis study.
Hypertriglyceridemia
Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.
Hypertriglyceridemia
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
Hypertriglyceridemia
Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
Hypertriglyceridemia
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Hypertriglyceridemia
Chylomicronemia caused by lipoprotein lipase gene mutation related to a hyper-response of insulin secretion to glucose.
Hypertriglyceridemia
Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia.
Hypertriglyceridemia
Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.
Hypertriglyceridemia
Clinical factors affecting lipid metabolism and optimal dose of heparin in preterm infants on parenteral nutrition.
Hypertriglyceridemia
Combination of apolipoprotein E2 and lipoprotein lipase heterozygosity causes severe hypertriglyceridemia during pregnancy.
Hypertriglyceridemia
Combined (n-3 and n-6) essential fatty deficiency is a potent modulator of plasma lipids, lipoprotein composition, and lipolytic enzymes.
Hypertriglyceridemia
Combined lipase deficiency in the mouse. Evidence of impaired lipase processing and secretion.
Hypertriglyceridemia
Common mutations of the lipoprotein lipase gene and their clinical significance.
Hypertriglyceridemia
Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment.
Hypertriglyceridemia
Comparison of assay methods for selective measurement of plasma lipase. The effect of clofibrate on hepatic and lipoprotein lipase in normals and patients with hypertriglyceridemia.
Hypertriglyceridemia
Comparison of plasmapheresis with medical apheresis in terms of efficacy and cost in the acute treatment of hypertriglyceridemia in children with lipoprotein lipase deficiency.
Hypertriglyceridemia
Compound but non-linked heterozygous p.W14X and p.L279 V LPL gene mutations in a Chinese patient with long-term severe hypertriglyceridemia and recurrent acute pancreatitis.
Hypertriglyceridemia
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
Hypertriglyceridemia
Correction of hypertriglyceridemia and impaired fat tolerance in lipoprotein lipase-deficient mice by adenovirus-mediated expression of human lipoprotein lipase.
Hypertriglyceridemia
Decline of postheparin plasma lipoprotein lipase in acromegalic patients.
Hypertriglyceridemia
Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein.
Hypertriglyceridemia
Decreased lipoprotein lipase as a risk factor for atypical neuroleptic-induced hypertriglyceridemia.
Hypertriglyceridemia
Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria.
Hypertriglyceridemia
Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats.
Hypertriglyceridemia
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.
Hypertriglyceridemia
Development of a sensitive ELISA to quantify apolipoprotein CIII in non-human primate serum.
Hypertriglyceridemia
Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
Hypertriglyceridemia
Diagnosis and management of familial dyslipoproteinemia in children and adolescents.
Hypertriglyceridemia
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Hypertriglyceridemia
Diethylaminoethoxyhexestrol causes hypertriglyceridemia in guinea pigs.
Hypertriglyceridemia
Differential modulation of intracellular energetics in A549 and MRC-5 cells.
Hypertriglyceridemia
Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia.
Hypertriglyceridemia
Dyslipidemia and cardiovascular health in childhood nephrotic syndrome.
Hypertriglyceridemia
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
Hypertriglyceridemia
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.
Hypertriglyceridemia
Effect of improved diabetes control on the expression of lipoprotein lipase in human adipose tissue.
Hypertriglyceridemia
Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma.
Hypertriglyceridemia
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.
Hypertriglyceridemia
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia.
Hypertriglyceridemia
Effects of dietary methionine and cystine on lipid metabolism in hepatoma-bearing rats with hyperlipidemia.
Hypertriglyceridemia
Effects of intralipid-induced hypertriglyceridemia on plasma high-density lipoprotein metabolism in the cynomolgus monkey.
Hypertriglyceridemia
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.
Hypertriglyceridemia
Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
Hypertriglyceridemia
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Hypertriglyceridemia
Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.
Hypertriglyceridemia
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Hypertriglyceridemia
Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells.
Hypertriglyceridemia
Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level.
Hypertriglyceridemia
Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice.
Hypertriglyceridemia
Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
Hypertriglyceridemia
Enhanced lipoprotein lipase secretion from human monocyte-derived macrophages caused by hypertriglyceridemic very low density lipoproteins.
Hypertriglyceridemia
Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.
Hypertriglyceridemia
Excessive hypertriglyceridemia and pancreatitis in pregnancy. Association with deficiency of lipoprotein lipase.
Hypertriglyceridemia
Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure.
Hypertriglyceridemia
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy.
Hypertriglyceridemia
Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the rat.
Hypertriglyceridemia
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Hypertriglyceridemia
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
Hypertriglyceridemia
Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase.
Hypertriglyceridemia
Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women.
Hypertriglyceridemia
Gene polymorphisms in the Quebec population: a risk to develop hypertriglyceridemia.
Hypertriglyceridemia
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
Hypertriglyceridemia
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Hypertriglyceridemia
Genetic screening of the lipoprotein lipase gene for mutations in Chinese subjects with or without hypertriglyceridemia.
Hypertriglyceridemia
Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Hypertriglyceridemia
Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat.
Hypertriglyceridemia
Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
Hypertriglyceridemia
Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia.
Hypertriglyceridemia
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia.
Hypertriglyceridemia
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Hypertriglyceridemia
Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
Hypertriglyceridemia
Homozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombination.
Hypertriglyceridemia
Human apolipoprotein A-II associates with triglyceride-rich lipoproteins in plasma and impairs their catabolism.
Hypertriglyceridemia
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Hypertriglyceridemia
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
Hypertriglyceridemia
Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
Hypertriglyceridemia
Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.
Hypertriglyceridemia
Hypertriglyceridemia and lipoprotein lipase activity in experimental uremia.
Hypertriglyceridemia
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
Hypertriglyceridemia
Hypertriglyceridemia associated with tumor necrosis factor-alpha in hamster cheek-pouch carcinogenesis.
Hypertriglyceridemia
Hypertriglyceridemia characterized by low-density lipoprotein phenotype and lipoprotein lipase gene mutation.
Hypertriglyceridemia
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.
Hypertriglyceridemia
Impaired triacylglycerol catabolism in hypertriglyceridemia of the diabetic, cholesterol-fed rabbit: a possible mechanism for protection from atherosclerosis.
Hypertriglyceridemia
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
Hypertriglyceridemia
Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma.
Hypertriglyceridemia
Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
Hypertriglyceridemia
Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase.
Hypertriglyceridemia
Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
Hypertriglyceridemia
Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells.
Hypertriglyceridemia
Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.
Hypertriglyceridemia
Inhibition of purified human postheparin lipoprotein lipase by beta-adrenergic blockers in vitro.
Hypertriglyceridemia
Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.
Hypertriglyceridemia
Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese.
Hypertriglyceridemia
Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target.
Hypertriglyceridemia
Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia.
Hypertriglyceridemia
Is the glucocorticoid-induced hypertriglyceridemia in uremic rats caused by decreased tissue lipoprotein lipase activity?
Hypertriglyceridemia
Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity?
Hypertriglyceridemia
JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function.
Hypertriglyceridemia
Leu452His Mutation in Lipoprotein Lipase Gene Transfer Associated with Hypertriglyceridemia in Mice in vivo.
Hypertriglyceridemia
Lipoprotein lipase activity and common gene variants in severely hypertriglyceridemic patients with and without diabetes.
Hypertriglyceridemia
Lipoprotein lipase activity and hypertriglyceridemia in alloxan diabetic rabbits.
Hypertriglyceridemia
Lipoprotein lipase activity in surgical patients: influence of trauma and infection.
Hypertriglyceridemia
Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy.
Hypertriglyceridemia
Lipoprotein lipase and hepatic lipase activity in post-heparin plasma of patients with hypertriglyceridemia.
Hypertriglyceridemia
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
Hypertriglyceridemia
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Hypertriglyceridemia
Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia.
Hypertriglyceridemia
Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people.
Hypertriglyceridemia
Lipoprotein Lipase Inhibitor, Nordihydroguaiaretic Acid, Aggravates Metabolic Phenotypes and Alters HDL Particle Size in the Western Diet-Fed db/db Mice.
Hypertriglyceridemia
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.
Hypertriglyceridemia
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
Hypertriglyceridemia
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Hypertriglyceridemia
LPL gene Pvu II polymorphism and hypertriglyceridemia: a meta-analysis involving 1,640 subjects.
Hypertriglyceridemia
Lpl-C310R mutation is associated with impaired glucose tolerance and endoplasmic reticulum stress in skeletal muscle.
Hypertriglyceridemia
Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity.
Hypertriglyceridemia
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
Hypertriglyceridemia
Medicinal plants in treatment of hypertriglyceridemia: A review based on their mechanisms and effectiveness.
Hypertriglyceridemia
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity.
Hypertriglyceridemia
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Hypertriglyceridemia
Molecular and functional characterization of familial chylomicronemia syndrome.
Hypertriglyceridemia
Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
Hypertriglyceridemia
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
Hypertriglyceridemia
Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.
Hypertriglyceridemia
Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan.
Hypertriglyceridemia
Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Hypertriglyceridemia
Newly identified missense mutation reduces lipoprotein lipase activity in Taiwanese patients with hypertriglyceridemia.
Hypertriglyceridemia
Nitric oxide mediates endotoxin-induced hypertriglyceridemia through its action on skeletal muscle lipoprotein lipase.
Hypertriglyceridemia
Novel Combined GPIHBP1 Mutations in a Patient with Hypertriglyceridemia Associated with CAD.
Hypertriglyceridemia
Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 diabetic pedigrees.
Hypertriglyceridemia
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia.
Hypertriglyceridemia
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia.
Hypertriglyceridemia
Pathogenetic mechanisms of the endogenous hypertriglyceridemia in a nonobese rat model.
Hypertriglyceridemia
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.
Hypertriglyceridemia
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Hypertriglyceridemia
Plasma lipoproteins and lipoprotein lipase in young diabetics with and without ketonuria.
Hypertriglyceridemia
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
Hypertriglyceridemia
Postprandial lipemia and lipoprotein lipase in the rabbit are modified by olive and coconut oil.
Hypertriglyceridemia
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Hypertriglyceridemia
Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity.
Hypertriglyceridemia
Progress of research on dyslipidemia accompanied by nephrotic syndrome.
Hypertriglyceridemia
Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
Hypertriglyceridemia
Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.
Hypertriglyceridemia
Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach.
Hypertriglyceridemia
Rare LPL gene missense mutation in an infant with hypertriglyceridemia.
Hypertriglyceridemia
Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases.
Hypertriglyceridemia
Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.
Hypertriglyceridemia
Recent advances in factors that alter lipid metabolism in chronic renal failure.
Hypertriglyceridemia
Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients.
Hypertriglyceridemia
Recommendations for Severe Hypertriglyceridemia Treatment, are There New Strategies?
Hypertriglyceridemia
Reduced hepatic triglyceride secretion in rats fed docosahexaenoic acid-rich fish oil suppresses postprandial hypertriglyceridemia.
Hypertriglyceridemia
Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
Hypertriglyceridemia
Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
Hypertriglyceridemia
Regulation of lipoprotein lipase by glucose in primary cultures of isolated human adipocytes. Relevance to hypertriglyceridemia of diabetes.
Hypertriglyceridemia
Regulation of secretion and enzymatic activity of lipoprotein lipase by C-mannosylation.
Hypertriglyceridemia
Relation of lipoprotein lipase activity in adipose tissue to adipocyte volume and its influence in hypertriglyceridemia pathogenesis.
Hypertriglyceridemia
Relationship of organ lipoprotein lipase activity and ketonuria to hypertriglyceridemia in starved and streptozocin-induced diabetic rats.
Hypertriglyceridemia
Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.
Hypertriglyceridemia
Resequencing the untranslated regions of the lipoprotein lipase (LPL) gene reveals that variants in microRNA target sequences are associated with triglyceride levels.
Hypertriglyceridemia
Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet.
Hypertriglyceridemia
Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism.
Hypertriglyceridemia
Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).
Hypertriglyceridemia
RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia.
Hypertriglyceridemia
Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins.
Hypertriglyceridemia
Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy.
Hypertriglyceridemia
Role of protein kinase C in the translational regulation of lipoprotein lipase in adipocytes.
Hypertriglyceridemia
Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle.
Hypertriglyceridemia
Sequencing of Lipoprotein Lipase Gene in 11 Cases of Chinese Patients with Severe Endogenous Hypertriglyceridemia.
Hypertriglyceridemia
Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia.
Hypertriglyceridemia
Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats.
Hypertriglyceridemia
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
Hypertriglyceridemia
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
Hypertriglyceridemia
Severe Hypertriglyceridemia due to a novel p.Q240H mutation in the Lipoprotein Lipase gene.
Hypertriglyceridemia
Severe hypertriglyceridemia due to two novel loss-of-function lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitis.
Hypertriglyceridemia
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
Hypertriglyceridemia
Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
Hypertriglyceridemia
Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.
Hypertriglyceridemia
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Hypertriglyceridemia
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
Hypertriglyceridemia
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia.
Hypertriglyceridemia
Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.
Hypertriglyceridemia
Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy.
Hypertriglyceridemia
Streptozotocin-induced diabetes decreases mammary gland lipoprotein lipase activity and messenger ribonucleic acid in pregnant and nonpregnant rats.
Hypertriglyceridemia
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
Hypertriglyceridemia
Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Hypertriglyceridemia
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Hypertriglyceridemia
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Hypertriglyceridemia
The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
Hypertriglyceridemia
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Hypertriglyceridemia
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
Hypertriglyceridemia
The recovery of dysfunctional lipoprotein lipase (Asp204-Glu) activity by modification of substrate.
Hypertriglyceridemia
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
Hypertriglyceridemia
The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism.
Hypertriglyceridemia
Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome.
Hypertriglyceridemia
Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat.
Hypertriglyceridemia
Tumor necrosis factor mediates hypertriglyceridemia during thermal injury in mice genetically susceptible to lipopolysaccharides.
Hypertriglyceridemia
Tumor necrosis factor, cytokines, and the hyperlipidemia of infection.
Hypertriglyceridemia
Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.
Hypertriglyceridemia
Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23.
Hypertriglyceridemia
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
Hypertriglyceridemia
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Hypertriglyceridemia
Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.
Hypertriglyceridemia
Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia.
Hypertriglyceridemia
Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
Hypertriglyceridemia
Whole-Exome Sequencing Reveals GPIHBP1 Mutations in A Case of Infantile Colitis with Severe Hypertriglyceridemia.
Hypertriglyceridemia
[A case of polymyositis associated with hypertriglyceridemia due to decline of lipoprotein lipase activity]
Hypertriglyceridemia
[Dyslipoproteinemia and metabolic syndrome. Effects of insulin resistance and hyperinsulinemia on lipid metabolism]
Hypertriglyceridemia
[Effects of intravenous glucose loads on endogenous and post-heparin lipoprotein lipase activity in plasma of normal subjects, patients with primary endogenous hypertriglyceridemia and diabetics]
Hypertriglyceridemia
[High-density lipoprotein subfractions and sex hormones in the blood plasma of men 40 to 59]
Hypertriglyceridemia
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Hypertriglyceridemia
[Hypertriglyceridemia in a deficiency of lipoprotein lipase and hepatic lipase]
Hypertriglyceridemia
[Lipoprotein lipase--physiological and pathophysiological roles of this gene variant in Croatian population]
Hypertriglyceridemia
[New kidney, but a sick heart. Why many patients with renal failure and kidney transplant patients die of cardiovascular disease]
Hypertriglyceridemia
[On the behavior of the endogenous lipoprotein lipase activity in plasma during an intravenous lipid infusion in normal persons and patients with hypertriglyceridemia]
Hypertriglyceridemia
[On the etiology of diabetic hyperlipidemia from the aspects of the metabolism of ApoHDL (author's transl)]
Hypertriglyceridemia
[Pathophysiology and therapy of lipid metabolism disorders in kidney diseases]
Hypertriglyceridemia
[Serum lipoprotein lipase activity in diabetes mellitus. II. Hypertriglyceridemia and lipoprotein lipase activity]
Hypertriglyceridemia
[Severe hypertriglyceridemia : Diagnostics and new treatment principles].
Hypertriglyceridemia
[Studies on hypertriglyceridemia in liver diseases by means of measurements of hepatic triglyceride lipase and plasma lipoprotein lipase activity in the heparinized plasma]
Hypertriglyceridemia
[TOTAL PARENTERAL NUTRITION IN A PREGNANT PATIENT WITH ACUTE PANCREATITIS AND LIPOPROTEIN LIPASE DEFICIENCY].
Hypertrophy, Left Ventricular
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
Hypoalbuminemia
Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
Hypoalbuminemia
Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
Hypoalphalipoproteinemias
Genetic polymorphisms and mutations of the lipoprotein lipase gene in Japanese schoolchildren with hypoalphalipoproteinemia.
Hypoalphalipoproteinemias
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Hypoalphalipoproteinemias
[High-density lipoprotein subfractions and sex hormones in the blood plasma of men 40 to 59]
Hypobetalipoproteinemias
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Hypobetalipoproteinemias
Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia.
Hypobetalipoproteinemias
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
Hypoglycemia
Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion.
Hypogonadism
Increase in hepatic lipase activity after testosterone substitution in men with hypogonadism of pituitary origin.
Hypokinesia
Effect of hypokinesia on lipoprotein lipase activity in skeletal muscles of rat.
Hypophosphatemia
Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men.
Hypothyroidism
Brain lipoprotein lipase is responsive to nutritional and hormonal modulation.
Hypothyroidism
Brown adipocytes differentiated in vitro can express the gene for the uncoupling protein thermogenin: effects of hypothyroidism and norepinephrine.
Hypothyroidism
Dyslipoproteinaemia in hypothyroidism of pituitary origin: effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins.
Hypothyroidism
Effects of hypothyroidism on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats.
Hypothyroidism
Expression of lipoprotein lipase in rat muscle: regulation by feeding and hypothyroidism.
Hypothyroidism
High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
Hypothyroidism
Influence of nutritional state on lipoprotein lipase activities in the hypothyroid rat.
Hypothyroidism
Lipoprotein lipase-mediated sequestration of long-chain polyunsaturated triacylglycerols in serum LDL from normal and hypothyroid rats.
Hypothyroidism
Reduced thermogenesis in muscle and disturbed lipoprotein metabolism in relation to thyroid function in haemodialysis patients.
Hypothyroidism
Regulation of myocardial lipoprotein lipase activity by diabetes and thyroid hormones.
Hypothyroidism
Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Hypothyroidism
Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism.
Hypothyroidism
Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism.
Hypothyroidism
Thyroid Hormone Effects on Whole-Body Energy Homeostasis and Tissue-Specific Fatty Acid Uptake in Vivo.
Hypothyroidism
Translational regulation of lipoprotein lipase by thyroid hormone is via a cytoplasmic repressor that interacts with the 3' untranslated region.
Hypothyroidism
[Heparin and lipoprotein lipase activity of the blood in primary hypothyroidism]
Infections
Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells.
Infections
Adipose tissue lipoprotein lipase activity in Plasmodium chabaudi and Plasmodium vinckei rodent malaria.
Infections
Changes in fat metabolism of black-bone chickens during early stages of infection with Newcastle disease virus.
Infections
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.
Infections
Lipoprotein lipase activity in surgical patients: influence of trauma and infection.
Infections
Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.
Infections
Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids.
Infections
Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.
Infections
Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.
Infections
Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Infections
Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins.
Infections
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
Infections
Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.
Infections
Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Influenza, Human
Hepatic steatosis during convalescence from influenza B infection in ferrets with postprandial hyperinsulinemia.
Insulin Resistance
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Insulin Resistance
Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase.
Insulin Resistance
Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice.
Insulin Resistance
Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
Insulin Resistance
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Insulin Resistance
Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice.
Insulin Resistance
Artemisia Iwayomogi Extract Attenuates High-Fat Diet-Induced Hypertriglyceridemia in Mice: Potential Involvement of the Adiponectin-AMPK Pathway and Very Low Density Lipoprotein Assembly in the Liver.
Insulin Resistance
Association of adiponectin with serum preheparin lipoprotein lipase mass in women independent of fat mass and distribution, insulin resistance, and inflammation.
Insulin Resistance
Association of lipoprotein lipase gene variation with the physiological components of the insulin-resistance syndrome in the population of the San Luis Valley, Colorado.
Insulin Resistance
Association of polymorphism genes
LPL
,
ADRB2
,
AGT
and
AGTR1
with risk of hyperinsulinism and insulin resistance in the Kazakh population.
Insulin Resistance
Associations between lipoprotein lipase gene polymorphisms and insulin resistance in coronary heart disease.
Insulin Resistance
Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population.
Insulin Resistance
Associations of Lower-Body Fat Mass with Favorable Profile of Lipoproteins and Adipokines in Healthy, Slim Women in Early Adulthood.
Insulin Resistance
C-peptide but not insulin concentrations are related to the serum lipoprotein levels during insulin treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients.
Insulin Resistance
Cardiorespiratory and metabolic characteristics of detraining in humans.
Insulin Resistance
Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice.
Insulin Resistance
Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus.
Insulin Resistance
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Insulin Resistance
Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.
Insulin Resistance
Crocetin improves the insulin resistance induced by high-fat diet in rats.
Insulin Resistance
Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.
Insulin Resistance
Defining the Regulated Secreted Proteome of Rodent Adipocytes upon the Induction of Insulin Resistance.
Insulin Resistance
Delayed postprandial metabolism of triglyceride-rich lipoproteins in obese young men compared to lean young men.
Insulin Resistance
Dietary iron overload induces visceral adipose tissue insulin resistance.
Insulin Resistance
Diets high in carbohydrate may not be appropriate for rs328 G carriers with the metabolic syndrome.
Insulin Resistance
Different Expression of Duodenal Genes Related to Insulin Resistance Between Nonobese Women and Those with Severe Obesity.
Insulin Resistance
Effect of dietary macronutrient composition on tissue-specific lipoprotein lipase activity and insulin action in normal-weight subjects.
Insulin Resistance
Effects of exercise training on abdominal obesity and related metabolic complications.
Insulin Resistance
Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Insulin Resistance
Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
Insulin Resistance
Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-? and leptin, and adipose tissue gene expression.
Insulin Resistance
Epigenetic regulation of lipoprotein lipase gene via BRD4, which is potentially associated with adipocyte differentiation and insulin resistance.
Insulin Resistance
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Insulin Resistance
Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism.
Insulin Resistance
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
Insulin Resistance
Fasting decreases free fatty acid turnover in mice overexpressing skeletal muscle lipoprotein lipase.
Insulin Resistance
Fibrate therapy in the management of diabetic dyslipidemia: there is no ACCORD to be found.
Insulin Resistance
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.
Insulin Resistance
Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction.
Insulin Resistance
Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats.
Insulin Resistance
High lipoprotein lipase activity increases insulin sensitivity in transgenic rabbits.
Insulin Resistance
Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity.
Insulin Resistance
Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects.
Insulin Resistance
Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
Insulin Resistance
Influence of Dietary Chitosan Feeding Duration on Glucose and Lipid Metabolism in a Diabetic Rat Model.
Insulin Resistance
Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals.
Insulin Resistance
Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
Insulin Resistance
Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner.
Insulin Resistance
Insulin Sensitivity Is Associated with Lipoprotein Lipase (LPL) and Catenin Delta 2 (CTNND2) DNA Methylation in Peripheral White Blood Cells in Non-Diabetic Young Women.
Insulin Resistance
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
Insulin Resistance
Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.
Insulin Resistance
Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM.
Insulin Resistance
Lipolytic enzymes, metablic syndrome and atherosclerosis (revisiting and revising a 40 years old study).
Insulin Resistance
Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity.
Insulin Resistance
Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity.
Insulin Resistance
Lipoprotein lipase at onset of obesity induced in rats by a high-fat diet.
Insulin Resistance
Lipoprotein lipase is a gene for insulin resistance in Mexican Americans.
Insulin Resistance
Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study.
Insulin Resistance
Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism.
Insulin Resistance
Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats.
Insulin Resistance
Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.
Insulin Resistance
Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men.
Insulin Resistance
Metabolic responses to exercise. Effects of endurance training and implications for diabetes.
Insulin Resistance
Mini review: physical activity and fitness and its relations to cardiovascular disease risk factors in children.
Insulin Resistance
Muscle fiber composition and capillarization in relation to metabolic alterations in hypertensive men.
Insulin Resistance
NO-1886 ameliorates glycogen metabolism in insulin-resistant HepG2 cells by GSK-3? signalling.
Insulin Resistance
NO-1886 suppresses diet-induced insulin resistance and cholesterol accumulation through STAT5-dependent upregulation of IGF-1 and CYP7A1.
Insulin Resistance
Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase.
Insulin Resistance
Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women.
Insulin Resistance
Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance.
Insulin Resistance
Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits.
Insulin Resistance
Peroxisome proliferator-activated receptor-? agonists have opposing effects on insulin resistance in high fat fed rats and mice due to different metabolic responses in muscle.
Insulin Resistance
Physical activity and blood lipids and lipoproteins in dialysis patients.
Insulin Resistance
Physiological concentrations of insulin and T3 stimulate 3T3-L1 adipocyte acyl-CoA synthetase gene transcription.
Insulin Resistance
Pioglitazone decreases plasma angiotensin II concentration in type 2 diabetes.
Insulin Resistance
PLTP activity in premenopausal women. Relationship with lipoprotein lipase, HDL, LDL, body fat, and insulin resistance.
Insulin Resistance
Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Insulin Resistance
Postprandial modulation of lipoprotein lipase in rats with insulin resistance.
Insulin Resistance
Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation.
Insulin Resistance
Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.
Insulin Resistance
Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.
Insulin Resistance
Preventive effect of diabegon, a polyherbal preparation, during progression of diabetes induced by high-fructose feeding in rats.
Insulin Resistance
Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia.
Insulin Resistance
Relationship between a lipoprotein lipase gene polymorphism in placental tissue and insulin resistance in patients with gestational diabetes mellitus.
Insulin Resistance
Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase.
Insulin Resistance
Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
Insulin Resistance
Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia.
Insulin Resistance
Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats.
Insulin Resistance
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
Insulin Resistance
Sarpogrelate hydrochloride decreases cardio-ankle vascular index accompanied by increased serum lipoprotein lipase mass in type 2 diabetic patients.
Insulin Resistance
ShRNA-mediated gene silencing of lipoprotein lipase improves insulin sensitivity in L6 skeletal muscle cells.
Insulin Resistance
Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Insulin Resistance
Subcutaneous Abdominal Adipose Tissue Subcompartments: Potential Role in Rosiglitazone Effects.
Insulin Resistance
Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
Insulin Resistance
The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity.
Insulin Resistance
The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats.
Insulin Resistance
The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
Insulin Resistance
The Association of a Rare Variant of -93, -53 Promoter Gene Polymorphisms of Lipoprotein Lipase gene with Obesity and Insulin Resistance.
Insulin Resistance
The effect of short-term alpha-glucosidase inhibition on carbohydrate and lipid metabolism in type II (noninsulin-dependent) diabetics.
Insulin Resistance
The effects of 20 days bed rest on serum lipids and lipoprotein concentrations in healthy young subjects.
Insulin Resistance
The heterozygous N291S mutation in the lipoprotein lipase gene impairs whole-body insulin sensitivity and affects a distinct set of plasma metabolites in humans.
Insulin Resistance
The influence of insulin infusion on the metabolism of amyloid ? peptides in plasma.
Insulin Resistance
The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet.
Insulin Resistance
The rise of the plasma lipid concentration elicited by dietary sodium chloride restriction in Wistar rats is due to an impairment of the plasma triacylglycerol removal rate.
Insulin Resistance
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.
Insulin Resistance
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Insulin Resistance
Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.
Insulin Resistance
Waging war on modern chronic diseases: primary prevention through exercise biology.
Insulin Resistance
Whole-body insulin resistance and energy expenditure indices, serum lipids, and skeletal muscle metabolome in a state of lipoprotein lipase overexpression.
Insulin Resistance
[A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis].
Insulin Resistance
[Clinical significance of preheparin serum lipoprotein lipase mass in normocholesterolemic patients with coronary artery disease]
Insulin Resistance
[Dyslipidemia in insulin resistance and its improvement by troglitazone]
Insulin Resistance
[Dyslipidemia, increased lipolysis, and depleted heparin system in insulin resistance].
Intellectual Disability
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Intracranial Hemorrhage, Hypertensive
HindIII Polymorphism in the Lipoprotein Lipase Gene and Hypertensive Intracerebral Hemorrhage in the Chinese Han Population.
Iron Deficiencies
Iron deficiency hyperlipidemia in 18-day-old rat pups: effects of milk lipids, lipoprotein lipase, and triglyceride synthesis.
Iron Overload
Rapid responses of adipocytes to iron overload increase serum TG level by decreasing adiponectin.
Ischemic Stroke
Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction.
Ischemic Stroke
Cholesteryl ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not associated with ischaemic stroke in Greek patients.
Ischemic Stroke
Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke.
Ischemic Stroke
Investigation of the Interaction Between the Ser447Term Polymorphism of Lipoprotein Lipase and the Stroke-Related Risk Factors in Ischemic Stroke.
Ischemic Stroke
Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis.
Ischemic Stroke
Lipoprotein lipase Ser447Ter polymorphism associated with the risk of ischemic stroke: A meta-analysis.
Ischemic Stroke
Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity.
Ischemic Stroke
Predictive role of polymorphisms in interleukin-5 receptor alpha-subunit, lipoprotein lipase, integrin A2 and nitric oxide synthase genes on ischemic stroke in type 2 diabetes-An 8-year prospective cohort analysis of 1327 Chinese patients.
Ischemic Stroke
The association of lipid metabolism relative gene polymorphisms and ischemic stroke in Han and Uighur population of Xinjiang.
Ischemic Stroke
The HindIII and PvuII polymorphisms of lipoprotein lipase (LPL) gene reduce the risk of ischemic stroke (IS): A meta-analysis.
Jaundice, Neonatal
Breast milk jaundice; the role of lipoprotein lipase and the free fatty acids.
Jaundice, Neonatal
[Lipoprotein lipase activity in human milk; inhibition in vitro of the glucuro-conjugation of bilirubin (author's transl)]
Ketosis
1,3,5,8-Tetrahydroxyxanthone regulates ANGPTL3-LPL pathway to lessen the ketosis in mice.
Ketosis
Gram-negative bacteria sepsis in the rat and tissue lipolytic activity on LCT and MCT/LCT-based commercial parenteral emulsions.
Ketosis
Metabolic syndrome and low-carbohydrate ketogenic diets in the medical school biochemistry curriculum.
Ketosis
Momilactone B Inhibits Ketosis In Vitro by Regulating the ANGPTL3-LPL Pathway and Inhibiting HMGCS2.
Ketosis
Plasma lipoproteins and lipoprotein lipase in young diabetics with and without ketonuria.
Ketosis
Relationship of organ lipoprotein lipase activity and ketonuria to hypertriglyceridemia in starved and streptozocin-induced diabetic rats.
Kidney Diseases
Lipoprotein lipase in the kidney: activity varies widely among animal species.
Kidney Diseases
Uremic toxins and lipases in haemodialysis: a process of repeated metabolic starvation.
Kidney Failure, Chronic
Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure.
Kidney Failure, Chronic
Effect of protein and peptide fractions from the peritoneal dialysate of patients with chronic renal failure on the lipoprotein lipase activity.
Kidney Failure, Chronic
Impaired lipoprotein lipase activation by uraemic and post-transplant sera.
Kidney Failure, Chronic
Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
Kidney Failure, Chronic
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Kidney Failure, Chronic
Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure.
Kidney Failure, Chronic
Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure.
Kidney Failure, Chronic
Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.
Kidney Failure, Chronic
Study on the inhibitory effect of uremic plasma on lipoprotein lipase.
Kidney Failure, Chronic
Upregulation of fatty acid synthase gene expression in experimental chronic renal failure.
Kidney Failure, Chronic
[Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure]
Kwashiorkor
Dietary effects in the early recovery phase of kwashiorkor. Plasma levels of triglycerides, FFA, D-beta-hydroxybutyrate, glycerol, postheparin lipoprotein lipase (LPL), glucose and insulin.
Kwashiorkor
Studies on hepatic and extrahepatic lipoprotein lipases in protein-calorie malnutrition.
Lecithin Cholesterol Acyltransferase Deficiency
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
Lecithin Cholesterol Acyltransferase Deficiency
Familial lecithin:cholesterol acyltransferase deficiency. Further studies on plasma lipoproteins and plasma postheparin lipase activity of a patient with normal renal function.
Lecithin Cholesterol Acyltransferase Deficiency
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
Lecithin Cholesterol Acyltransferase Deficiency
Lipid compositions of plasma major lipoproteins and lipoprotein lipase activity in hypolipidemic and hyperlipidemic siblings with familial LCAT deficiency.
Leishmaniasis, Visceral
Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.
Leukemia
Cells of a human monocytic leukemia cell line (THP-1) synthesize and secrete apolipoprotein E and lipoprotein lipase.
Leukemia
DNA sequence of lipoprotein lipase cDNA cloned from human monocytic leukemia THP-1 cells.
Leukemia
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes.
Leukemia
Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
Leukemia
Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
Leukemia
Transcriptional activation of the lipoprotein lipase gene in macrophages by dexamethasone.
Leukemia, Lymphocytic, Chronic, B-Cell
Correction: Lipoprotein Lipase SNPs rs13702 and rs301 Correlate with Clinical Outcome in Chronic Lymphocytic Leukemia Patients.
Leukemia, Lymphocytic, Chronic, B-Cell
Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression.
Leukemia, Lymphocytic, Chronic, B-Cell
Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
Leukemia, Lymphocytic, Chronic, B-Cell
EXPRESSION OF LIPOPROTEIN LIPASE AND c-MYC ONCOGENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFFECTED BY THE CHORNOBYL ACCIDENT.
Leukemia, Lymphocytic, Chronic, B-Cell
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein lipase as a predictor for survival in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients.
Leukemia, Lymphocytic, Chronic, B-Cell
Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Prognostic value of lipoprotein lipase expression among egyptian B-chronic lymphocytic leukemia patients.
Leukemia, Lymphocytic, Chronic, B-Cell
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
Leukemia, Lymphocytic, Chronic, B-Cell
The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
[Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors]
Leukemia, Lymphoid
Prognostic value of lipoprotein lipase expression among egyptian B-chronic lymphocytic leukemia patients.
Leydig Cell Tumor
Lipid metabolism in cachectic tumor-bearing rats at different stages of tumor growth.
Leydig Cell Tumor
Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
Liddle Syndrome
Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man.
Lipid Metabolism Disorders
Effects of Portulaca Oleracea Extract on Acute Alcoholic Liver Injury of Rats.
Lipid Metabolism Disorders
Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases.
Lipidoses
Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
Lipidoses
Effect of rumen-protected choline supplementation on liver and adipose gene expression during the transition period in dairy cattle.
Lipodystrophy
Advanced Lipoprotein Analysis Shows Atherogenic Lipid Profile That Improves After Metreleptin in Patients with Lipodystrophy.
Lipodystrophy
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.
Lipodystrophy
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Lipodystrophy, Familial Partial
The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
Lipoma
Are the metabolic characteristics of congenital intraspinal lipoma cells identical to, or different from normal adipocytes?
Lipoma
Lipoprotein lipase activity in normal human adipose tissue and its absence in human lipomas.
Lipoma
Lipoprotein lipase and hormone-sensitive lipase activities in human subcutaneous lipomas: comparison with normal subcutaneous adipose tissue.
Lipomatosis
Metabolic abnormalities in multiple symmetric lipomatosis: elevated lipoprotein lipase activity in adipose tissue with hyperalphalipoproteinemia.
Lipomatosis, Multiple Symmetrical
Metabolic abnormalities in multiple symmetric lipomatosis: elevated lipoprotein lipase activity in adipose tissue with hyperalphalipoproteinemia.
lipoprotein lipase deficiency
11-year Follow-up in Biliopancreatic Diversion for Recurrent Pancreatitis Due to Lipoprotein Lipase Deficiency.
lipoprotein lipase deficiency
A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion.
lipoprotein lipase deficiency
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
lipoprotein lipase deficiency
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
lipoprotein lipase deficiency
A family-based study of hyperinsulinemia and hypertriglyceridemia in heterozygous lipoprotein lipase deficiency.
lipoprotein lipase deficiency
A G----C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family.
lipoprotein lipase deficiency
A Japanese patient with lipoprotein lipase deficiency homozygous for the Gly188Glu mutation prevalent worldwide.
lipoprotein lipase deficiency
A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency.
lipoprotein lipase deficiency
A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries.
lipoprotein lipase deficiency
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.
lipoprotein lipase deficiency
A new Italian case of lipoprotein lipase deficiency: a Leu365- > Val change resulting in loss of enzyme activity.
lipoprotein lipase deficiency
A new mutation in the human lipoprotein lipase gene causing familial hyperchylomicronaemia.
lipoprotein lipase deficiency
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
lipoprotein lipase deficiency
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
lipoprotein lipase deficiency
A sweet heart: Increased cardiac glucose uptake in patients with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Absence of serum-stimulated lipase activity and altered lipid content in milk from a patient with type I hyperlipoproteinaemia.
lipoprotein lipase deficiency
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
lipoprotein lipase deficiency
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
lipoprotein lipase deficiency
Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.
lipoprotein lipase deficiency
Adipose cell size and distribution in familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Adipose Specific Lipoprotein Lipase Deficiency More Profoundly Affects Brown Than White Fat Biology.
lipoprotein lipase deficiency
Adipose tissue fatty acid composition in humans with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Alterations in erythrocyte membrane lipid composition and fluidity in primary lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin.
lipoprotein lipase deficiency
An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
lipoprotein lipase deficiency
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
lipoprotein lipase deficiency
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
lipoprotein lipase deficiency
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
lipoprotein lipase deficiency
Bio F1B hamster: a unique animal model with reduced lipoprotein lipase activity to investigate nutrient mediated regulation of lipoprotein metabolism.
lipoprotein lipase deficiency
Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro.
lipoprotein lipase deficiency
C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
lipoprotein lipase deficiency
Capecitabine-induced severe hypertriglyceridemia: report of two cases.
lipoprotein lipase deficiency
Catalytic triad residue mutation (Asp156----Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447----Ter) in a Turkish family.
lipoprotein lipase deficiency
Cell therapy could be a potential way to improve lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
lipoprotein lipase deficiency
Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: A case report.
lipoprotein lipase deficiency
Comparison of plasmapheresis with medical apheresis in terms of efficacy and cost in the acute treatment of hypertriglyceridemia in children with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
lipoprotein lipase deficiency
Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene.
lipoprotein lipase deficiency
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
lipoprotein lipase deficiency
Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy.
lipoprotein lipase deficiency
Congenital lipoprotein lipase deficiency in hyperlipemic kitten siblings.
lipoprotein lipase deficiency
Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation.
lipoprotein lipase deficiency
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
lipoprotein lipase deficiency
Cost-Effectiveness Analysis of Glybera for The Treatment of Lipoprotein Lipase Deficiency.
lipoprotein lipase deficiency
Critical review of non-statin treatments for dyslipoproteinemia.
lipoprotein lipase deficiency
Deceptive hyperbilirubinaemia in a newborn with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Detailed analysis of lipolytic enzymes in a Japanese woman of familial lipoprotein lipase deficiency - Effects of pemafibrate treatment.
lipoprotein lipase deficiency
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Detection of a new compound heterozygote (del G916/G1401A) for lipoprotein lipase deficiency and a comparative haplotype analysis of the mutant lipoprotein lipase gene from Japanese patients.
lipoprotein lipase deficiency
Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia.
lipoprotein lipase deficiency
Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations.
lipoprotein lipase deficiency
Development and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis(®) Fixed-Bed Bioreactor.
lipoprotein lipase deficiency
Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
lipoprotein lipase deficiency
Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism.
lipoprotein lipase deficiency
Dissociation between plasma triglyceride concentration and tissue lipoprotein lipase deficiency in insulin-deficient rats.
lipoprotein lipase deficiency
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
lipoprotein lipase deficiency
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
lipoprotein lipase deficiency
Effects of exercise and fat ingestion on high density lipoprotein production by peripheral tissues.
lipoprotein lipase deficiency
Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man.
lipoprotein lipase deficiency
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
lipoprotein lipase deficiency
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
lipoprotein lipase deficiency
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
lipoprotein lipase deficiency
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification.
lipoprotein lipase deficiency
Exchange transfusions for extreme hypertriglyceridemia in a 7-week-old infant with multi-organ failure.
lipoprotein lipase deficiency
Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy.
lipoprotein lipase deficiency
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
lipoprotein lipase deficiency
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
lipoprotein lipase deficiency
Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
lipoprotein lipase deficiency
Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutations.
lipoprotein lipase deficiency
Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study.
lipoprotein lipase deficiency
Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
lipoprotein lipase deficiency
Familial lipoprotein lipase deficiency: abnormal lipoproteins and defective metabolism of low density lipoproteins in cultured human skin fibroblasts.
lipoprotein lipase deficiency
Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Gene polymorphism identified by PvuII in familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Gene therapy for genetic lipid disorders: lipoprotein lipase deficiency as a paradigm.
lipoprotein lipase deficiency
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
lipoprotein lipase deficiency
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
lipoprotein lipase deficiency
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
lipoprotein lipase deficiency
Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions.
lipoprotein lipase deficiency
Gene therapy on demand: site specific regulation of gene therapy.
lipoprotein lipase deficiency
Gene-based therapies in lipidology: current status and future challenges.
lipoprotein lipase deficiency
Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec.
lipoprotein lipase deficiency
Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.
lipoprotein lipase deficiency
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns.
lipoprotein lipase deficiency
Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.
lipoprotein lipase deficiency
Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Québec, Canada).
lipoprotein lipase deficiency
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
lipoprotein lipase deficiency
Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
lipoprotein lipase deficiency
HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family.
lipoprotein lipase deficiency
Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
lipoprotein lipase deficiency
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
lipoprotein lipase deficiency
High frequency of lipoprotein lipase deficiency in the Quebec population.
lipoprotein lipase deficiency
Homozygous deletion of exon 9 causes lipoprotein lipase deficiency: possible intron-Alu recombination.
lipoprotein lipase deficiency
Homozygous LPL p.Gly188Glu Mutation in a Mexican Girl With Lipoprotein Lipase Deficiency.
lipoprotein lipase deficiency
Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells?
lipoprotein lipase deficiency
Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.
lipoprotein lipase deficiency
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Hyperlipidemia Resulting in Abnormal Density and Signal Intensity of Blood in a Neonate with Lipoprotein Lipase Deficiency.
lipoprotein lipase deficiency
Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus.
lipoprotein lipase deficiency
Hyperlipoproteinemias: Part I. Lipoprotein classification and abnormalities.
lipoprotein lipase deficiency
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction.
lipoprotein lipase deficiency
Immune Responses to Intramuscular Administration of Alipogene Tiparvovec (AAV1-LPL(S447X)) in a Phase II Clinical Trial of Lipoprotein Lipase Deficiency Gene Therapy.
lipoprotein lipase deficiency
Improved visual function with dietary intervention in a child with lipemia retinalis.
lipoprotein lipase deficiency
In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.
lipoprotein lipase deficiency
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis.
lipoprotein lipase deficiency
Initial diagnosis of lipoprotein lipase deficiency in a 75-year-old man.
lipoprotein lipase deficiency
Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Irradiation-induced free cholesterol accumulation in very-low-density lipoproteins. Role of lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) - First Step Towards a Pro Measure in Lpld.
lipoprotein lipase deficiency
Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Lipaemia retinalis in a 29-day-old infant with type 1 hyperlipoproteinaemia.
lipoprotein lipase deficiency
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
lipoprotein lipase deficiency
Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
lipoprotein lipase deficiency
Lipoprotein Lipase Deficiency (R243H) in a Type 2 Diabetes Patient with Multiple Arterial Aneurysms.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency and transient diabetes mellitus in a neonate.
lipoprotein lipase deficiency
Lipoprotein Lipase Deficiency Arising in Type V Dyslipidemia.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency due to a 3' splice site mutation in intron 6 of the lipoprotein lipase gene.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency due to long-term heparinization presenting as severe hypertriglyceridaemia in pregnancy.
lipoprotein lipase deficiency
Lipoprotein Lipase Deficiency Impairs Bone Marrow Myelopoiesis and Reduces Circulating Monocyte Levels.
lipoprotein lipase deficiency
Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein (ASP) plasma levels.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency leads to ?-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency presenting with neonatal perianal abscesses.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency: benefits and limitations of a novel therapeutic surgical approach.
lipoprotein lipase deficiency
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
lipoprotein lipase deficiency
Lipoprotein lipase secretion by human monocyte-derived macrophages.
lipoprotein lipase deficiency
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
lipoprotein lipase deficiency
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
lipoprotein lipase deficiency
Management of patients with severe hypertriglyceridaemia during pregnancy: report of two cases with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
lipoprotein lipase deficiency
Management strategy and novel ophthalmological findings in neonatal severe hypertriglyceridemia: a case report and literature review.
lipoprotein lipase deficiency
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Maternal expression of functional lipoprotein lipase and effects on body fat mass and body condition scores of mature cats with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Mechanisms of atherogenesis: endothelial hypoxia proposed as the major initiator.
lipoprotein lipase deficiency
Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humans.
lipoprotein lipase deficiency
Metabolic surgery for the treatment of hypertriglyceridemia-related pancreatitis due to familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
lipoprotein lipase deficiency
Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
lipoprotein lipase deficiency
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia.
lipoprotein lipase deficiency
Molecular genetics of apoC-II and lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Neonatal pancreatitis associated with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism.
lipoprotein lipase deficiency
Novel compound heterozygous mutations for lipoprotein lipase deficiency. A G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5' splice site mutation of intron 8.
lipoprotein lipase deficiency
Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review.
lipoprotein lipase deficiency
Occurrence of idiopathic, familial hyperchylomicronaemia in a cat.
lipoprotein lipase deficiency
Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
lipoprotein lipase deficiency
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
lipoprotein lipase deficiency
Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer.
lipoprotein lipase deficiency
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
lipoprotein lipase deficiency
Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Postprandial adipose tissue lipoprotein lipase activity in primary hypertriglyceridemia.
lipoprotein lipase deficiency
Potential of AAV vectors in the treatment of metabolic disease.
lipoprotein lipase deficiency
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
lipoprotein lipase deficiency
Pregnancy-induced hyperlipoproteinemia: review of the literature.
lipoprotein lipase deficiency
Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
lipoprotein lipase deficiency
Prevalence, geographical distribution and genealogical investigations of mutation 188 of lipoprotein lipase gene in the French Canadian population of Québec.
lipoprotein lipase deficiency
Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy.
lipoprotein lipase deficiency
Primary type 1 hyperlipoproteinemia: significance of lipoprotein lipase and hepatic triglyceride lipase activity in heterozygotes of patients with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
lipoprotein lipase deficiency
Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia.
lipoprotein lipase deficiency
Reduced cholesteryl ester transfer in plasma of patients with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Risk factors for coronary artery disease: a study comparing hypercholesterolaemia and hypertriglyceridaemia in angiographically characterized patients.
lipoprotein lipase deficiency
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).
lipoprotein lipase deficiency
Scientifically-based strategies for nutrition of the high-risk low birth weight infant.
lipoprotein lipase deficiency
Serum HDL-C values: An extremely useful marker for differentiating homozygous lipoprotein lipase deficiency from severe hypertriglyceridemia with other causes in Japan: A meta-analysis based on literatures on Japanese homozygous lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
lipoprotein lipase deficiency
Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).
lipoprotein lipase deficiency
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
lipoprotein lipase deficiency
Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience.
lipoprotein lipase deficiency
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
lipoprotein lipase deficiency
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
lipoprotein lipase deficiency
Severe hypertriglyceridemia, large lipoproteins and protection against atherosclerosis.
lipoprotein lipase deficiency
Severe, gestational, non-familial, non-genetic hypertriglyceridemia.
lipoprotein lipase deficiency
Siblings with hepatosplenomegaly and lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
lipoprotein lipase deficiency
The burden of familial chylomicronemia syndrome in Canadian patients.
lipoprotein lipase deficiency
The effect of gestational age on intralipid tolerance in newborn infants.
lipoprotein lipase deficiency
The impact of lipoprotein lipase deficiency on health-related quality of life: a detailed, structured, qualitative study.
lipoprotein lipase deficiency
The molecular genetics of pediatric lipid disorders: recent progress and future research directions.
lipoprotein lipase deficiency
The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
lipoprotein lipase deficiency
The role of lecithin: cholesterol acyltransferase in high density lipoprotein3/high density lipoprotein2 interconversion.
lipoprotein lipase deficiency
The role of patient registries for rare genetic lipid disorders.
lipoprotein lipase deficiency
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
lipoprotein lipase deficiency
The ultrastructural pathology of five lipoprotein lipase-deficient cats.
lipoprotein lipase deficiency
Tocopherol content of adipose tissue from vitamin E-deficient humans.
lipoprotein lipase deficiency
Transient lipoprotein lipase deficiency with hyperchylomicronemia.
lipoprotein lipase deficiency
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Type I hyperlipidaemia caused by lipoprotein lipase deficiency in a nurseling: the role of the clinical laboratory in processing biological samples and contributing to the diagnosis and therapeutic follow-up of patients.
lipoprotein lipase deficiency
Use of plasma lipoprotein lipase activity without heparin injection for detection of homozygous and heterozygous lipoprotein lipase deficiency.
lipoprotein lipase deficiency
Whole exome sequencing for non-selective pediatric patients with hyperlipidemia.
lipoprotein lipase deficiency
Xanthoma of bone associated with lipoprotein lipase deficiency.
lipoprotein lipase deficiency
[A case of neonatal lipoprotein lipase deficiency caused by novel compound heterozygous variants of LPL gene].
lipoprotein lipase deficiency
[A gene analysis of familial lipoprotein lipase deficiency in China]
lipoprotein lipase deficiency
[Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene]
lipoprotein lipase deficiency
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
lipoprotein lipase deficiency
[Lipoprotein lipase deficiency due to lipoprotein lipase gene mutations (current overview)]
lipoprotein lipase deficiency
[Lipoprotein lipase deficiency in 2 young patients (hyperlipoproteinemia type I)]
lipoprotein lipase deficiency
[Lipoprotein lipase: a multifunctional enzyme in lipoprotein metabolism]
lipoprotein lipase deficiency
[Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome]
lipoprotein lipase deficiency
[Primary lipoprotein lipase deficiency: clinical and genetic aspects]
Liver Cirrhosis
Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
Liver Cirrhosis
Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.
Liver Cirrhosis
[Free fatty acids and the activities of postheparinesterase and lipoprotein lipase in liver cirrhosis]
Liver Cirrhosis
[On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis]
Liver Cirrhosis
[Plasma unesterified fatty acids and lipoprotein lipase activity in liver cirrhosis]
Liver Cirrhosis, Biliary
Lipoprotein pattern and plasma lipoprotein lipase activities in patients with primary biliary cirrhosis. Relationship with increase of HDL2 fraction in Lp-X-positive and Lp-X-negative subjects.
Liver Diseases
A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
Liver Diseases
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Liver Diseases
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Liver Diseases
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Liver Diseases
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Liver Diseases
Triglyceride lipase activity in postheparin plasma and plasma lipoproteins in liver disease.
Liver Diseases
[Studies on hypertriglyceridemia in liver diseases by means of measurements of hepatic triglyceride lipase and plasma lipoprotein lipase activity in the heparinized plasma]
Lung Diseases
Assessment of lipoprotein lipase activity in patients with atherosclerosis and nonspecific pulmonary diseases.
Lung Neoplasms
Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity.
Lung Neoplasms
Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Lung Neoplasms
Lipolytic and lipoprotein lipase (LPL)-inhibiting activities produced by a human lung cancer cell line responsible for cachexia induction.
Lung Neoplasms
Lipoprotein lipase activity and gene expression in lung cancer and in adjacent noncancer lung tissue.
Lung Neoplasms
Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.
Lung Neoplasms
Reply: Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Lung Neoplasms
Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
Lupus Erythematosus, Systemic
Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
Lupus Erythematosus, Systemic
Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Lupus Erythematosus, Systemic
Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease.
Lupus Erythematosus, Systemic
Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus.
Lymphohistiocytosis, Hemophagocytic
Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis.
Lymphoma
Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.
Magnesium Deficiency
Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat.
Malabsorption Syndromes
[Alimentary lipemia and postheparin activity of lipoprotein lipase in children with malabsorption syndrome]
Malaria
Adipose tissue lipoprotein lipase activity in Plasmodium chabaudi and Plasmodium vinckei rodent malaria.
Malaria
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Malnutrition
Effects of pre- and early postnatal protein malnutrition on carcass composition and lipoprotein lipase activity in male rats.
Malnutrition
Maternal undernutrition leads to elevated hepatic triglycerides in male rat offspring due to increased expression of lipoprotein lipase.
Malnutrition
Rat plasma VLDL composition and concentration and hepatic lipase and lipoprotein lipase activities are impaired during two types of protein malnutrition and unaffected by balanced refeeding.
Malnutrition
Refeeding meal-fed rats increases lipoprotein lipase activity and deposition of dietary [14C]lipid in white adipose tissue and decreases oxidation to 14CO2. The role of undernutrition.
Malnutrition
The effect of maternal malnutrition on the progeny in the rat. Studies in vitro of adipose tissue lipogenesis and lipoprotein lipase activity following fructose feeding.
Mastitis
Factors affecting the distribution of lipoprotein lipase activity between serum and casein micelles in bovine milk.
Mastitis
The relationship between the levels of free fatty acids, lipoprotein lipase, carboxylesterase, N-acetyl-beta-D-glucosaminidase, somatic cell count and other mastitis indices in bovine milk.
Melanoma
Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor.
Melanoma
Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish.
Melanoma
Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line.
Melanoma, Experimental
Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.
Mesothelioma
Lipolysis of polyenoic fatty acid esters of human chylomicrons by lipoprotein lipase.
Metabolic Diseases
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.
Metabolic Syndrome
Adipose Tissue LPL Methylation is Associated with Triglyceride Concentrations in the Metabolic Syndrome.
Metabolic Syndrome
Age Stratification in Genetic Variation of Lipoprotein Lipase in Metabolic Syndrome Javanese Ethnics of Indonesia.
Metabolic Syndrome
Association of Metabolic Syndrome with Serum Adipokines in Community-Living Elderly Japanese Women: Independent Association with Plasminogen Activator-Inhibitor-1.
Metabolic Syndrome
Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice.
Metabolic Syndrome
Clinical determination of the severity of metabolic syndrome: preheparin lipoprotein lipase mass as a new marker of metabolic syndrome.
Metabolic Syndrome
Corrigendum to "Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran" [Gene 706 (2019) 13-18].
Metabolic Syndrome
Diets high in carbohydrate may not be appropriate for rs328 G carriers with the metabolic syndrome.
Metabolic Syndrome
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Metabolic Syndrome
Effect of Glycine on Adipocyte Hypertrophy in a Metabolic Syndrome Rat Model.
Metabolic Syndrome
Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.
Metabolic Syndrome
Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran.
Metabolic Syndrome
Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism.
Metabolic Syndrome
Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor ?.
Metabolic Syndrome
Lipid Profiles and Associated Gene Polymorphisms in Young Asian Indian Patients with Acute Myocardial Infarction and the Metabolic Syndrome.
Metabolic Syndrome
Lipoprotein Lipase Inhibitor, Nordihydroguaiaretic Acid, Aggravates Metabolic Phenotypes and Alters HDL Particle Size in the Western Diet-Fed db/db Mice.
Metabolic Syndrome
Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the Metabolic Syndrome.
Metabolic Syndrome
Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
Metabolic Syndrome
Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome.
Metabolic Syndrome
Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking.
Metabolic Syndrome
Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome.
Metabolic Syndrome
Reduced LPL and subcutaneous lipid storage capacity are associated with metabolic syndrome in postmenopausal women with obesity.
Metabolic Syndrome
Relationship between serum preheparin lipoprotein lipase mass, plasma glucose and metabolic syndrome in older subjects.
Metabolic Syndrome
Relationship Between Two Common Lipoprotein Lipase Variants and the Metabolic Syndrome and Its Individual Components.
Metabolic Syndrome
The association of lipoprotein lipase PvuII polymorphism and niacin intake in the prevalence of metabolic syndrome: a KMSRI-Seoul study.
Metabolic Syndrome
The gene-diet interaction, LPL PvuII and HindIII and carbohydrate, on the criteria of metabolic syndrome: KMSRI-Seoul Study.
Metabolic Syndrome
The heterozygous N291S mutation in the lipoprotein lipase gene impairs whole-body insulin sensitivity and affects a distinct set of plasma metabolites in humans.
Metabolic Syndrome
The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
Metabolic Syndrome
The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks.
Metabolic Syndrome
[Association of lipoprotein lipase gene Hind III and S447X polymorphisms in metabolic syndrome patients among Kazakh and Han ethnics from Xinjiang.]
Metabolic Syndrome
[Polymorphisms of lipoprotein lipase gene and their participation in metabolic processes].
Metabolic Syndrome
[Remnant lipoprotein cholesterol level measured by homogeneous assay reflects the quantity of intermediate-density lipoprotein]
Metabolic Syndrome
[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension]
Metabolism, Inborn Errors
Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.
Migraine Disorders
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Multiple Sclerosis
[Behavior of lipoprotein lipase in multiple sclerosis and other neurologic diseases]
Multiple Sclerosis
[Lipoprotein lipase in the blood and cerebrospinal fluid of patients with multiple sclerosis]
Muscular Atrophy, Spinal
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Muscular Diseases
Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.
Muscular Diseases
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Myocardial Infarction
Alterations in plasma proteins and lipoproteins in acute myocardial infarction: effects on activation of lipoprotein lipase.
Myocardial Infarction
Association between preheparin serum lipoprotein lipase mass and acute myocardial infarction in Japanese men.
Myocardial Infarction
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study.
Myocardial Infarction
Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.
Myocardial Infarction
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes The genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.
Myocardial Infarction
Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.
Myocardial Infarction
Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction.
Myocardial Infarction
Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
Myocardial Infarction
Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction.
Myocardial Infarction
Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica.
Myocardial Infarction
Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction.
Myocardial Infarction
Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.
Myocardial Infarction
Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults.
Myocardial Infarction
Lipoprotein lipase gene HindIII polymorphism and risk of myocardial infarction in South Indian population.
Myocardial Infarction
Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.
Myocardial Infarction
Lipoprotein Lipase Gene Polymorphisms Are Associated with Myocardial Infarction Risk: A Meta-Analysis.
Myocardial Infarction
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
Myocardial Infarction
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).
Myocardial Infarction
Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.
Myocardial Infarction
Polymorphisms of the human lipoprotein lipase gene: possible association with lipid levels in patients with coronary heart disease in Beijing area.
Myocardial Infarction
Relationship between two AMI risk factors: low serum lipoprotein lipase mass and hypoadiponectinemia.
Myocardial Infarction
[Connection of HindIII-polymorphism in the lipoprotein lipase gene with myocardial infarct and life span in elderly ischemic heart disease patients]
Myocardial Infarction
[Connection of HindIII-polymorphism of the lipoprotein lipase gene with risk of developing myocardial infarct]
Myocardial Infarction
[Coronary heart disease in patients with primary type V hyperlipoproteinemia (author's transl)]
Myocardial Infarction
[HindIII polymorphism of lipoprotein lipase gene and risk of myocardial infarction]
Myocardial Infarction
[Lipoprotein lipase activity and the effect of heparin on blood sugar level and blood lipids in patients with acute myocardial infarct]
Myocardial Infarction
[Lipoprotein lipase activity following heparin infusion. II. Patients with healed myocardial infarct]
Myocardial Infarction
[Myocardial infarct. Lipoprotein lipase in the myocardium and the infarct]
Myocardial Ischemia
A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men.
Myocardial Ischemia
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
Myocardial Ischemia
An application of the patient rule-induction method for evaluating the contribution of the Apolipoprotein E and Lipoprotein Lipase genes to predicting ischemic heart disease.
Myocardial Ischemia
Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Myocardial Ischemia
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Myocardial Ischemia
Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.
Myocardial Ischemia
Lipoprotein lipase Ser447Ter polymorphism associated with the risk of ischemic stroke: A meta-analysis.
Myocardial Ischemia
Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study.
Myocardial Ischemia
Myocardial lipoproteins lipase activity during acute myocardial ischemia in dogs.
Myocardial Ischemia
Reduced adipose tissue lipoprotein lipase responses, postprandial lipemia, and low high-density lipoprotein-2 subspecies levels in older athletes with silent myocardial ischemia.
Myocardial Ischemia
Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study.
Myocardial Ischemia
[Change in the functional state of the sympathetic-adrenal system and the activity of lipoprotein lipase in patients with ischemic heart disease under the effect of refinded carbohydrates included in diets of different caloric value]
Myocardial Ischemia
[Connection of HindIII-polymorphism in the lipoprotein lipase gene with myocardial infarct and life span in elderly ischemic heart disease patients]
Myocardial Ischemia
[HindIII DNA-polymorphism of lipoprotein lipase gene in elderly patients with ischemic heart disease]
Myocardial Ischemia
[Lipoprotein lipase activity of ischemic heart disease patients with different types of hyperlipoproteinemia on the basis of fat loading]
Myotoxicity
Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity.
Neoplasms
?-Estradiol Enhanced Secretion of Lipoprotein Lipase from Mouse Mammary Tumor FM3A Cells.
Neoplasms
A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue.
Neoplasms
A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q.
Neoplasms
Abnormality of hepatic triglyceride metabolism in ApcMin/+ mice with colon cancer cachexia.
Neoplasms
Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats.
Neoplasms
Aloe-emodin inhibits adipocyte differentiation and maturation during in vitro human mesenchymal stem cell adipogenesis.
Neoplasms
Alterations in plasma lipoproteins and heparin-releasable lipase activities in mice bearing the GRSL ascites tumor.
Neoplasms
ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Neoplasms
Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.
Neoplasms
Antiadipogenic Effects of Loganic Acid in 3T3-L1 Preadipocytes and Ovariectomized Mice.
Neoplasms
Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.
Neoplasms
Augmentation of tumor necrosis factor-alpha-induced suppression of lipoprotein lipase by nitric oxide donors in cultured brown adipocytes.
Neoplasms
Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor.
Neoplasms
Bacterial lipopolysaccharide suppresses the expression of lipoprotein lipase in murine macrophages: a process independent of tumor necrosis factor or interleukin 1.
Neoplasms
Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes.
Neoplasms
Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.
Neoplasms
CAMK1 Phosphoinositide Signal-Mediated Protein Sorting and Transport Network in Human Hepatocellular Carcinoma (HCC) by Biocomputation.
Neoplasms
Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor.
Neoplasms
Cellular Glycolysis and The Differential Survival of Lung Fibroblast and Lung Carcinoma Cell Lines.
Neoplasms
Changes in activity of lipoprotein lipase, plasma free fatty acids and triglycerides with weight loss in a cachexia model.
Neoplasms
Changes in lipoprotein lipase activity (LPLA) in tumor cells and tissues in mice bearing Ehrlich ascites tumor.
Neoplasms
Changes in the activities of lipoprotein lipase and the lipogenic enzymes in tumor-bearing rats.
Neoplasms
Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes.
Neoplasms
Cytokine production in five tumor cell lines with activity to induce cancer cachexia syndrome in nude mice.
Neoplasms
Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities.
Neoplasms
Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells.
Neoplasms
Differentiation of human monocytes to monocyte-derived macrophages is associated with increased lipoprotein lipase-induced tumor necrosis factor-alpha expression and production: a process involving cell surface proteoglycans and protein kinase C.
Neoplasms
Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line.
Neoplasms
Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
Neoplasms
Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat.
Neoplasms
Effects of intravenous infusion of trans-10, cis-12 18:2 on mammary lipid metabolism in lactating dairy cows.
Neoplasms
Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-? and leptin, and adipose tissue gene expression.
Neoplasms
Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis.
Neoplasms
Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish.
Neoplasms
Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans.
Neoplasms
Evidence of endoplasmic reticulum stress and liver inflammation in the American mink Neovison vison with benign hepatic steatosis.
Neoplasms
Exogenous supplement of N-acetylneuraminic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice.
Neoplasms
Expression of the apolipoprotein E gene in a human macrophage-like cell line, THP-1.
Neoplasms
Genetic variation in APOJ, LPL, and TNFRSF10B affects the plasma fatty acid distribution in Alaskan Eskimos.
Neoplasms
Genome scale metabolic models as tools for drug design and personalized medicine.
Neoplasms
Hepatic triglyceride lipase and lipoprotein lipase activities in post-heparin plasma of patients with various cancers.
Neoplasms
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Neoplasms
Hypertriglyceridemia associated with tumor necrosis factor-alpha in hamster cheek-pouch carcinogenesis.
Neoplasms
Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings.
Neoplasms
Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients.
Neoplasms
Increased lipoprotein lipase activity in non-small cell lung cancer tissue predicts shorter patient survival.
Neoplasms
Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
Neoplasms
Induction of tumor necrosis factor alpha gene expression by lipoprotein lipase requires protein kinase C activation.
Neoplasms
Influence of Dietary Chitosan Feeding Duration on Glucose and Lipid Metabolism in a Diabetic Rat Model.
Neoplasms
Inhibitory effect of tumor necrosis factor on gene expression of hormone sensitive lipase in 3T3-L1 adipocytes.
Neoplasms
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
Neoplasms
Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.
Neoplasms
Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes.
Neoplasms
Lipid and lipoprotein metabolism in familial combined hyperlipidaemia during treatment of sporadic phaeochromocytoma: a case study.
Neoplasms
Lipid emulsions of palmitoylrhizoxin: effects of composition on lipolysis and biodistribution.
Neoplasms
Lipid metabolism during the initiation of lactation in the rat. The effects of starvation and tumour growth.
Neoplasms
Lipid metabolism in cachectic tumor-bearing rats at different stages of tumor growth.
Neoplasms
Lipid metabolism in tumour-bearing mice: studies with knockout mice for tumour necrosis factor receptor 1 protein.
Neoplasms
Lipolytic and lipoprotein lipase (LPL)-inhibiting activities produced by a human lung cancer cell line responsible for cachexia induction.
Neoplasms
Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms.
Neoplasms
Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor.
Neoplasms
Lipoprotein lipase synergizes with interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production.
Neoplasms
Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression.
Neoplasms
Lysosome labilizers potentiate the antitumor effects of tumor necrosis factor-alpha.
Neoplasms
Modified lipoprotein lipase activities, rates of lipogenesis, and lipolysis as factors leading to lipid depletion in C57BL mice bearing the preputial gland tumor, ESR-586.
Neoplasms
Modulation of lipoprotein lipase activity in mouse peritoneal macrophages by recombinant human tumor necrosis factor.
Neoplasms
Molecular characterisation of tumour necrosis factor alpha and its potential connection with lipoprotein lipase and peroxisome proliferator-activated receptors in blunt snout bream (Megalobrama amblycephala).
Neoplasms
Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes.
Neoplasms
Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
Neoplasms
Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients.
Neoplasms
Platyphylloside Isolated From Betula platyphylla Inhibit Adipocyte Differentiation and Induce Lipolysis Via Regulating Adipokines Including PPAR? in 3T3-L1 Cells.
Neoplasms
Polyunsaturated fatty acids augment tumoricidal action of 5-fluorouracil on gastric cancer cells by their action on vascular endothelial growth factor, tumor necrosis factor-? and lipid metabolism related factors.
Neoplasms
Preliminary assessment of differential expression of candidate genes associated with atherosclerosis.
Neoplasms
Production and characterization of monoclonal antibodies against recombinant human tumor necrosis factor/cachectin.
Neoplasms
Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256.
Neoplasms
Protein kinase C mediates tumor necrosis factor-alpha-induced inhibition of obese gene expression and leptin secretion in brown adipocytes.
Neoplasms
Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved.
Neoplasms
Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes.
Neoplasms
Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes.
Neoplasms
Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.
Neoplasms
Reduced meal frequency alleviates high-fat diet-induced lipid accumulation and inflammation in adipose tissue of pigs under the circumstance of fixed feed allowance.
Neoplasms
Reduced plasma lipoprotein lipase activity in patients with malignancy-associated weight loss.
Neoplasms
Regulation of lipid metabolism and peroxisome proliferator-activated receptors in rainbow trout adipose tissue by lipolytic and antilipolytic endocrine factors.
Neoplasms
Regulation of lipoprotein lipase activity and mRNA content in rat epididymal adipose tissue in vitro by recombinant tumour necrosis factor.
Neoplasms
Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumour necrosis factor.
Neoplasms
Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor--the primary regulatory role of the hormone in 3T3-L1 adipocytes.
Neoplasms
Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Further proof for identity with tumour necrosis factor.
Neoplasms
Relationship of classical and non-classical risk factors with genetic variants relevant to coronary heart disease.
Neoplasms
Release of lipoprotein lipase from Ehrlich ascites tumor produced by an association with a rapid increase in cyclic AMP content.
Neoplasms
Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia.
Neoplasms
Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats.
Neoplasms
Short communication: Effect of heat stress during the dry period on gene expression in mammary tissue and peripheral blood mononuclear cells.
Neoplasms
Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study.
Neoplasms
Sodium acetate, propionate, and butyrate reduce fat accumulation in mice via modulating appetite and relevant genes.
Neoplasms
Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
Neoplasms
Stimulatory release of lipoprotein lipase activity with activation of protein tyrosine kinase produced by low molecular weight dextran sulfate in Ehrlich ascites tumor cells.
Neoplasms
Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
Neoplasms
Synergism between interferon gamma and tumour necrosis factor alpha in the regulation of lipoprotein lipase in the macrophage J774.2 cell line.
Neoplasms
The effect of tumor necrosis factor alpha on the activity of lipoprotein lipase in adipose tissue.
Neoplasms
The effects of a biological response modifier, OK-432, on tumor-induced alterations in the host metabolism.
Neoplasms
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
Neoplasms
The stimulation of tumor necrosis factor and inhibition of glucose transport and lipoprotein lipase in adipose cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Neoplasms
Tissue-specific effects of rapid tumour growth on lipid metabolism in the rat during lactation and on litter removal.
Neoplasms
Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver.
Neoplasms
Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.
Neoplasms
Tumor necrosis factor mediates hypertriglyceridemia during thermal injury in mice genetically susceptible to lipopolysaccharides.
Neoplasms
Tumor necrosis factor-alpha eliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes.
Neoplasms
Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats.
Neoplasms
Tumor necrosis factor-mediated biological activities involve a G-protein-dependent mechanism.
Neoplasms
Ubá mango juices intake decreases adiposity and inflammation in high-fat diet-induced obese Wistar rats.
Neoplasms
[Reduced plasma lipoprotein lipase activity in patients with various cancers: preliminary report]
Neoplasms
[Stimulation of tissue lipoprotein lipase activity in cancer cachectic rats: preliminary report]
Neoplasms, Germ Cell and Embryonal
Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms.
Nephrosis
Changes in biological activity and immunoreactive mass of lipoprotein lipase in congenital nephrosis: relationship to hypertriglyceridaemia.
Nephrosis
Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Nephrotic Syndrome
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Nephrotic Syndrome
Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
Nephrotic Syndrome
Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipase.
Nephrotic Syndrome
Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
Nephrotic Syndrome
Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis.
Nephrotic Syndrome
Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats.
Nephrotic Syndrome
Inhibition of lipoprotein lipase by plasma from children with the steroid responsive nephrotic syndrome.
Nephrotic Syndrome
Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome.
Nephrotic Syndrome
Plasma lipoprotein lipase in children with idiopathic nephrotic syndrome.
Nephrotic Syndrome
Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome.
Nephrotic Syndrome
Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Nephrotic Syndrome
The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
Nephrotic Syndrome
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Nephrotic Syndrome
[Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome]
Nephrotic Syndrome
[In vitro inhibition of lipoprotein lipase by a monoclonal immunoglobulin in a case of nephrotic syndrome with hyperlipemia caused by auto-antibodies]
Nephrotic Syndrome
[Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome]
Nephrotic Syndrome
[Study of plasma levels of free fatty acids and lipoprotein lipase activity in patients with nephrotic syndrome caused by intrinsic renal disease]
Neurodegenerative Diseases
Association Studies of Specific Cholesterol Related Genes (APOE, LPL, and CETP) with Lipid Profile and Memory Function: A Correlative Study Among Rural and Tribal Population of Dharmapuri District, India.
Non-alcoholic Fatty Liver Disease
A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.
Non-alcoholic Fatty Liver Disease
A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.
Non-alcoholic Fatty Liver Disease
Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Non-alcoholic Fatty Liver Disease
Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Non-alcoholic Fatty Liver Disease
Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-?-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell.
Obesity
Activity of lipoprotein lipase and effect of heparin on blood lipids in exogenous obesity.
Obesity
Adipose tissue lipoprotein lipase and glycerol release in fasted Zucker (fa/fa) rats.
Obesity
Apolipoprotein A5 and Lipoprotein Lipase Interact to Modulate Anthropometric Measures in Hispanics of Caribbean Origin.
Obesity
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Obesity
Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice.
Obesity
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Obesity
Association between peroxisome proliferator-activated receptor, UCP3 and lipoprotein lipase gene polymorphisms and obesity in Chinese adolescents.
Obesity
Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population.
Obesity
Association of sets of alleles of genes encoding beta3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity.
Obesity
Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families.
Obesity
Characterization of lipase activities in obese Pima indians. Decreases with weight reduction.
Obesity
Cyanidin-3-O-?-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity
Obesity
Cyanidin-3-O-?-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity.
Obesity
Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity.
Obesity
Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats.
Obesity
Determinants of HDL particle size in patients with the null (P207L) or defective (D9N) mutation in the lipoprotein lipase gene: the Québec LipD Study.
Obesity
Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.
Obesity
Developmental changes in adipose and muscle lipoprotein lipase activity in the atherosclerosis-prone JCR:LA-corpulent rat.
Obesity
Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia.
Obesity
Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue.
Obesity
Effect of obesity on HDL and LDL particle sizes in carriers of the null P207L or defective D9N mutation in the lipoprotein lipase gene: the Québec LipD Study.
Obesity
Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: Studies using genetically engineered mouse models.
Obesity
Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity.
Obesity
Effect of sucrose overfeeding on brown adipose tissue lipogenesis and lipoprotein lipase activity in rats.
Obesity
Effects of estradiol and progesterone on food intake, body weight, and carcass adiposity in weanling rats.
Obesity
Effects of weight loss and weight maintenance on the serum lipids, lipoprotein lipase and hepatic triglyceride lipase activities in obese rats.
Obesity
Effects of weight reduction on plasma lipoproteins and adipose tissue metabolism in obese subjects.
Obesity
Elevated adipose tissue lipoprotein lipase in the pathogenesis of obesity in the Prader-Willi syndrome.
Obesity
Epididymal fat depot lipoprotein lipase activity is lower in animals with high endogenous fat preferences.
Obesity
Erratum to "Association between peroxisome proliferator-activated receptor, UCP3 and lipoprotein lipase gene polymorphisms and obesity in Chinese adolescents" [Obes Res Clin Pract 2017;11(January-February1):27-33].
Obesity
Exercise and detraining: effect on food intake, adiposity and lipogenesis in Osborne-Mendel rats made obese by a high fat diet.
Obesity
Fasting and postprandial adipose tissue LPL and HSL in obesity and type 2 diabetes.
Obesity
Formula Diet is Effective for the Reduction and Differentiation of Visceral Adipose Tissue in Zucker Fatty Rats.
Obesity
Gender-related relation between metabolic syndrome and S447X and HindIII polymorphisms of lipoprotein lipase gene in northern Iran.
Obesity
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity.
Obesity
Human adipose tissue lipoprotein lipase: comparison of assay methods and expressions of activity.
Obesity
Impact of walking on adipose tissue lipoprotein lipase activity and expression in pre- and postmenopausal women.
Obesity
Increased adipose-tissue lipoprotein-lipase activity in moderately obese men after weight reduction.
Obesity
Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity.
Obesity
Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
Obesity
Increasing adipocyte lipoprotein lipase improves glucose metabolism in high fat diet-induced obesity.
Obesity
Influence of lipoprotein lipase gene Ser447Stop and beta1-adrenergic receptor gene Arg389Gly polymorphisms and their interaction on obesity from childhood to adulthood: the Bogalusa Heart Study.
Obesity
Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity.
Obesity
Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese.
Obesity
Lipoprotein lipase activator NO-1886 (ibrolipim) accelerates the mRNA expression of fatty acid oxidation-related enzymes in rat liver.
Obesity
Lipoprotein lipase activities in adipose tissues and muscle in the obese Zucker rat.
Obesity
Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.
Obesity
Lipoprotein lipase activity in adipose tissue and in postheparin plasma in human obesity.
Obesity
Lipoprotein lipase activity of adipose tissue, skeletal muscle and post-heparin plasma in primary endogenous hypertriglyceridaemia: relation to lipoprotein pattern and to obesity.
Obesity
Lipoprotein lipase of adipose tissue and skeletal muscle in human obesity: response to glucose and to semistarvation.
Obesity
Lipoprotein lipase variants interact with polyunsaturated fatty acids for obesity traits in women: replication in two populations.
Obesity
Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism.
Obesity
Long-term effects on adiposity after preweaning nutritional manipulations in the gastrostomy-reared rat.
Obesity
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
Obesity
Mice with altered brain lipoprotein metabolism display maladaptive responses to environmental challenges that may predispose to weight gain.
Obesity
Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia.
Obesity
NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
Obesity
Obesity development in neuron-specific lipoprotein lipase deficient mice is not responsive to increased dietary fat content or change in fat composition.
Obesity
Overexpression of human lipoprotein lipase increases hormone-sensitive lipase activity in adipose tissue of mice.
Obesity
Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits.
Obesity
Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity.
Obesity
Postheparin plasma lipase activities in obesity: failure to increase with adipose organ enlargement.
Obesity
Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Obesity
POTENTIAL ADMINISTRATION OF LIPOIC ACID AND COENZYME Q AGAINST ADIPOGENSIS: TARGET FOR WEIGHT REDUCTION.
Obesity
Predictors of adipose tissue lipoprotein lipase in middle-aged and older men: relationship to leptin and obesity, but not cardiovascular fitness.
Obesity
Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase.
Obesity
Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery.
Obesity
Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes.
Obesity
Regulation of lipoprotein lipase activity in the sand rat: effect of nutritional state and cAMP modulation.
Obesity
Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.
Obesity
Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions.
Obesity
Relationships of PPARgamma and PPARgamma2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys.
Obesity
Sex differences in obesity development in pair-fed neuronal lipoprotein lipase deficient mice.
Obesity
The Association of a Rare Variant of -93, -53 Promoter Gene Polymorphisms of Lipoprotein Lipase gene with Obesity and Insulin Resistance.
Obesity
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
Obesity
The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet.
Obesity
The lipoprotein lipase S447X and cholesteryl ester transfer protein rs5882 polymorphisms and their relationship with lipid profile in human serum of obese individuals.
Obesity
The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin--A biochemical study in rats subjected to experimental hyperlipidemia and obesity.
Obesity
The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue.
Obesity
Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes.
Obesity
Tissue-specific lipoprotein lipase: relationships to body composition and body fat distribution in normal weight humans.
Obesity
Trangenic and knockout rodents: novel insights into mechanisms of body weight regulation.
Obesity
Whole-body insulin resistance and energy expenditure indices, serum lipids, and skeletal muscle metabolome in a state of lipoprotein lipase overexpression.
Obesity
[Activity of lipoprotein lipase and the effect of heparin on the blood lipids pattern in exogenous obesity]
Obesity
[Effect of electroacupuncture on metabolism of lipids in rats of obesity induced by sodium glutamate]
Obesity
[Effect of lipoprotein lipase gene polymorphism on plasma lipid levels,BMI and subcutaneous fat distribution in simple obesity children]
Obesity
[Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity.]
Obesity
[Lipoprotein lipase gene polymorphism in non-insulin-dependent diabetics: preliminary study]
Obesity
[Studies of lipoprotein lipase activity and adipocyte characteristics in the human: effect of obesity and diabetes (author's transl)]
Obesity, Abdominal
Association of the lipoprotein lipase gene T+495G polymorphism with central obesity and serum lipids in a twin study.
Obesity, Abdominal
Differential expression of lipoprotein lipase gene in tissues of the rat model with visceral obesity and postprandial hyperlipidemia.
Obesity, Abdominal
Formula Diet is Effective for the Reduction and Differentiation of Visceral Adipose Tissue in Zucker Fatty Rats.
Obesity, Abdominal
Genetic susceptibility to visceral obesity and related clinical implications.
Obesity, Abdominal
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
Obesity, Abdominal
Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study.
Obesity, Abdominal
Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study.
Obesity, Abdominal
Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity.
Obesity, Abdominal
Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.
Obesity, Abdominal
The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity.
Obesity, Morbid
Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans.
Optic Atrophy
LncRNAs expression signatures of human brain arteriovenous malformation revealed by microarray.
Osteoporosis
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Osteosarcoma
Effect of cortisol on cell proliferation and the expression of lipoprotein lipase and vascular endothelial growth factor in a human osteosarcoma cell line.
Osteosarcoma
Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.
Overweight
Effects of fasting on lipoprotein lipase activity in different depots of white and brown adipose tissues in diet-induced overweight rats.
Overweight
Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet.
Overweight
Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women.
Overweight
Reduced LPL and subcutaneous lipid storage capacity are associated with metabolic syndrome in postmenopausal women with obesity.
Overweight
Relation of lipoprotein lipase activity in adipose tissue to adipocyte volume and its influence in hypertriglyceridemia pathogenesis.
Overweight
Serum lipoprotein and lipoprotein lipase in overweight, type II diabetics during and after supplemented fasting.
Pancreatitis
11-year Follow-up in Biliopancreatic Diversion for Recurrent Pancreatitis Due to Lipoprotein Lipase Deficiency.
Pancreatitis
A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
Pancreatitis
A case of non-alcoholic steatohepatitis complicated with severe acute pancreatitis induced by decreased lipoprotein lipase and hepatic triglyceride lipase activity levels in a young Japanese woman.
Pancreatitis
A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (Glu242Lys and Leu252VaL) in the lipoprotein lipase gene.
Pancreatitis
A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.
Pancreatitis
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
Pancreatitis
A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis.
Pancreatitis
A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis.
Pancreatitis
A novel substitution at the translation initiator codon (ATG-->ATC) of the lipoprotein lipase gene is mainly responsible for lipoprotein lipase deficiency in a patient with severe hypertriglyceridemia and recurrent pancreatitis.
Pancreatitis
A serum metabolomic investigation on lipoprotein lipase-deficient mice with hyperlipidemic pancreatitis using gas chromatography/mass spectrometry.
Pancreatitis
Acute hypertriglyceridaemic pancreatitis in a pregnant Indian: a new lipoprotein lipase gene mutation.
Pancreatitis
Acute hypertriglyceridemic pancreatitis during pregnancy due to homozygous lipoprotein lipase gene mutation.
Pancreatitis
Alipogene tiparvovec: a review of its use in adults with familial lipoprotein lipase deficiency.
Pancreatitis
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Pancreatitis
Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiency.
Pancreatitis
Association of the HindIII Lipoprotein Lipase Gene Polymorphism with the Development of the Non-Biliary Acute Pancreatitis: a Pilot Study.
Pancreatitis
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.
Pancreatitis
Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia.
Pancreatitis
Composition of free fatty acid and triglyceride fractions in human necrotic pancreatic tissue.
Pancreatitis
Compound but non-linked heterozygous p.W14X and p.L279 V LPL gene mutations in a Chinese patient with long-term severe hypertriglyceridemia and recurrent acute pancreatitis.
Pancreatitis
Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a chinese patient with hypertriglyceridemia.
Pancreatitis
Correction of Feline Lipoprotein Lipase Deficiency with Adeno-Associated Virus Serotype 1-Mediated Gene Transfer of the Lipoprotein Lipase S447X Beneficial Mutation.
Pancreatitis
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
Pancreatitis
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia.
Pancreatitis
Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
Pancreatitis
Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.
Pancreatitis
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial.
Pancreatitis
Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells.
Pancreatitis
Excessive hypertriglyceridemia and pancreatitis in pregnancy. Association with deficiency of lipoprotein lipase.
Pancreatitis
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
Pancreatitis
Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
Pancreatitis
Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application.
Pancreatitis
Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
Pancreatitis
Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions.
Pancreatitis
Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Pancreatitis
Genetic Variants Associated With Increased Plasma Levels of Triglycerides, via Effects on the Lipoprotein Lipase Pathway, Increase Risk of Acute Pancreatitis.
Pancreatitis
Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype.
Pancreatitis
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Pancreatitis
Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
Pancreatitis
Hyperlipemia in acute pancreatitis. Metabolic studies in a patient and demonstration of abnormal lipoprotein-triglyceride complexes resistant to the action of lipoprotein lipase.
Pancreatitis
Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene.
Pancreatitis
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.
Pancreatitis
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis.
Pancreatitis
Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis.
Pancreatitis
Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology.
Pancreatitis
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
Pancreatitis
Lipoprotein lipase gene analyses in one Turkish family and three different Chinese families with severe hypertriglyceridaemia: One novel and several established mutations.
Pancreatitis
Lipoprotein lipase gene-deficient mice with hypertriglyceridaemia associated with acute pancreatitis.
Pancreatitis
Lipoprotein Lipase Mutation S447X Associated With Pancreatic Calcification and Steatorrhea in Hyperlipidemic Pancreatitis.
Pancreatitis
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
Pancreatitis
Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.
Pancreatitis
Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis.
Pancreatitis
Management of severe hypertriglyceridemia due to lipoprotein lipase deficiency in children
Pancreatitis
Metabolic surgery for the treatment of hypertriglyceridemia-related pancreatitis due to familial lipoprotein lipase deficiency.
Pancreatitis
Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.
Pancreatitis
Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan.
Pancreatitis
Neonatal hyperlipidemia with pancreatitis: Novel gene mutation of lipoprotein lipase.
Pancreatitis
Pancreatitis associated with hyperlipoproteinaemia type I in mink (Mustela vison): earliest detectable changes occur in mitochondria of exocrine cells.
Pancreatitis
Pancreatitis in a child with lipemia due to novel lipoprotein lipase mutations.
Pancreatitis
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Pancreatitis
Potential of essential fatty acid deficiency with extremely low fat diet in lipoprotein lipase deficiency during pregnancy: A case report.
Pancreatitis
Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy.
Pancreatitis
Pseudodominance of lipoprotein lipase (LPL) deficiency due to a nonsense mutation (Tyr302>Term) in exon 6 of LPL gene in an Italian family from Sardinia (LPL(Olbia)).
Pancreatitis
Recurrent pancreatitis and chylomicronemia in an extended Dutch kindred is caused by a Gly154-->Ser substitution in lipoprotein lipase.
Pancreatitis
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
Pancreatitis
Severe Familial Hypertriglyceridemia: Successful Treatment With Insulin and a Modified Meal Plan.
Pancreatitis
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genes.
Pancreatitis
Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience.
Pancreatitis
Severe hypertriglyceridemia due to two novel loss-of-function lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitis.
Pancreatitis
Severe Hypertriglyceridemia in a Newborn with Monogenic Lipoprotein Lipase Deficiency: An Unconventional Therapeutic Approach with Exchange Transfusion.
Pancreatitis
Severe hypertriglyceridemia with plasma inhibitory factor(s) on lipoprotein lipase activity in a patient with a common Ser(447)-Ter LPL mutation.
Pancreatitis
Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency.
Pancreatitis
The role of free fatty acids, pancreatic lipase and Ca+ signalling in injury of isolated acinar cells and pancreatitis model in lipoprotein lipase-deficient mice.
Pancreatitis
The role of registries in rare genetic lipid disorders: Review and introduction of the first global registry in lipoprotein lipase deficiency.
Pancreatitis
Therapeutic plasma exchange for the management of severe gestational hypertriglyceridaemic pancreatitis due to lipoprotein lipase mutation.
Pancreatitis
Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome.
Pancreatitis
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.
Pancreatitis
Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.
Pancreatitis
Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease).
Pancreatitis
[Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis]
Pancreatitis
[LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis]
Pancreatitis
[Lipoprotein lipase activity and PHLA inhibitors level in acute pancreatitis (author's transl)]
Pancreatitis
[Lipoprotein lipase--physiological and pathophysiological roles of this gene variant in Croatian population]
Pancreatitis
[TOTAL PARENTERAL NUTRITION IN A PREGNANT PATIENT WITH ACUTE PANCREATITIS AND LIPOPROTEIN LIPASE DEFICIENCY].
Pancreatitis, Acute Necrotizing
Severe acute necrotizing pancreatitis associated with lipoprotein lipase deficiency in childhood.
Pancreatitis, Alcoholic
LIPOPROTEIN LIPASE INHIBITION IN THE HYPERLIPEMIA OF ACUTE ALCOHOLIC PANCREATITIS.
Pancreatitis, Chronic
Lipoprotein Lipase Mutation S447X Associated With Pancreatic Calcification and Steatorrhea in Hyperlipidemic Pancreatitis.
Pancytopenia
Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency.
Pediatric Obesity
APOE, CETP and LPL genes show strong association with lipid levels in Greek children.
Pediatric Obesity
Lipoprotein lipase gene polymorphisms and risks of childhood obesity in Chinese preschool children.
Peptic Ulcer
[Lipoprotein lipase activity and the effect of blood serum on the lipolytic activity of fatty tissue in patients with peptic ulcer]
Perinatal Death
Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
Peripheral Nervous System Diseases
Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy.
Peritonitis
Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.
Peritonitis
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.
Persistent Infection
Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes.
Persistent Infection
Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge.
phosphatidylcholine-sterol o-acyltransferase deficiency
Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph.
phosphatidylcholine-sterol o-acyltransferase deficiency
Familial lecithin:cholesterol acyltransferase deficiency. Further studies on plasma lipoproteins and plasma postheparin lipase activity of a patient with normal renal function.
phosphatidylcholine-sterol o-acyltransferase deficiency
Gene therapy for dyslipidemia: clinical prospects.
Pituitary ACTH Hypersecretion
Salt resistant lipase activity in human adrenal gland is increased in Cushing's disease.
Pneumonia
[Blood lipoprotein lipase, non-esterified and unsaturated fatty acids in pneumonia]
Polycystic Ovary Syndrome
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.
Polymyositis
[A case of polymyositis associated with hypertriglyceridemia due to decline of lipoprotein lipase activity]
Prader-Willi Syndrome
Elevated adipose tissue lipoprotein lipase in the pathogenesis of obesity in the Prader-Willi syndrome.
Prader-Willi Syndrome
Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
Pre-Eclampsia
Association between the levels of CGI-58 and lipoprotein lipase in the placenta of patients with preeclampsia.
Pre-Eclampsia
Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
Pre-Eclampsia
Functional variants of the lipoprotein lipase gene and the risk of preeclampsia among non-Hispanic Caucasian women.
Pre-Eclampsia
Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia.
Prolactinoma
Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma.
Prostatic Neoplasms
Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
Prostatic Neoplasms
PAGE4 is a cytoplasmic protein that is expressed in normal prostate and in prostate cancers.
Prostatic Neoplasms
[Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma]
Protein Deficiency
Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
Protein Deficiency
Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification.
Protein-Energy Malnutrition
Lipoprotein lipase activity in marasmic type of protein-calorie malnutrition.
Proteinuria
Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
Proteinuria
Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.
Proteinuria
Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.
Psoriasis
[A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate]
Renal Insufficiency
Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats.
Renal Insufficiency
Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.
Renal Insufficiency
Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl.
Renal Insufficiency
Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.
Renal Insufficiency
[Effects of Shenshuai Yangzhen capsule on lipid metabolism disorder in rats with chronic renal failure]
Renal Insufficiency
[New kidney, but a sick heart. Why many patients with renal failure and kidney transplant patients die of cardiovascular disease]
Renal Insufficiency
[Relative concentration of VLDL C-apolipoproteins in the hyperlipoproteinaemia of haemodialysis-treated chronic renal failure (author's transl)]
Renal Insufficiency, Chronic
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease.
Renal Insufficiency, Chronic
Hypercholesterolemia in rats with chronic renal insufficiency not aggravated by recombinant human growth hormone.
Renal Insufficiency, Chronic
Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
Renal Insufficiency, Chronic
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Renal Insufficiency, Chronic
Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
Renal Insufficiency, Chronic
[Reduction of post-heparin lipoprotein lipase activity by acidotic blood pH]
Respiratory Insufficiency
Respiratory failure in acute pancreatitis: the role of free fatty acids.
Retinal Degeneration
Exploring Excitotoxicity and Regulation of a Constitutively Active TRP Ca2+ Channel in Drosophila.
Retinal Diseases
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery.
Rhabdomyosarcoma
Increased fat oxidation and regulation of metabolic genes with ultraendurance exercise.
Rheumatic Diseases
Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Rheumatic Diseases
[Activity of the clearing factor (lipoproteinase) in the blood plasma of children with rheumatism.]
Rickets
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Sarcoma
The synthesis and activity of lipoprotein lipase in the subcutaneous adipose tissue of patients with musculoskeletal sarcomas.
Sepsis
Alterations in lipogenic enzymes and lipoprotein lipase activity during gram-negative sepsis in the rat.
Sepsis
Gram-negative bacteria sepsis in the rat and tissue lipolytic activity on LCT and MCT/LCT-based commercial parenteral emulsions.
Sepsis
Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.
Sepsis
Insulin stimulates lipoprotein lipase activity and synthesis in adipocytes from septic rats.
Sepsis
Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle.
Sepsis
Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor alpha during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia.
Shock, Septic
Synergism between lipopolysaccharide and interferon gamma in the regulation of lipoprotein lipase in macrophages.
Sialic Acid Storage Disease
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Sialorrhea
Dyslipidaemia in a boy with recurrent abdominal pain, hypersalivation and decreased lipoprotein lipase activity.
Silicosis
[The clearing factor and several other indices of lipid metabolism in silicosis and silico-tuberculosis]
Silicosis
[The lungs and lipid metabolism. Behavior of the lipoprotein lipase, electrophoretic lipoproteins and total blood cholesterol in emphysema and pulmonary silicosis.]
Sjogren's Syndrome
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.
Sleep Apnea Syndromes
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4.
Sleep Apnea Syndromes
[Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Sleep Apnea, Obstructive
Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis.
Sleep Apnea, Obstructive
[Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
ST Elevation Myocardial Infarction
Proteomic Discovery and Validation of the Confounding Effect of Heparin Administration on the Analysis of Candidate Cardiovascular Biomarkers.
Starvation
Cardiac lipoprotein lipase activities in relation to glucose utilization during progressive starvation.
Starvation
Changes in lipoprotein lipase activities in adipose tissue, heart and skeletal muscle during continuous or interrupted feeding.
Starvation
Changes with starvation in the rat of the lipoprotein lipase activity and hydrolysis of triacylglycerols from triacylglycerol-rich lipoproteins in adipose tissue preparations.
Starvation
Effect of starvation on activities and mRNA expression of lipoprotein lipase and hormone-sensitive lipase in tilapia (Oreochromis niloticus x O. areus).
Starvation
Effect of starvation on lipoprotein lipase activity in different tissues during gestation in the rat.
Starvation
Effect of starvation on lipoprotein lipase activity in the liver of developing rats.
Starvation
Effects of fasting on lipoprotein lipase activity in different depots of white and brown adipose tissues in diet-induced overweight rats.
Starvation
Lipid metabolism during the initiation of lactation in the rat. The effects of starvation and tumour growth.
Starvation
Lipid metabolism in the obese Zucker rat. Disposal of an oral [14C]triolein load and lipoprotein lipase activity.
Starvation
Lipoprotein lipase and hepatic lipase in Wistar and Sprague-Dawley rat tissues. Differences in the effects of gender and fasting.
Starvation
Mechanisms of decreased lipoprotein lipase activity in adipocytes of starved rats depend on duration of starvation.
Starvation
Nutrition in the critically ill patient: part I. Essential physiology and pathophysiology.
Starvation
Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy.
Starvation
The activities of lipoprotein lipase and of enzymes involved in triacylglycerol synthesis in rat adipose tissue. Effects of starvation, dietary modification and of corticotropin injection.
Starvation
The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart.
Starvation
The effect of nutritional state on the lipoprotein lipase activity of isolated fat cells.
Starvation
The effect of short-term starvation on the lipoprotein lipase activity of adipose tissue and cardiac muscle during postnatal development of the rat.
Starvation
The effects of starvation and of cold stress on clearing factor lipase activity and triglyceride fatty acid utilization in rat heart.
Starvation
The influence of starvation and refeeding on the lipoprotein lipase activity of skeletal muscle and adipose tissue of lean and obese Zucker rats.
Starvation
The lipoprotein lipase of white adipose tissue. Studies on the intracellular distribution of the adipocyte-associated enzyme.
Starvation
The relationship between the basal lipolytic and lipoprotein lipase activities in human adipose tissue.
Status Epilepticus
[Lipoprotein lipase expression in the hippocampus and its effects on vitamin E levels in rats with epilepsy]
Steatorrhea
Lipoprotein Lipase Mutation S447X Associated With Pancreatic Calcification and Steatorrhea in Hyperlipidemic Pancreatitis.
Stomach Neoplasms
Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival.
Stomach Neoplasms
Polyunsaturated fatty acids augment tumoricidal action of 5-fluorouracil on gastric cancer cells by their action on vascular endothelial growth factor, tumor necrosis factor-? and lipid metabolism related factors.
Stroke
Association between HindIII (rs320) variant in the lipoprotein lipase gene and the presence of coronary artery disease and stroke among the Saudi population.
Stroke
Association between Lipoprotein Lipase Polymorphism and the Risk of Stroke: A Meta-analysis.
Stroke
Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study.
Stroke
Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke.
Stroke
Investigation of the Interaction Between the Ser447Term Polymorphism of Lipoprotein Lipase and the Stroke-Related Risk Factors in Ischemic Stroke.
Stroke
Lipoprotein lipase gene polymorphisms as risk factors for stroke: a computational and meta-analysis.
Stroke
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
Stroke
MicroRNA-410 regulated lipoprotein lipase variant rs13702 is associated with stroke incidence and modulated by diet in the randomized controlled PREDIMED trial.
Stroke
Polymorphisms of the lipoprotein lipase gene as genetic markers for stroke in colombian population: a case control study.
Stroke
[Activity of lipoprotein lipase in families of patients with different types of stroke]
Tangier Disease
A discrepancy between in vivo and in vitro lipoprotein lipase activity in a patient with Tangier disease.
Tangier Disease
Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease.
Tangier Disease
Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Tangier Disease
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Thalassemia
Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease.
Thrombocytopenia
Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
triacylglycerol lipase deficiency
Accumulation of large VLDL in cyclophosphamide treated rabbits. Relationship with lipoprotein lipase deficiency.
triacylglycerol lipase deficiency
Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies.
triacylglycerol lipase deficiency
Adrenal and liver in normal and cld/cld mice synthesize and secrete hepatic lipase, but the lipase is inactive in cld/cld mice.
triacylglycerol lipase deficiency
Combined lipase deficiency (cld/cld) in mice affects differently post-translational processing of lipoprotein lipase, hepatic lipase and pancreatic lipase.
triacylglycerol lipase deficiency
Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized.
triacylglycerol lipase deficiency
Differential effect of combined lipase deficiency (cld/cld) on human hepatic lipase and lipoprotein lipase secretion.
triacylglycerol lipase deficiency
Effect of combined lipase deficiency (cld/cld) on hepatic and lipoprotein lipase activities in liver and plasma of newborn mice.
triacylglycerol lipase deficiency
Effect of the combined lipase deficiency mutation (cld/cld) on ultrastructure of tissues in mice. Diaphragm, heart, brown adipose tissue, lung, and liver.
triacylglycerol lipase deficiency
Expression of lipoprotein lipase gene in combined lipase deficiency.
triacylglycerol lipase deficiency
Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure.
triacylglycerol lipase deficiency
High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
triacylglycerol lipase deficiency
Irradiation-induced free cholesterol accumulation in very-low-density lipoproteins. Role of lipoprotein lipase deficiency.
triacylglycerol lipase deficiency
Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency.
triacylglycerol lipase deficiency
Lipoprotein lipase and hepatic lipase deficiencies associated with impaired chylomicron clearance in D-(+) galactosamine hepatitis.
triacylglycerol lipase deficiency
Lipoprotein lipase mRNA in neonatal and adult mouse tissues: comparison of normal and combined lipase deficiency (cld) mice assessed by in situ hybridization.
triacylglycerol lipase deficiency
Molecular cloning of mouse hepatic triacylglycerol lipase: gene expression in combined lipase-deficient (cld/cld) mice.
triacylglycerol lipase deficiency
Naturally occurring mutations in mice affecting lipid transport and metabolism.
triacylglycerol lipase deficiency
Plasma lipoproteins in familial hepatic lipase deficiency.
triacylglycerol lipase deficiency
Synthesis of inactive nonsecretable high mannose-type lipoprotein lipase by cultured brown adipocytes of combined lipase-deficient cld/cld mice.
triacylglycerol lipase deficiency
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome.
Triple Negative Breast Neoplasms
Lipoprotein lipase hydrolysis products induce pro-inflammatory cytokine expression in triple-negative breast cancer cells.
Tuberculosis, Pulmonary
[Lipoprotein lipase activity of the blood in patients with pulmonary tuberculosis]
Uremia
Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma.
Uremia
Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia.
Urinary Bladder Neoplasms
Transcriptional regulatory networks in human lung adenocarcinoma.
Vascular Diseases
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Vascular Diseases
Genetic polymorphism of heparan sulfate proteoglycan (perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population.
Vascular Diseases
Genetics of the lipoprotein lipase gene and hypertriglyceridaemia.
Vascular Diseases
Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque.
Vascular Diseases
Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese.
Vascular Diseases
Recent advances in factors that alter lipid metabolism in chronic renal failure.
Vascular Diseases
[Determination of total plasma lipoprotein lipase in patients with vascular diseases and hyperlipemia]
Vascular Diseases
[Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases]
Vascular Diseases
[Studies on neutral fat, lipoproteins and lipoprotein lipase in relation to vascular disease in young Indian diabetics]
Venous Thromboembolism
Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
Venous Thrombosis
Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis.
Venous Thrombosis
[Effects of a natural mucopolysaccharide-fibrinolytic complex on venous thrombosis and on the clearing factor]
Virus Diseases
Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins.
Vitamin E Deficiency
Dietary vitamin E deficiency inhibits fat metabolism, antioxidant capacity, and immune regulation of inflammatory response in genetically improved farmed tilapia (GIFT, Oreochromis niloticus) fingerlings following Streptococcus iniae infection.
von Hippel-Lindau Disease
Peripheral genotype-phenotype correlations in Asian Indians with type 2 diabetes mellitus.
Whooping Cough
Tumor necrosis factor-mediated biological activities involve a G-protein-dependent mechanism.
Xanthomatosis
A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
Xanthomatosis
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency.
Xanthomatosis
ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy.
Xanthomatosis
C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature.
Xanthomatosis
Lipoprotein lipase deficiency: clinical, biochemical and molecular characteristics in three patients with novel mutations in the LPL gene.
Xanthomatosis
Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan.
Xanthomatosis
[Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene]
Xanthomatosis
[Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
additional information
additional information
-
Km-values of the chimeric molecule between human lipoprotein lipase and rat hepatic lipase
-
additional information
additional information
Michaelis-Menten kinetics
-
additional information
additional information
initial rates and kinetics for complete hydrolysis of plasma lipids in postheparin plasma
-
additional information
additional information
-
initial rates and kinetics for complete hydrolysis of plasma lipids in postheparin plasma
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
0.5
3-[4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)biphenyl-3-yl]propanoic acid
Homo sapiens
pH and temperature not specified in the publication
0.02
4-ethylphenylboronic acid
Homo sapiens
pH and temperature not specified in the publication
0.0014
4-nonylphenylboronic acid
Homo sapiens
pH and temperature not specified in the publication
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
37
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pI VALUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ORGANISM
COMMENTARY
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
-
80840, 80845, 80846, 80847, 80887, 80888, 80890, 80894, 80899, 80909, 80912, 80913, 650369, 650738, 651409, 652186, 652428, 652702, 652707, 665343, 665649, 679124
-
-
brenda
-
681258, 682283, 690453, 690660, 692579, 692691, 693158, 693229, 693348, 693511, 693516, 693523, 693527
-
-
brenda
-
SwissProt
brenda
functional deficiency of enzyme in a patient with severe hypertriglyceridemia
-
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
SOURCE
-
decreased to 78% and 73% of baseline values 2 h and 4 h after glucose administration, respectively
brenda
-
GPIHBP1 shuttles lipoprotein lipase from subendothelial spaces to the capillary lumen
brenda
noncancer tissue. Lipoprotein lipase activity is higher in cancer tissue than in noncancer tissue. Lipoprotein lipase gene expression is higher in noncancer tissue compared to cancer tissue
brenda
-
in the mammary gland, synthesis of LpL is induced during late pregnancy and lactation
brenda
-
highest expression is found in white adipose tissue
brenda
additional information
-
patient with severe hypertriglyceridemia, post-heparin enzyme mass is almost normal, but the enzyme activity is remarkably decreased
brenda
-
LpL is present in the liver during fetal and early postnatal life, but is then suppressed by a putative transcriptional regulatory mechanism
brenda
noncancer tissue. Lipoprotein lipase activity is higher in cancer tissue than in noncancer tissue. Lipoprotein lipase gene expression is higher in noncancer tissue compared to cancer tissue
brenda
additional information
-
LpL mRNA is not detected in peritoneal macrophages or plasma white cells of transgenic mice
brenda
additional information
adipose tissue LPL activity is markedly higher than placental LPL activity. In pregnant women, adipose tissue LPL activity, which hydrolyzes triglycerides to free fatty acids for uptake into maternal fat, is not correlated with body weight or newborn adiposity
brenda
additional information
enzyme LPL is produced and secreted from parenchymal cells like adipocytes and myocytes for transport to the luminal side of the endothelium via interaction with the glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1 (GPIHBP1)
brenda
additional information
-
enzyme LPL is produced and secreted from parenchymal cells like adipocytes and myocytes for transport to the luminal side of the endothelium via interaction with the glycosylphosphatidylinositol-anchored high density lipoprotein binding protein 1 (GPIHBP1)
brenda
additional information
GPIHBP1 is the protein responsible for translocation of enzyme LPL to the capillary lumen
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY
GeneOntology No.
LITERATURE
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
malfunction
metabolism
-
the phosphoinositide-3-kinase pathway is involved in the regulation of LPL gene transcription through Sp1/Sp3, signalling pathways that impact on the IFN-mediated regulation of Sp1/Sp3 binding and LPL gene transcription in macrophages, overview. The synergism between IFN- and TNF- on LPL gene transcription is not mediated at the level of Sp1/Sp3 DNA binding
physiological function
additional information
malfunction
acute hypoxia strongly inhibits lipoprotein lipase activity in differentiated human preadipocytes and increases non-esterified fatty acid release, adversely affecting postprandial lipemia. In differentiated preadipocytes, acute hypoxia induces a 6fold reduction in lipoprotein lipase activity. Acute intermittent hypoxia increases circulating plasma non-esterified fatty acid in young healthy men, but does not seem to affect postprandial triglyceride levels, nor subcutaneous abdominal adipose tissue lipoprotein lipase activity and adipocyte lipolysis. The reduction in adipose tissue LPL activity appears to be explained by the upregulation of an important posttranslational repressor of LPL, angiopoietin-like protein 4 (ANGPTL4)
malfunction
lipoprotein lipase (LPL) is increased during the onset of remyelination, which is associated with an anti-inflammatory reparative microglial phenotype, and may facilitate the uptake of myelin-derived lipids in the CNS
physiological function
-
lipoprotein lipase serves a dual function as a triglyceride lipase of circulating chylomicrons and very-low-density lipoproteins and facilitates receptor-mediated lipoprotein uptake into heart, muscle and adipose tissue
physiological function
-
overexpression of human lipoprotein lipase in mouse mammary glands leads to reduction of milk triglyceride and delayed growth of suckling pups
physiological function
the up-regulation of enzyme activity may be beneficial in obesity and diabetes
physiological function
adipose tissue regulates postprandial lipid metabolism by storing dietary fat through lipoprotein lipase-mediated hydrolysis of exogenous triglycerides, and by inhibiting delivery of endogenous non-esterified fatty acid to nonadipose tissues. In humans, the rise in postprandial triglyceride levels does not differ between normoxia and intermittent hypoxia. Nonesterified fatty acid levels are higher during intermittent hypoxia session. Intermittent hypoxia does not affect subcutaneous abdominal adipose tissue lipoprotein lipase activity. No differences are observed in lipolytic responses of isolated subcutaneous abdominal adipocytes between normoxia and intermittent hypoxia sessions
physiological function
lipoprotein lipase (LPL) is a key enzyme in facilitating fatty acid uptake from lipoproteins. Very low-density lipoprotein-triglyceride (VLDL-TG) is a quantitative important substrate for lipid oxidation contributing with 10-20% to total energy expenditure, but only 3-6% during exercise despite an increase in total lipid oxidation. VLDL-TG storage is measured in adipose tissue biopsies. Exercise does not affect muscle LPL activity. No association is observed between muscle LPL activity and VLDL-TG oxidation, neither in the basal state nor during exercise. Exercise does not affect upper body or lower body adipose tissue LPL activity. The basal adipose tissue fractional VLDL-TG storage is not associated with upper body or lower body subcutaneous adipose tissue LPL activity. Muscle LPL activity does not predict VLDL-TG oxidation during rest or exercise. In addition, adipose tissue LPL activity is not associated with VLDL-TG storage
physiological function
lipoprotein lipase is a feature of alternatively-activated microglia and may facilitate lipid uptake in the CNS during demyelination. Lipoprotein lipase is involved in microglial lipid uptake. Lipoprotein lipase (LPL) is the rate-limiting enzyme in the hydrolysis of triglyceride-rich lipoproteins and is increased in Schwann cells and macrophages following nerve crush injury in the peripheral nervous system (PNS), suggesting that LPL may help scavenge myelin-derived lipids. Role of LPL in microglia, overview
physiological function
LPL is responsible for bridging the uptake of LDL and VLDL particles by the liver through an interaction mediated by the C-terminus of LPL. Angiopoietin-like protein 4 (ANGPTL4) and apolipoproteins regulate LPL, ANGPTL4 inhibits LPL by a noncompetitive mechanism
physiological function
placental lipoprotein lipase activity is positively associated with newborn adiposity. Placental lipoprotein lipase (pLPL) hydrolyzes triglycerides (TG), both dietary chylomicron TG (CM-TG) and very-low density lipoprotein TG (VLDL-TG), to free fatty acids (FFA). This may promote fetal fat accretion by increasing the available FFA pool for placental uptake. pLPL activity, but not maternal adipose tissue LPL activity, is associated with newborn adiposity and higher maternal TG. Placental LPL activity is positively correlated with birthweight and newborn percent body fat, but maternal adipose tissue LPL is not. Maternal TG and BMI are not correlated with pLPL. pLPL gene expression, while modestly correlated with enzymatic activity, is not correlated with newborn adiposity. Placental lipase regulation and the role of pLPL in pregnancies, overview
physiological function
the enzyme is the key enzyme responsible for intravascular triglyceride lipolysis. The acute alcohol consumption can induce hypertriglyceridemia, partly by influencing of lipoprotein lipase (LPL) through alcohol. LPL is the key enzyme responsible for triglyceride hydrolysis in circulation. The acute effects of alcohol consumption, especially on postprandial lipemia, seem to be accentuated in hypertriglyceridemic subjects
physiological function
the hydrolytic breakdown of plasma triglycerides by LPL at the capillary endothelium is a crucial event that contributes to control of the levels of triglycerides in plasma. LPL hydrolyzes triglycerides in plasma lipoproteins through a complex regulation mechanism
additional information
enzyme ligand interaction analysis by isothermal titration calorimetry (ITC) using human plasma as substrate. ITC can be used for quantitative measurements of LPL activity and interactions under in vivo-like conditions, for comparisons of the properties of plasma samples from patients and control subjects as substrates for LPL, as well as for testing of drug candidates, method evaluation, overview
additional information
-
enzyme ligand interaction analysis by isothermal titration calorimetry (ITC) using human plasma as substrate. ITC can be used for quantitative measurements of LPL activity and interactions under in vivo-like conditions, for comparisons of the properties of plasma samples from patients and control subjects as substrates for LPL, as well as for testing of drug candidates, method evaluation, overview
additional information
the enzyme interacts with glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) and lipoprotein receptor-related protein (LRP), enzyme ligand interaction analysis by surface plasmon resonance. Enzyme structure modeling
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable).
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). LIPL_HUMAN
475
0
53162
Swiss-Prot
Secretory Pathway (Reliability: 1)
A0A1B1RVA9_HUMAN
475
0
53162
TrEMBL
Secretory Pathway (Reliability: 1)
B3KRV7_HUMAN
461
0
51736
TrEMBL
Secretory Pathway (Reliability: 5)
Q6IAV0_HUMAN
475
0
53213
TrEMBL
Secretory Pathway (Reliability: 2)
A8K2M5_HUMAN
475
0
53195
TrEMBL
Secretory Pathway (Reliability: 2)
Q53HW6_HUMAN
475
0
53191
TrEMBL
Secretory Pathway (Reliability: 1)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PDB
SCOP
CATH
UNIPROT
ORGANISM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
55000
-
2 * 55000, dissociation of the dimer into monomers leads to irreversible loss of activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
dimer
homodimer
dissociation of the dimeric form to the monomeric form is associated with a conformational change of the molecule and irreversible loss of catalytic activity
dimer
-
2 * 55000, dissociation of the dimer into monomers leads to irreversible loss of activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
glycoprotein
side-chain modification
side-chain modification
-
8% carbohydrate, 2% mannose, 2% galactose, 3% glucosamine
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
C418Y
-
the mutation abolishes lipoprotein lipases's ability to bind to GPIHBP1 and therefore abolishes LPL transport across endothelial cells byGPIHBP1, without interfering with the enzyme catalytic activity or binding to heparin
D204E
-
homozygous missense mutation identified in a patient with severe hypertriglyceridemia, post-heparin enzyme mass is almost normal, but the enzyme activity is remarkably decreased. In presence of phosphatidylethenolamine, phospatidylserine, and cardiolipin as emulsifier, triolein-hydrolizing activity of the mutant is higher than wild-type activity
D9N
the mutation is associated with partial changes in enzyme function, plasma high density lipoprotein-C, triglyceride levels, and differential susceptibility to cardiovascular disease
E421K
-
the mutation abolishes lipoprotein lipases's ability to bind to GPIHBP1 and therefore abolishes LPL transport across endothelial cells byGPIHBP1, without interfering with the enzyme catalytic activity or binding to heparin
K430A/R432A/K434A/K440A/K441A
-
the mutant LPL has little or no ability to bind to GPIHBP1 on the surface of cells
N291S
the mutation is associated with partial changes in enzyme function, plasma high density lipoprotein-C, triglyceride levels, and differential susceptibility to cardiovascular disease
S447X
additional information
S447X
-
the mutation is associated with a higher risk for pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis
S447X
the mutation results in truncation of the last two amino acids of the mature LPL and is the only mutation reported to increase enzymatic activity, the mutation is associated with differential susceptibility to cardiovascular disease
S447X
site-directed mutagenesis, the mutant is inhibited by angiopoietin-like protein 4 in the same way as the wild-type enzyme
additional information
-
chimeric molecule between human lipoprotein lipase and rat hepatic lipase
additional information
-
nonsense mutation Gln106Stop, missense mutations: Gly142Glu, Ala176Thr, Gly188Glu, Ile194Thr, Pro207Leu and Arg243His
additional information
-
chimeric lipase constructed of the N-terminal 329 residues of rat hepatic lipase linked to the C-terminal 136 residues of human lipoprotein lipase. The chimera hydrolyzes both monodisperse short-chain (esterase) and emulsified long-chain (lipase) triacylglycerol substrates with catalytic and kinetic properties closely resembling those of native lipase
additional information
-
chimeric lipase consisting of the amino-terminal 314 amino acids of human lipoprotein lipase and the carboxyl-terminal 146 amino acids of human hepatic lipase. The chimeric enzyme hydrolyzes both long chain and short chain fatty acid triacylglycerols and has catalytic properties that are similar to lipoprotein lipase
additional information
-
exchanging lids between lipoprotein lipase and endothelial lipase only partially shifts the substrate specificity of the enzymes. Studies of a double chimera possessing both the lid and the C-terminal domain (C-domain) of endothelial lipase in the lipoprotein lipase backbone showed that the role of the lid in determining substrate specificity does not depend on the nature of the C-domain of the lipase
additional information
-
two LPL intronic variants may be associated with development of the hypertension endophenotype with elevated plasma triglycerid level (cSNPs g.7663364C4A in exon 8 and g.7664652C4G in exon 9)
additional information
construction of the lipoprotein lipase truncation variant, LPLS447X, the truncation leads to increased lipoprotein uptake of the cells, gain-of-function phenotype in vivo. Mutant LPLS447X enhances lipoprotein uptake to a greater degree than wild-type LPL does
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
recombinant wild-type and mutant enzymes by heparin affinity chromatography
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
chimeric lipase consisting of the amino-terminal 314 amino acids of human lipoprotein lipase and the carboxyl-terminal 146 amino acids of human hepatic lipase
-
expression in rabbit inhibits diet-induced hypercholesterolemia and atherosclerosis
-
expression in Sf21 insect cells, coexpression with calreticulin enhances yield of active LPL by a factor 9
-
fusion protein consisting of the complete lipoprotein lipase molecule and the mature form of apolipoprotein CII, expression in human embryonic kidney 293 cells
-
LPL overexpression in Mus musculus skeletal muscle increases cold tolerance by enhancing capacity for fat oxidation, producing an avian-like phenotype in which skeletal muscle contributes significantly to the thermogenic response to cold temperatures
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
interferon mediates inhibition of lipoprotein lipase gene transcription in macrophages, the mechanism involves a reduction in the binding of transcription factors Sp1 and Sp3 to regulatory sequences in the LPL gene with casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
APPLICATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
medicine
medicine
-
comparison of protein and mRNA levels of enzyme and several muscle lipid-binding proteins in healthy, nonobese, nontrained, moderately trained, and endurance-trained women and men. In the nontrained state, women have higher muscle RNA levels of several proteins related to lipid metabolism compared with men. In the endurance-trained state, only the gender difference in lipoprotein lipase mRNA persists
medicine
-
determination of enzyme and of hepatic triacylglycerol lipase activity and comparison with serum adiponectin levels in Japanese hyperlipidemic men. Co-linearity between insulin sensitivity and adiponectin as well as insulin sensitivity and enzyme/hepatic triacylglycerol lipase activity
medicine
-
enzyme significantly suppresses TNF-alpha-induced gene expression, and this suppression is reversed by tetrahydrolipstatin and heparinase. In contrast, enzyme synergistically enhances IFN-gamma-induced gene expression
medicine
-
expression of enzyme in transgenic rabbit, no significant difference in plasma glucose clearance rate between transgenic and control animals. Transgenic animals show reduced plasma levels for free fatty acids and glucose and increased postheparin plasma enzyme activity
medicine
-
measurement of enzyme activity using intravenous fat tolerance test before and after oral administration of glucose. Enzyme activity decreases to 78% and 73% of control levels 2 and 4 h after glucose administration, resp. Use of intravenous fat tolerance test for studying acute changes in enzyme activity
medicine
-
the intravenous fat tolerance test is a promising approach for studying acute changes in LPL activity in circulation
medicine
-
excess vascular wall LpL augments vascular dysfunction in the setting of inflammation
medicine
LPL mutations represent a risk factor which contributes to the development of cardiovascular disease
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Augustin, J.; Freeze, H.; Tejada, P.; Brown, W.V.
A comparison of molecular properties of hepatic triglyceride lipase and lipoprotein lipase from human post-heparin plasma
J. Biol. Chem.
253
2912-2920
1978
Homo sapiens
brenda
Davis, R.C.; Wong, H.; Nikazy, J.; Wang, K.; Han, Q.; Schotz, M.C.
Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties
J. Biol. Chem.
267
21499-21504
1992
Homo sapiens
brenda
Dichek, H.L.; Parrott, C.; Ronan, R.; Brunzell, J.D.; Brewer, H.B.; Santamarina-Fojo, S.
Functional characterization of a chimeric lipase genetically engineered from human lipoprotein lipase and human hepatic lipase
J. Lipid Res.
34
1393-1401
1993
Homo sapiens
brenda
Wong, H.; Davis, R.C.; Nikazy, J.; Seebart, K.E.; Schotz, M.C.
Domain exchange: characterization of a chimeric lipase of hepatic lipase and lipoprotein lipase
Proc. Natl. Acad. Sci. USA
88
11290-11294
1991
Homo sapiens
brenda
Iverius, P.H.; stlund-Lindqvist, A.M.
Preparation, characterization, and measurement of lipoprotein lipase
Methods Enzymol.
129
691-704
1986
Bos taurus, Homo sapiens, Rattus norvegicus
brenda
Hayashi, R.; Tajima, S.; Yamamoto, A.
Purification and characterization of lipoprotein lipase from human postheparin plasma and its comparison with purified bovine milk lipoprotein lipase
J. Biochem.
100
319-331
1986
Bos taurus, Homo sapiens
brenda
Bengtsson-Olivecrona, G.; Olivecrona, T.; Jrnvall, H.
Lipoprotein lipases from cow, guinea-pig and man. Structural characterization and identification of protease-sensitive internal regions
Eur. J. Biochem.
161
281-288
1986
Bos taurus, Cavia porcellus, Homo sapiens
brenda
Cheng, C.F.; Bensadoun, A.; Bersot, T.; Hsu, J.S.; Melford, K.H.
Purification and characterization of human lipoprotein lipase and hepatic triglyceride lipase. Reactivity with monoclonal antibodies to hepatic triglyceride lipase
J. Biol. Chem.
260
10720-10727
1985
Homo sapiens
brenda
Becht, I.; Schrecker, O.; Klose, G.; Greten, H.
Purification of human plasma lipoprotein lipase
Biochim. Biophys. Acta
620
583-591
1980
Homo sapiens
brenda
Hoffmann, M.H.; Stoffel, W.
Construction and functional characterization of recombinant fusion proteins of human lipoprotein lipase and apolipoprotein CII
Eur. J. Biochem.
237
545-552
1996
Homo sapiens
brenda
Wang, C.S.; Hartsuck, J.; McConathy, J.
Structure and functional properties of lipoprotein lipase
Biochim. Biophys. Acta
1123
1-17
1992
Bos taurus, Cavia porcellus, Gallus gallus, Homo sapiens, Mus musculus
brenda
Goldberg, I.J.; Blaner, W.S.; Goodman, D.S.
Immunologic and enzymatic comparisons between human and bovine lipoprotein lipase
Arch. Biochem. Biophys.
244
580-584
1986
Bos taurus, Homo sapiens
brenda
Kidani, T.; Sakayama, K.; Masuno, H.; Takubo, N.; Matsuda, Y.; Okuda, H.; Yamamoto, H.
Active-dimeric form of lipoprotein lipase increases in the adipose tissue of patients with rheumatoid arthritis treated with prednisolone
Biochim. Biophys. Acta
1584
31-36
2002
Homo sapiens
brenda
Esenabhalu, V.E.; Cerimagic, M.; Malli, R.; Osibow, K.; Levak-Frank, S.; Frieden, M.; Sattler, W.; Kostner, G.M.; Zechner, R.; Graier, W.F.
Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice
Br. J. Pharmacol.
135
143-154
2002
Homo sapiens
brenda
Lindberg, A.; Olivecrona, G.
Lipoprotein lipase from rainbow trout differs in several respects from the enzyme in mammals
Gene
292
213-223
2002
Bos taurus, Homo sapiens, Oncorhynchus mykiss (Q9W6Y2), Oncorhynchus mykiss
brenda
Fan, J.; Unoki, H.; Kojima, N.; Sun, H.; Shimoyamada, H.; Deng, H.; Okazaki, M.; Shikama, H.; Yamada, N.; Watanabe, T.
Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis
J. Biol. Chem.
276
40071-40079
2001
Homo sapiens
brenda
Zhang, L.; Wu, G.; Tate, C.G.; Lookene, A.; Olivecrona, G.
Calreticulin promotes folding/dimerization of human lipoprotein lipase expressed in insect cells (sf21)
J. Biol. Chem.
278
29344-29351
2003
Homo sapiens
brenda
Keiper, T.; Schneider, J.G.; Dugi, K.A.
Novel site in lipoprotein lipase (LPL415-438) essential for substrate interaction and dimer stability
J. Lipid Res.
42
1180-1186
2001
Homo sapiens
brenda
McCoy, M.G.; Sun, G.S.; Marchadier, D.; Maugeais, C.; Glick, J.M.; Rader, D.J.
Characterization of the lipolytic activity of endothelial lipase
J. Lipid Res.
43
921-929
2002
Homo sapiens
brenda
Murano, T.; Sako, T.; Oikawa, S.; Shirai, K.
The recovery of dysfunctional lipoprotein lipase (Asp204-Glu) activity by modification of substrate
Atherosclerosis
183
101-107
2005
Homo sapiens
brenda
Kobayashi, J.; Kusunoki, M.; Murase, Y.; Kawashiri, M.; Higashikata, T.; Miwa, K.; Katsuda, S.; Takata, M.; Asano, A.; Nohara, A.; Inazu, A.; Mabuchi, H.
Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men
Horm. Metab. Res.
37
505-509
2005
Homo sapiens
brenda
Kiens, B.; Roepstorff, C.; Glatz, J.F.; Bonen, A.; Schjerling, P.; Knudsen, J.; Nielsen, J.N.
Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender
J. Appl. Physiol.
97
1209-1218
2004
Homo sapiens
brenda
Kota, R.S.; Ramana, C.V.; Tenorio, F.A.; Enelow, R.I.; Rutledge, J.C.
Differential effects of lipoprotein lipase on tumor necrosis factor-alpha and interferon-gamma-mediated gene expression in human endothelial cells
J. Biol. Chem.
280
31076-31084
2005
Homo sapiens
brenda
Liu, E.; Kitajima, S.; Higaki, Y.; Morimoto, M.; Sun, H.; Watanabe, T.; Yamada, N.; Fan, J.
High lipoprotein lipase activity increases insulin sensitivity in transgenic rabbits
Metabolism
54
132-138
2005
Homo sapiens
brenda
Jindrichova, E.; Kratochvilova, S.; Kovar, J.
Glucose administration downregulates lipoprotein lipase activity in vivo. A study using repeated intravenous fat tolerance test
Physiol. Res.
0
1-19
2006
Homo sapiens
brenda
Andreo, U.; Maillard, P.; Kalinina, O.; Walic, M.; Meurs, E.; Martinot, M.; Marcellin, P.; Budkowska, A.
Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection
Cell. Microbiol.
9
2445-2456
2007
Homo sapiens, Bos taurus (P11151)
brenda
Cerne, D.; Melkic, E.; Trost, Z.; Sok, M.; Marc, J.
Lipoprotein lipase activity and gene expression in lung cancer and in adjacent noncancer lung tissue
Exp. Lung Res.
33
217-225
2007
Homo sapiens (P06858), Homo sapiens
brenda
Griffon, N.; Budreck, E.C.; Long, C.J.; Broedl, U.C.; Marchadier, D.H.; Glick, J.M.; Rader, D.J.
Substrate specificity of lipoprotein lipase and endothelial lipase: studies of lid chimeras
J. Lipid Res.
47
1803-1811
2006
Homo sapiens
brenda
Jindrichova, E.; Kratochvilova, S.; Kovar, J.
Glucose administration downregulates lipoprotein lipase activity in vivo: a study using repeated intravenous fat tolerance test
Physiol. Res.
56
175-181
2007
Homo sapiens
brenda
Sakayama, K.; Kidani, T.; Tanji, N.; Yamamoto, H.; Masuno, H.
The synthesis and activity of lipoprotein lipase in the subcutaneous adipose tissue of patients with musculoskeletal sarcomas
Anticancer Res.
28
2081-2086
2008
Homo sapiens
brenda
Takahashi, M.; Hiyama, Y.; Yokoyama, M.; Yu, S.; Hu, Y.; Melford, K.; Bensadoun, A.; Goldberg, I.J.
In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation
Arterioscler. Thromb. Vasc. Biol.
28
455-462
2008
Homo sapiens
brenda
Chen, P.; Jou, Y.S.; Fann, C.S.; Chen, J.W.; Chung, C.M.; Lin, C.Y.; Wu, S.Y.; Kang, M.J.; Chen, Y.C.; Jong, Y.S.; Lo, H.M.; Kang, C.S.; Chen, C.C.; Chang, H.C.; Huang, N.K.; Wu, Y.L.; Pan, W.H.
Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides
Hum. Mutat.
30
49-55
2009
Homo sapiens
brenda
Tory, R.; Sachs-Barrable, K.; Hill, J.S.; Wasan, K.M.
Cyclosporine A and rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma
Int. J. Pharm.
358
219-223
2008
Homo sapiens
brenda
Gin, P.; Yin, L.; Davies, B.S.; Weinstein, M.M.; Ryan, R.O.; Bensadoun, A.; Fong, L.G.; Young, S.G.; Beigneux, A.P.
The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons
J. Biol. Chem.
283
29554-29562
2008
Homo sapiens
brenda
Shan, L.; Yu, X.C.; Liu, Z.; Hu, Y.; Sturgis, L.T.; Miranda, M.L.; Liu, Q.
The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms
J. Biol. Chem.
284
1419-1424
2009
Homo sapiens
brenda
Chang, Y.T.; Chang, M.C.; Su, T.C.; Liang, P.C.; Su, Y.N.; Kuo, C.H.; Wei, S.C.; Wong, J.M.
Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis
J. Clin. Gastroenterol.
43
591-596
2009
Homo sapiens
brenda
Imamura, S.; Kobayashi, J.; Nakajima, K.; Sakasegawa, S.; Nohara, A.; Noguchi, T.; Kawashiri, M.A.; Inazu, A.; Deeb, S.S.; Mabuchi, H.; Brunzell, J.D.
A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma
J. Lipid Res.
49
1431-1437
2008
Homo sapiens
brenda
Maingrette, F.; Li, L.; Renier, G.
C-reactive protein enhances macrophage lipoprotein lipase expression
J. Lipid Res.
49
1926-1935
2008
Homo sapiens
brenda
Jensen, D.R.; Knaub, L.A.; Konhilas, J.P.; Leinwand, L.A.; MacLean, P.S.; Eckel, R.H.
Increased thermoregulation in cold-exposed transgenic mice overexpressing lipoprotein lipase in skeletal muscle: an avian phenotype?
J. Lipid Res.
49
870-879
2008
Homo sapiens
brenda
Goldberg, I.G.; Eckel, R.H.; Abumrad, N.A.
Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways
J. Lipid Res.
50
S86-S90
2009
Homo sapiens
brenda
Glisic, S.; Arrigo, P.; Alavantic, D.; Perovic, V.; Prljic, J.; Veljkovic, N.
Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease
Proteins Struct. Funct. Bioinform.
70
855-862
2008
Homo sapiens (P06858)
brenda
Harris, S.M.; Harvey, E.J.; Hughes, T.R.; Ramji, D.P.
The interferon- -mediated inhibition of lipoprotein lipase gene transcription in macrophages involves casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3
Cell. Signal.
20
2296-2301
2008
Homo sapiens, Mus musculus
brenda
Holmes, R.S.; Vandeberg, J.L.; Cox, L.A.
Comparative studies of vertebrate lipoprotein lipase: a key enzyme of very low density lipoprotein metabolism
Comp. Biochem. Physiol. D
6
224-234
2011
Homo sapiens
brenda
Nielsen, J.; Lindegaard, M.; Friis-Hansen, L.; Almstrup, K.; Leffers, H.; Nielsen, L.; Rajpert-De Meyts, E.
Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms
Int. J. Androl.
33
e207-e215
2010
Homo sapiens
brenda
Wang, Y.; Tong, J.; Li, S.; Zhang, R.; Chen, L.; Wang, Y.; Zheng, M.; Wang, M.; Liu, G.; Dai, Y.; Zhao, Y.; Li, N.
Over-expression of human lipoprotein lipase in mouse mammary glands leads to reduction of milk triglyceride and delayed growth of suckling pups
PLoS ONE
6
e20895
2011
Homo sapiens
brenda
Voss, C.V.; Davies, B.S.; Tat, S.; Gin, P.; Fong, L.G.; Pelletier, C.; Mottler, C.D.; Bensadoun, A.; Beigneux, A.P.; Young, S.G.
Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1
Proc. Natl. Acad. Sci. USA
108
7980-7984
2011
Homo sapiens
brenda
Badia-Villanueva, M.; Carulla, P.; Carrascal, M.; Abian, J.; Llobera, M.; Casanovas, A.; Dolores Lopez-Tejero, M.
Lipoprotein lipase isoelectric point isoforms in humans
Biochem. Biophys. Res. Commun.
445
480-485
2014
Homo sapiens
brenda
Wang, Z.; Li, S.; Sun, L.; Fan, J.; Liu, Z.
Comparative analyses of lipoprotein lipase, hepatic lipase, and endothelial lipase, and their binding properties with known inhibitors
PLoS ONE
8
e72146
2013
Homo sapiens (P06858)
brenda
Hayne, C.K.; Lafferty, M.J.; Eglinger, B.J.; Kane, J.P.; Neher, S.B.
Biochemical analysis of the lipoprotein lipase truncation variant, LPLS447X, reveals increased lipoprotein uptake
Biochemistry
56
525-533
2017
Homo sapiens (P06858)
brenda
Bruce, K.D.; Gorkhali, S.; Given, K.; Coates, A.M.; Boyle, K.E.; Macklin, W.B.; Eckel, R.H.
Lipoprotein lipase is a feature of alternatively-activated microglia and may facilitate lipid uptake in the CNS during demyelination
Front. Mol. Neurosci.
11
57
2018
Homo sapiens (P06858), Homo sapiens, Mus musculus (P11152), Mus musculus C57BL/6J (P11152)
brenda
Reimund, M.; Kovrov, O.; Olivecrona, G.; Lookene, A.
Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry
J. Lipid Res.
58
279-288
2017
Homo sapiens (P06858), Homo sapiens
brenda
Mahat, B.; Chasse, E.; Mauger, J.F.; Imbeault, P.
Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis
J. Transl. Med.
14
212
2016
Homo sapiens (P06858), Homo sapiens
brenda
Zemankova, K.; Makoveichuk, E.; Vlasakova, Z.; Olivecrona, G.; Kovar, J.
Acute alcohol consumption downregulates lipoprotein lipase activity in vivo
Metab. Clin. Exp.
64
1592-1596
2015
Homo sapiens (P06858)
brenda
Heerwagen, M.J.R.; Gumina, D.L.; Hernandez, T.L.; Van Pelt, R.E.; Kramer, A.W.; Janssen, R.C.; Jensen, D.R.; Powell, T.L.; Friedman, J.E.; Winn, V.D.; Barbour, L.A.
Placental lipoprotein lipase activity is positively associated with newborn adiposity
Placenta
64
53-60
2018
Homo sapiens (P06858)
brenda
Soendergaard, E.; Andersen, I.R.; Soerensen, L.P.; Gormsen, L.C.; Nielsen, S.
Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise
Scand. J. Med. Sci. Sports
27
474-481
2017
Homo sapiens (P06858), Homo sapiens
brenda
EXTERNAL LINKS (specific for EC-Number 3.1.1.34)
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
About BRENDA
Social media
Help
Survey
Download
Contribution
Legal
Curated at
Member of
